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Abstract 
 
Insomnia is one of the most common complaints in medical practice and the sleep disorder 
of highest prevalence. At least 10% of the worldwide population has chronic insomnia, 
which has been associated with a range of negative health outcomes. Within the clinical 
setting, patient subtypes have been defined according to symptomology. More recently 
insomnia researchers have proposed phenotypes based on total sleep time during overnight 
polysomnography (PSG). Short-sleeping insomnia patients are purported to be a biologically 
severe phenotype at higher risk of cardiovascular morbidity, poor mental health, and 
obesity (compared to healthy controls). Heart rate variability (HRV) is an objective marker 
that provides insight into autonomic nervous system dynamics. The overarching aim of my 
research was to explore a large clinical sample of patients with Insomnia Disorder to 
determine whether differences in HRV exist during sleep in empirically-derived insomnia 
patient subtypes. 
The aim of the work presented within Chapter 2 was to identify all previous insomnia-HRV 
research to determine if HRV was impaired in adult patients with insomnia, and whether 
treatments altered HRV. A systematic review of five web databases located 22 relevant 
articles; 17 case-control studies and 5 interventions studies. Results were difficult to 
synthesise due to incomparable methodology and reporting. There was a high risk of bias in 
the majority of studies. It was concluded that although HRV impairment in insomnia may be 
a widely-accepted concept, it is not supported by research nor has it been determined if it 
varies after treatment or according to patient subtype. 
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The aim of the first empirical study of the thesis (Chapter 3) was to objectively-derive 
insomnia patient subtypes and evaluate their physiological signals (HRV and 
electroencephalography [EEG]) during sleep onset. Patients (n = 96) with clinically-
diagnosed Insomnia Disorder underwent overnight PSG to determine sleep metrics for 
cluster analysis using Ward’s method: Total Sleep Time (TST), Wake After Sleep Onset 
(WASO) and Sleep Onset Latency (SOL). Electrocardiogram (ECG) from the PSG was 
extracted in the 10 minutes before and after sleep onset. After R-wave detection, the ECG 
was visually checked and manually corrected as required. Six time and frequency-domain 
HRV measures were analyzed; heart rate (HR), standard deviation of all N-N intervals 
(SDNN), root mean square of successive R-R intervals (RMSSD), percentage of successive R-R 
intervals that differ by > 50 ms (PNN50), high frequency (HF), and low frequency (LF)/HF 
ratio. Cluster analysis derived two solutions; one comprising two subtypes and another with 
three subtypes. The two cluster solution consisted of insomnia with short-sleep duration (I-
SSD: n = 43) and insomnia with normal objective sleep duration (I-NSD: n = 53). At sleep 
onset, between-group HRV analysis revealed reduced parasympathetic activity (PNN50 and 
RMSSD) in the short-sleeping subtype. This was not mirrored by significant increases in HR 
and/or the LF/HF ratio. These findings suggested that reduced parasympathetic activity 
during sleep onset might contribute to poor cardiometabolic health outcomes previously 
reported in short-sleeping insomnia patients.  
The final component of this thesis was a case-control study (Chapter 4) which examined 
whether HRV measures differed between insomnia subtypes across the nocturnal period. It 
was hypothesized that short-sleeping insomnia patients would have impaired HRV 
compared to normal-sleep duration insomnia patients, consistent with differences observed 
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at sleep onset (Chapter 3). Insomnia patients underwent overnight PSG, which provided 
sleep metrics for cluster analysis and ECG for HRV analysis. ECG was visually checked for 
accurate R-wave detection, and manually corrected as required. HRV analysis was 
performed from lights-off to lights-on (and separately by sleep/wake stage) using time and 
frequency-domain measures. Differences in HRV measures (HR, SDNN, RMSSD, LF, HF, 
LF/HF) were tested between the subtypes using General Linear Models controlling for age as 
a core confounder. Short-sleeping insomnia patients (I-SSD: n = 34; 45.5 ± 10.5 years) and 
normal-sleep duration insomnia patients (I-NSD: n = 41; 37.6 ± 10.9 years) were included in 
the HRV analysis. There were no statistically significant nocturnal HRV differences between 
subtypes after controlling for age. As such, short-sleeping insomnia patients did not have 
statistically significant reductions in HRV measures representative of parasympathetic 
activity. 
In summary, there was a lack of persistent nocturnal HRV disparities (between empirically-
derived insomnia patient subtypes) that extended beyond sleep onset in this large clinical 
sample of patients with Insomnia Disorder. The central tenet of 24-hour hyperarousal 
amongst short-sleep duration insomnia patients cannot be supported by the combined 
findings of these two empirical studies. Post-hoc calculations revealed larger sample sizes 
would be required to determine a small to medium effect size difference in nocturnal HRV 
between insomnia patient subtypes. Until this time, the directional relationship between 
insomnia, heart rate variability, hyperarousal and cardiovascular disease remains unclear in 
the heterogeneous insomnia population. 
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Chapter 1: Introduction 
 
Insomnia Disorder is the most prominent sleep disorder with a worldwide 
prevalence estimate of 10% (Morin et al., 2015; Ohayon, 2002; Ohayon & Reynolds, 2009). 
Higher prevalence rates are evident with increasing age and also amongst females, who are 
affected two times more than their male counterparts (Morin et al., 2015; Ohayon, 2002).  
When chronic, median duration is three years (Morin et al., 2015). It is difficult to report the 
precise prevalence of Insomnia Disorder in Australia. Over the past 35 years there have 
been only five Australian prevalence studies, between them using four different definitions 
of insomnia. A brief overview of Australian studies is presented in Table 1. 
Table 1. Insomnia in Australia   
Prevalence 
estimate (%) 
Reference n 
Year 
sampled 
Location Details 
6 Wilson and Lack (1983) 100 
 
NR 
 
SA 
Telephone survey : 
- ‘self-described 
insomniac?’ 
5 
‘insomniac’ 
13 
‘sleeping 
difficulties’ 
Lack, Miller, and Turner 
(1988) 
216 
 
NR 
 
SA 
Telephone survey : 
- ‘self-described 
insomniac?’ 
- ‘often experience 
sleeping difficulties?’ 
33 
Bartlett, Marshall, Williams, 
and Grunstein (2008) 
3400 
 
NR 
 
NSW 
Telephone survey, using 
Athens Insomnia Scale 
(AIS) and question, 
‘difficulties falling asleep 
or staying asleep or a 
combination of both?’ 
4 
Knox, Harrison, Britt, and 
Henderson (2008) 
9156 2005 National 
Family-physician survey, 
patients that report 
insomnia syndrome as 
per ICD-10 
6 
Bin, Marshall, and Glozier 
(2012) 
8841 2007 National 
General household 
survey, including question 
on ‘sleeping only in short 
bursts and being awake 
most of the night?’ 
Note. ICD-10 = International Classification of Mental and Behavioural Disorders from the International 
Classification of Diseases, Tenth Revision; n = number sampled; National = Australia-wide; NR = Not Reported; 
NSW = New South Wales, Australia; SA = South Australia, Australia. 
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Several classifications exist for the clinical diagnosis of Insomnia Disorder (American 
Academy of Sleep Medicine, 2005; American Psychiatric Association, 2013; World Health 
Organization, 1993). According to the Diagnostic and Statistical Manual of Mental Disorders, 
fifth edition (DSM-5), Insomnia Disorder occurs when poor sleep at night results in daytime 
impairment and distress (American Psychiatric Association, 2013). Criteria also require the 
patient to report difficulty with sleep onset, and/or sleep maintenance, and/or early 
morning awakening at least three nights per week for three months or more, despite 
sufficient sleep opportunity (American Psychiatric Association, 2013). 
Insomnia Disorder places a significant burden on primary health care (Charles, 
Harrison, & Britt, 2009; Morin et al., 2015). It is the sleep disorder most commonly seen by 
Australian family-physicians with 1.7 million encounters per year, 95% of which are 
managed using pharmacotherapy (Charles et al., 2009). Beyond primary health care and 
pharmaceuticals, Insomnia Disorder is known to have considerable, yet somewhat 
immeasurable, indirect costs from occupational (absenteeism/presenteeism), health 
(medical/psychological morbidity), and safety (accidents/injury) sequelae (Daley, Morin, 
LeBlanc, Grégoire, & Savard, 2009; Daley, Morin, LeBlanc, Grégoire, Savard, et al., 2009; 
Deloitte Access Economics, 2011; Léger & Bayon, 2010; Sivertsen, Øverland, Bjorvatn, 
Mæland, & Mykletun, 2009; Vgontzas, Fernandez-Mendoza, Liao, & Bixler, 2013). 
Whilst the impact of Insomnia Disorder is well-recognised, the precise aetiology 
remains uncertain. Early mechanistic models were based upon psychological paradigms 
reflecting insomnia as a subjective complaint of sleep loss. The ‘Stimulus Control Model’ 
suggested by Bootzin in 1972 is centred around the premise of faulty conditioning with 
maladaptive sleep-wake processes (Bootzin, 1973). The development of chronic insomnia 
can be explained by Spielman’s ‘Three P Model’ (Spielman, Caruso, & Glovinsky, 1987). This 
diathesis-stress theory delineates predisposing, precipitating, and perpetuating factors of 
classic psychophysiological insomnia (American Academy of Sleep Medicine, 2001). From a 
psychobiological perspective, a number of proposals exist including the ‘Neurocognitive 
Model’ (Perlis, Giles, Mendelson, Bootzin, & Wyatt, 1997); the ‘Psychobiological Model’ 
(Espie, 2002; Espie, Broomfield, MacMahon, Macphee, & Taylor, 2006); and the 
‘Neurobiological Model’ (Buysse, Germain, Hall, Monk, & Nofzinger, 2011). Taken together, 
these connect subjectively-reported insomnia to the presence of physiological disruption via 
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a synergistic cognitive, cortical, and somatic hyperarousal (Bonnet & Arand, 1997; Bonnet & 
Arand, 2010a, 2010b; Perlis, Gehrman, Pigeon, Findley, & Drummond, 2009; Riemann, 2010; 
Riemann et al., 2010).  
A wide range of objective, physiological measures have been used to support the 
notion of chronic insomnia as a disorder of 24-hour hyperarousal including, but not limited 
to, nocturnal and daytime electroencephalography (Edinger, Means, & Krystal, 2013; 
Freedman, 1986; Freedman & Sattler, 1982), quantitative electroencephalography (Hall et 
al., 2007), temperature and skin resistance (Monroe, 1967), hormones (including cortisol, 
ACTH, and catecholamines) (Bonnet & Arand, 1995; Irwin, Clark, Kennedy, Christian Gillin, & 
Ziegler, 2003), blood pressure (Fernandez-Mendoza et al., 2012; Li et al., 2015), heart rate 
(HR), and heart rate variability (HRV) (Bonnet & Arand, 1998; Monroe, 1967; Vgontzas & 
Fernandez-Mendoza, 2013) (see Figure 1).  
 
 
Figure 1. Schematic of systemic physiological hyperarousal. EEG = electroencephalogram. Reprinted from 
Morin, C. M., Drake, C. L., Harvey, A. G., Krystal, A. D., Manber, R., Riemann, D., & Spiegelhalder, K. (2015). 
Insomnia disorder. Nature Reviews Disease Primers, 15026. doi: 10.1038/nrdp.2015.26.  
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Heart rate variability is a common, non-invasive tool for assessing autonomic activity 
(Malik, 1998). It has been shown to be a predictor of cardiovascular mortality (Kleiger, 
Miller, Bigger, & Moss, 1987; Kleiger, Stein, & Bigger, 2005), but the connection between 
HRV impairment and cardiac disease aetiology is yet to be clarified. Nonetheless, HRV has 
been used broadly in clinical research and specifically as a measure of hyperarousal in a 
number of insomnia case-control studies (Bonnet & Arand, 1998; Jiang et al., 2015; 
Spiegelhalder et al., 2011). Although insomnia has been posited as a modifiable 
cardiovascular risk factor, a direct relationship between insomnia and the pathophysiology 
of cardiovascular disease has not been established (Grandner et al., 2016; Hertenstein, 
Johann, Baglioni, Spiegelhalder, & Riemann, 2016; Redline & Foody, 2011; Spiegelhalder, 
Scholtes, & Riemann, 2010; Strand et al., 2012).  
Certain subtypes of the heterogeneous insomnia population may have varied 
aetiologies and reflect different pathophysiologies. The delineation of insomnia patient 
subtypes is not an entirely novel paradigm. Long-recognised patient groupings include those 
based on various diagnostic-criteria subtypes, the timing of symptoms (e.g. sleep onset 
insomnia vs sleep maintenance insomnia), the presence of comorbid sleep (or other health) 
disorders, and/or duration of symptoms (e.g. acute vs chronic) (Edinger et al., 2004; Edinger 
et al., 1996). However, the few studies that have investigated the validity of these subtypes 
have found them to have somewhat unsatisfactory when compared using quantitative 
measures and/or empirically derived patient subtypes (Edinger et al., 1996; Pillai, Roth, & 
Drake, 2015).   
Previous associations have been reported between short-sleep duration and poor 
health outcomes (including obesity, diabetes, cardiovascular morbidity, mortality) although 
participants of these studies were not pre-screened insomnia patients (Ayas et al., 2003; 
Gangwisch, Feskanich, Malaspina, Shen, & Forman, 2013; Kjeldsen et al., 2014; Tamakoshi & 
Ohno, 2004). The concept of short-sleep insomnia was introduced in 2009 by the Vgontzas 
research group after findings from the Penn State Cohort showed a positive association 
between objectively-derived sleep duration (of less than six hours) and hypertension 
(Vgontzas, Liao, Bixler, Chrousos, & Vela-Bueno, 2009). In 2010, they reported objectively-
derived short-sleep insomnia patients) had higher risk of mortality and in 2012, incident 
hypertension (Fernandez-Mendoza et al., 2012; Vgontzas et al., 2010). This group continues 
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to advocate that insomnia patients with short-sleep duration have greater cognitive and 
physiological hyperarousal and activation of the stress systems (hypothalamic-pituitary 
adrenal and sympathetic-adrenal medulla axes) compared to their relatively longer-sleep 
duration insomnia counterparts who were more likely to have psychological-originated 
insomnia and less risk of medical sequelae (Vgontzas et al., 2013) (see Figure 2). 
 
 
Figure 2. Model of insomnia phenotypes, incorporating pathophysiological mechanisms and clinical sequelae. 
Reprinted from Vgontzas, A. N., Fernandez-Mendoza, J., Liao, D., & Bixler, E. (2013). Insomnia with objective 
short sleep duration: The most biologically severe phenotype of the disorder. Sleep Med Rev, 17(4), 241-254. 
doi:10.1016/j.smrv.2012.09.005. 
 
Therefore, the primary aim of my research project was to explore a large clinical 
sample of patients with Insomnia Disorder to determine whether differences in HRV exist 
during sleep in empirically-derived insomnia patient subtypes. This multi-component project 
includes a critical literature review of all HRV-insomnia research that has been performed to 
date. Two case-control studies are then presented.  
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The first compared the HRV of empirically-derived insomnia patient subtypes across 
the sleep onset period, a time of clinical and physiological significance. The second study 
compared HRV of previously derived patient subtypes across the whole night. It was 
hypothesized that insomnia patients with short-sleep duration would have impaired HRV 
when compared to longer-sleeping insomnia patients. This work is the first to compare 
directly the HRV of empirically-derived insomnia patient subtypes and contributes 
significantly to the physiological understanding of short-sleeping insomnia patients.  
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Chapter 2:  Literature Review 
 
Preamble 
Insomnia is a highly prevalent and heterogeneous disorder (Edinger et al., 2004; 
Ohayon, 2002; Ohayon & Reynolds, 2009). Epidemiological studies support the presence of 
an association with cardiovascular disease yet the mechanistic link remains elusive 
(Grandner, 2014). Although the aetiology of insomnia is still debated, the hyperarousal 
hypothesis is currently one of the most prominent models, leading to the exploration of 
physiological and cognitive hyperarousal using a variety of objective measures.  
Cardiovascular autonomic activity can be quantified using HR, HRV, blood pressure, 
blood pressure variability, baroreflex activity, cardiovascular impedance, muscle 
sympathetic nerve activity recordings, and measures of catecholamine levels (Trinder, 
2007). However, only one – HR – is routinely recorded during overnight polysomnography 
(PSG) and the interpretation of HRV provides suitable surrogates of autonomic activity. 
HR is modulated by the autonomic nervous system and is the basis of HRV. 
Therefore, if the ability to modulate the HR is impaired this would result in decreased beat-
to-beat variability. This phenomenon has been shown in large cardiovascular studies from 
the 1980s that not only linked impaired HRV to sudden cardiac death, but also 
demonstrated its ability to be used to risk-stratify patients post-myocardial infarction 
(Kleiger et al., 1987; Singer et al., 1988). A significant advancement in the technique was 
introduced by Askelrod (1981) with the introduction spectral analysis of HRV. As 
parasympathetic and sympathetic branches of the nervous system have different 
mechanisms that are imposed at different speeds, spectral analysis enabled greater 
correlation to be made to physiological function and the estimation of sympathovagal 
balance (Ernst, 2014).  
 The purpose of this critical literature review (Chapter 2) was to identify all studies 
that had assessed the HRV of insomnia patients. In regards to HRV, only studies using time 
and/or frequency domain HRV measures were employed. Whilst a number of advanced 
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signal analysis methods can now be performed (using nonlinear dynamics, entropy, and 
fractal signals), traditional methods are still preferred when assessing basic physiological 
function, and for pathophysiological modelling (Sassi et al., 2015). No studies were excluded 
on the basis of the classification system used to diagnose insomnia. As such, the review 
incorporated studies of all patients with insomnia that resulted in sleep-wake impairments.  
 Since this manuscript was accepted for publication, only one other article has been 
published that would have otherwise been included. Authored by Jarrin et al (2016), the 
research studied 65 insomnia patients before and after treatment with six weeks of 
Cognitive Behavioural Therapy for Insomnia. No changes in HRV (High Frequency [HF] and 
the Low Frequency/High Frequency ratio [LF/HF]) were found in the sleep stages N2 or REM 
after treatment, regardless of whether the patient had responded to therapy. Nonetheless, 
associations were found between HRV measures and PSG-derived WASO, TST, and SE. These 
findings, however, were only in select HRV parameters and reported inconsistently (i.e. not 
in both N2 and REM). As such, this study does not alter the findings, practice points or 
research agenda of the literature review presented below. 
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Heart Rate Variability in Insoms u m m a r y
Heart rate variability (HRV) is an objective marker that provides insight into autonomic nervous system
dynamics. There is conﬂicting evidence regarding the presence of HRV impairment in insomnia patients.
Web-based databases were used to systematically search the literature for all studies that compared the
HRV of insomnia patients to controls or reported the HRV of insomnia patients before and after an
intervention. 22 relevant papers were identiﬁed. Study characteristics were summarised, HRV measures
were extracted and a risk of bias assessment for each study was performed. We were limited in our
ability to synthesise outcome measures and perform meta-analyses due to considerable differences in
patient (and control) selection, study protocols, measurement and processing techniques and outcome
reporting. Risk of bias was deemed to be high in the majority of studies. As such, we cannot conﬁrm that
HRV is reliably impaired in insomnia patients nor determine the HRV response to interventions. Whilst
HRV impairment in insomnia is a widely accepted concept, it is not supported by empirical evidence.
Large longitudinal studies incorporating 24-hour recordings are required to elucidate the precise nature
of HRV dynamics in insomnia patients.
© 2016 Elsevier Ltd. All rights reserved.Introduction
Heart rate variability (HRV) describes the variation in time be-
tween consecutive heart beats, which is commonly referred to as
the RR (R wave to R wave) or NN (normal beat to normal beat)
interval. Pacemaker cells located in the sinoatrial node of the heart
possess autorhythmicity to maintain heart rate regularity. The
heart rate (HR), however, is modulated by a number of physiolog-
ical factors which alter autonomic nervous system control and in-
crease variability at various frequencies. There are two prominent
approaches for quantifying heart rate variation which use spectral
or non-spectral techniques to generate HRV measures.
Non-spectral methods involve mathematical derivations of the
NN interval. When taken from an electrocardiogram (ECG), this02 e Sydney Nursing School,
alia. Tel.: þ61 2 9351 0586;
(C.J. Gordon).
et al., Heart rate variability in
mrv.2016.06.004
nia Patient Subtypesinterval is determined by measuring the length in time between
consecutive sinoatrial R wave peaks. As many non-spectral deri-
vations report the HRV in time (milliseconds) or units, they are
collectively referred to as time-domain measures. Four time-
domain measures are recommended for use by the task force of
the European society of cardiology and the North American society
of pacing and electrophysiology when assessing HRV for estimation
of short term (root mean square of successive differences of NN
intervals (RMSSD)), long term (standard deviation of the averages
of NN intervals in ﬁve minute segments of entire recording
(SDANN)) and overall HRV (standard deviation of NN intervals
(SDNN), HRV triangular index) [1]. A description of these HRV
measures can be found in Table 1.
Spectral analysis of HRV enables the evaluation of frequency-
domain measures. As parasympathetic-mediated changes to HR
occur more quickly than sympathetic adjustments, the use of
spectral analysis to determine frequency can provide insight into
autonomic nervous system dynamics. It has been accepted previ-
ously that low frequency (LF) activity is a correlate ofinsomnia patients: A critical review of the literature, Sleep Medicine
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Abbreviations
ECG electrocardiogram
EEG electroencephalogram
HF high frequency power
HFnorm high frequency power (in normalised units)
HR heart rate
HRV heart rate variability
LF low frequency power
LF/HF low frequency to high frequency ratio
LFnorm low frequency power (in normalised units)
NN interval interval in time between successive normal beats
(typically measured from the R wave of a QRS
complex)
NREM non rapid eye movement
pNN50 percent of NN intervals > 50 milliseconds different
from previous
PSG polysomnography
REM rapid eye movement
RMSSD root mean square of successive differences of NN
intervals for period of interest
RR interval interval in time between successive R waves (of a
QRS complex)
SDANN standard deviation of the averages of NN intervals in
ﬁve minute segments of entire recording
SDNN standard deviation of NN intervals for period of
interest
TP total power
K.L. Dodds et al. / Sleep Medicine Reviews xxx (2016) 1e132parasympathetic and sympathetic activity whilst high frequency
(HF) activity reﬂects parasympathetic activity only. As such the
ratio between these (the LF/HF ratio) provides an estimate of
sympathovagal balance which is the putative equilibrium of the
sympathetic and parasympathetic systems. However, the physio-
logical signiﬁcance of the lower frequency bands (including LF andTable 1
Summary of common heart rate variability measures and their physiological correlates.
Measure Description
Time-domain measures
HRV triangular
index
Baseline width of the minimum square difference triangular
interpolation of the highest peak of the histogram of all NN inter
reﬂects total HRV
NN interval Time between two successive normal R wave peaks of a QRS com
pNN50 Percentage of number of adjacent NN interval pairs greater than 5
divided by the total number of NN intervals
RMSSD Square root of the mean of the squared differences between succe
NN intervals
SDANN Standard deviation of the average of NN intervals in all 5-minute
segments of a 24 h recording, primarily reﬂects circadian HRV
SDNN Standard deviation of all NN intervals, typically from a 24 h recor
reﬂects total HRV
Frequency-domain measures
HF High frequency power (0.15e0.4 Hz)
HFnorm Similar to HF but the high frequency power is normalised using t
power
LF Low frequency power (0.04e0.15 Hz), signiﬁcance is debated
LF/HF Ratio of LF to HF, signiﬁcance is debated
LFnorm Similar to LF but the low frequency power is normalised using to
power, signiﬁcance is debated
Total power Variance of all NN intervals, reﬂects total HRV
VLF Very low frequency power (0.003e0.04 Hz)
Abbreviations: HRV: heart rate variability; ms: milliseconds; nu: normalised units. Refs.:
Please cite this article in press as: Dodds KL, et al., Heart rate variability in
Reviews (2016), http://dx.doi.org/10.1016/j.smrv.2016.06.004
Heart Rate Variability in Insomnia Patient Subtypesthe LF/HF ratio) has been contested and caution is required when
interpreting these measures [2e4]. This is further summarised in
Table 1. For a more detailed explanation of the physiological cor-
relates of HRVmeasures refer to the previous review of Stein and Pu
[5].
Heart rate variability recordings are employed in a vast range of
settings, popular due to the non-invasive methods used for data
collection. The clinical utility of HRV was realised in the late 1980s
when decreased HRV, deﬁned by a reduction in 24-hour SDNN, was
found to be a strong predictor of mortality post myocardial infarct
[6]. HRV has since been used to investigate health and disease
states for clinical and research purposes.
The incorporation of HRV analysis during sleep has been a
logical extension as the ECG is a component of overnight poly-
somnography (PSG). This has acted as a catalyst for further exam-
ination on the bidirectional relationship between autonomic
nervous system activity and sleep physiology [7]. It is not surprising
that time and frequency-domain HRV measures, primarily from
short recordings (i.e., less than 24 h), are increasingly being re-
ported in the sleep literature.
HRV has circadian periodicity with signiﬁcant alterations during
the transition from wake to sleep and across sleep cycles [8,9].
Bonnemeier et al. [10] and Li et al. [11] have shown that vagal HRV
measures follow a day-night pattern increasing during the night
[12]. Importantly, these changes are correlated with age and sex
[10,11]. There is also a shift in sympathovagal balance between non
rapid eye movement (NREM) and rapid eye movement (REM) sleep
[5,9,13]. Research has now progressed to investigating the associ-
ations between HRV, sleep disorders and their subsequent comor-
bidities and the incorporation of non-traditional HRV techniques
[5,13,14].
Given the interplay between HRV and cardiac autonomic ac-
tivity, the use of HRV in insomnia research may assist further
investigation into the pathophysiology and potential health im-
pacts of insomnia. With an estimated worldwide prevalence of 10%,
insomnia is the most common sleep disorder [15e17]. Clinical
diagnosis in accordance with the most recent diagnostic andUnits Autonomic inference
vals,
ms e
plex ms e
0 ms % Parasympathetic activity
ssive ms Parasympathetic activity
ms e
ding, ms e
ms2 Parasympathetic activity
otal nu Sympathovagal balance, with higher values representing
increases in parasympathetic prevalence
ms2 Purported to reﬂect both parasympathetic and sympathetic
activity
ratio Purported to reﬂect sympathovagal balance
tal nu Sympathovagal balance, higher values may represent
increases in sympathetic prevalence
ms2 e
ms2 Parasympathetic activity and the non-autonomic renin-
angiotensin system effects
[1e5].
insomnia patients: A critical review of the literature, Sleep Medicine
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K.L. Dodds et al. / Sleep Medicine Reviews xxx (2016) 1e13 3statistical manual of mental disorders requires the patient to report
difﬁculty initiating and/or maintaining sleep with subsequent
daytime impairments greater than three nights per week and for at
least three months [18]. Insomnia patients also have increased
medical and psychological comorbidities [17].
Hyperarousal has been deﬁned as ‘a state of increased arousal at
the physiological, cortical, cognitive or emotional level’ [17] and
hypothesised to contribute to the development, maintenance and
24-hour systemic sequelae of insomnia [19]. The notion of physi-
ological hyperarousal has been investigated by measuring HRV in
insomnia patients despite the uncertain relationship between
autonomic dysfunction, insomnia and cardiovascular disease [19].
Heart rate variability studies of the insomnia population have
increased since 1998 after the inﬂuential work of Bonnet and Arand
[20] which was supportive of the hyperarousal theory. This study
revealed altered sympathovagal balance in patients with insomnia
compared to controls [20]. However, the extant research literature
has not been able to replicate these ﬁndings with comparable detail
and instead yielded somewhat inconsistent, divergent ﬁndings
[21].
Whilst two reviews examining HRV, sleep and sleep disorders
have been published previously they did not systematically syn-
thesise the ﬁndings of the insomnia e HRV literature and we were
aware of additional studies that were not included [5,13]. Therefore,
the aim of this review was to identify all insomnia related research
studies using HRV to determine if HRV was impaired in adult pa-
tients with insomnia and whether interventions alter HRV.
Methods
We undertook an extensive search of the literature using
CINAHL, Embase, Google Scholar, PubMed, Scopus and Web of
Science databases on 25th January 2016. Where possible the search
incorporated a subject heading and key word strategy, combining
“heart rate variability” or “HRV” and “insomnia”. The systematic
search strategy was modiﬁed as necessary according to the data-
base being searched, as shown in Appendix A. No limitations were
used with the exception of Google Scholar where restrictions were
used to exclude patents and citations. We had two main questions:
1) whether there were any differences in HRV of insomnia patients
compared to controls (observational) and 2) whether treatment
interventions resulted in changes to the HRV of insomnia patients
(interventional).
In order to be included for review, studies required the
following:
1) Participants e humans 18 years old (observational) or
insomnia patients (interventional)
2) Exposure e diagnosed with insomnia (observational) or a
treatment for insomnia (interventional)
3) Comparisons e controls who were deemed to be good sleepers
(observational) or the same group of patients compared before
and after treatment or an ineffective or placebo treatment
(interventional)
4) Outcomes e standard time and/or frequency-domain HRV
measures with recordings of any length at any time during sleep
and/or wake
5) Study design e case-control studies, observational cohort and
cross-sectional studies (observational) and randomised
controlled trials, non-randomised controlled trials and uncon-
trolled trials (before and after studies; interventional).
We included research studies that incorporated HRV measure-
ments as either primary or secondary outcomes. Case studies and
publications without original data were excluded from the review.Please cite this article in press as: Dodds KL, et al., Heart rate variability in
Reviews (2016), http://dx.doi.org/10.1016/j.smrv.2016.06.004
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insomnia treatments, but rather any interventions that were con-
ducted in insomnia patients and included pre- and post HRV
measurements.
On completion of the database searches, duplicates were
removed. All remaining studies were reviewed for eligibility by one
author (KD) using the study title, abstract and, when required, full
text. The reference lists of remaining publications and the bibli-
ographies of relevant review articles were also searched for grey
literature and otherwise missed publications.
Study measures were collected through the use of tables that
identiﬁed study characteristics and standard time and frequency-
domain HRV measures. Two tools were used by one author (KD)
to assist with assessing the risk of bias within studies. Case-control
studies were evaluated using a modiﬁed version of the national
institute for health and care excellence methodology checklist [22].
This checklist assisted in reviewing studies for internal validity by
methodically appraising the selection of cases and controls, con-
founding factors and statistical methods [22]. Intervention studies
were evaluated using the Cochrane collaboration's tool for assess-
ing risk of bias. Designed for randomised controlled studies, this
helped to scrutinise the studies for selection, performance, detec-
tion, attrition or reporting bias [23].
Findings
Search process
The database search yielded 555 records (CINAHL 9, Embase
182, Google Scholar 21, PubMed 60, Scopus 140, Web of Science
143). After removal of duplicates, 275 publications remained and of
these 22 met the inclusion criteria. No additional publications were
identiﬁed after a manual search of the reference lists. There were 17
case-control studies [20,21,24e38], one of whichwas a nested case-
control study from a larger cohort [36]. We did not identify any
cohort or cross-sectional study designs. Five research studies
compared insomnia patients before and after an intervention. The
types of interventions were cognitive behavioural therapy for
insomnia [39], pharmacotherapy (gabapentin) [40], acupuncture
[41], acupressure [42] and paced breathing [43]. There were no
randomised controlled trials. A diagrammatic schema of the search
results is shown in Fig. 1.
Observational studies
Demographics
Participant numbers and demographics of the observational
studies are presented in Table 2. The sample size of patients ranged
from 8 to 85 (with 8 to 55 controls respectively) [27,29]. Three
studies exclusively involved female participants [33,34,36] and one
study involved only males [32]. Bonnet and Arand [20] did not
report the sex-ratio of their study participants. The age of partici-
pants was also variable with the average patient age ranging from
23.0 (SD 2.4) to 53.2 (SD 13.6) years. In accordance with the time
span of included studies, the majority of studies involved patients
diagnosed according to the fourth edition of the diagnostic and
statistical manual of mental disorders [21,26e28,30e33,35,36,38].
In contrast, Varkevisser et al. [37] and Farina et al. [29] utilised the
international classiﬁcation of sleep disorders, whilst two other
studies used the research diagnostic criteria for primary insomnia,
which set the benchmark at the time of publication [24,25]. Finally,
there were two studies that utilised non-standard criterion based
upon a combination of subjective symptomology and arbitrary PSG
criteria, incorporating sleep efﬁciency and/or sleep onset latency
[20,34].insomnia patients: A critical review of the literature, Sleep Medicine
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Fig. 1. Modiﬁed PRISMA study inclusion ﬂowchart.
K.L. Dodds et al. / Sleep Medicine Reviews xxx (2016) 1e134Data collection
Most night time HRV data collectionwas performed in the sleep
laboratory, with the exception of four studies that included testing
in participants' homes or an alternative health care facility
[29,34,36,38]. As shown in Table 2, HR data collection was achieved
through the use of Holter monitors, heart monitor belts and PSG-
based ECGs, resulting in sampling rates ranging from 125 to
1024 Hz. [30,34,36].HRV measures
It was difﬁcult to synthesise the ﬁndings of HRV measures re-
ported in the observational studies. Total power (TP) was the only
HRV measure that provided unequivocal ﬁndings across observa-
tional studies e no signiﬁcant differences were reported between
insomnia patients and controls (Table 3). The next most consistent
ﬁnding was that mean HR was found to be higher in insomnia
patients compared to controls [20,27,29,38]; nevertheless, others
reported no signiﬁcant group differences in this measure
[21,24,26,31,33,37]. Both Bonnet and Arand [20] and Farina et al.Please cite this article in press as: Dodds KL, et al., Heart rate variability in
Reviews (2016), http://dx.doi.org/10.1016/j.smrv.2016.06.004
Heart Rate Variability in Insomnia Patient Subtypes[29] found the LF/HF ratio to be increased in insomnia patients
compared to controls although 11 other studies did not show this
response.
The classic ﬁndings of increased sympathetic-related measures
(LF/HF ratio) with a reciprocal reduction in parasympathetic mea-
sures (HFnorm) in insomnia patients compared to controls [20] has
not been replicated comprehensively. Four studies have corrobo-
rated some of these ﬁndings but not across all HRV measures and
sleep stages [21,29,31,38]. We were not able to identify any other
study with HRV outcome measures suggestive of both increased
sympathetic and decreased parasympathetic activity that would
link autonomic dysfunction and physiological hyperarousal [44,45].
Table 3 provides an overview of the HRV outcomes of the case-
control studies.Sleep onset
Heart rate variability during the transition fromwake to sleep is
of particular interest given the changes in autonomic activity and
the reported heightened symptomatology in insomnia patients atinsomnia patients: A critical review of the literature, Sleep Medicine
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Table 2
Study characteristics of 17 observational (case-control) studies comparing heart rate variability in insomnia patients and controls.
Author/s, date,
reference number
Patient number,
sex, age (mean, SD,
range)
Diagnostic criteria Insomnia severity Comparators
number, sex, age
(mean, SD, range)
Case-match
methodology
Setting HRV data capture and analysis
Bonnet & Arand,
1998 [20]
12 M and F
unknown ratio
31.2 y ± 6.8, 18e50
Subjective report of
insomnia four nights per
week for one year and EEG
SOL >30 min or SE <85% on
both PSG nights
Subjective SOL, TST and
length of insomnia
available for review
12 M and F,
unknown ratio
29.1 y ± 5.2, 18e50
Sex, age (within ﬁve
years), body mass
(within 25 pounds) and
sleep characteristics
Sleep laboratory 36 h (two
nights, one day). Data from
second night
ECG sampled at 500 Hz
5 min time periods
Automated RRI detection with
repeated visual artifact check
McMillan 2001
[34]
Insomnia: 13F
46.3 y ± 2.8, 25e60
Fibromyalgia: 16F
46.3 y ± 7.0, 25e60
Subjective report of
insomnia for at least three
months and sleep efﬁciency
index 85% on night 2
NS From ﬁbromyalgia
study
16F
43.6 ± 6.0, 25e60
Sex, age, BMI
(<40 kg/m2) and SE
>85% on night 2
Sleep laboratory and
participants' homes >2
nights recorded sleep. Data
from second night
ECG sampled at 125e250 Hz
5min time periods with >90% ‘good
beats’
Visual ECG check
Outliers removed from RRI time
series
Varkevisser et al.,
2005 [37]
6M, 5F
43.8 y ± 8.9, 31e54
ICSD revised edition (with
home PSG conﬁrmation
prior to testing)
Actigraphy times
available for review
7M, 6F
44.9 y ± 7.7, 33e53
Sex and age
Controls had actigraphy
SE <85% and NS
differences in
actigraphy TIB, SOL,
mean wake time
48 h ambulatory PSG (pre-
study) in participants'
homes and 26 h sleep
deprivation protocol in
sleep laboratory
ECG sampled at 1000 Hz
30 min time periods every 3 h
(before performance testing)
30 s time periods
Outlier IBI values removed
(<300 or >1800 ms)
Fang et al., 2008
[28]
6M, 12F
34.16 y ± 14.46, 20
e63
DSM IV, Chinese PSQI 6
and at least one of the
following on three day
actigraphy and seven day
sleep diary: WASO
>30 min, TST 6.5 h, SE
85%
Chinese PSQI
11.78 ± 2.18, ESS, sleep
diary and actigraphy
times available for
review
7M, 14F
27.81 y ± 8.67, 20
e50
Controls were included
when Chinese PSQI 5,
actigraphy and sleep
diary conﬁrming WASO
30 min, TST >6.5 h
and SE >85%
Home actigraphy and sleep
diaries followed by
laboratory testing. Lab
sessions from 14:00
e17:00 h 5 min wake ECG
Controlled breathing rate
ECG sampled at 500 Hz
5 min time periods
Examined for ectopic beats and
artifact. Manually adjusted
Jurysta et al.,
2009 [32]
14M
42 y ± 12, 16e63
DSM IV and ICSD revised
edition
Sleep characteristics
available for review
14M
41 y ± 10, 16e55
Age and BMI Sleep laboratory three
consecutive nights. Data
from third night
ECG sampled at 500 Hz
2 min time periods
Automatic detection and removal
ectopics RRI time series corrected
with interpolation
Visual inspection of detected events
and interpolated values
de Zambotti et al.,
2011 [27]
4M, 4F
23.25 y ± 2.43, 20
e26
PSQI and AIS6 and ISI11
(at screening) and then
enrolled according to DSM
IV
PSQI 9.62 (1.30), AIS
9.62 (3.16), ISI 13.37
(3.25), further sleep
characteristics available
for review
3M, 5F
23.25 y ± 3.24, 19
e28
Controls were included
when PSQI and AIS <6
and ISI <11 (at
screening)
Sleep laboratory two
consecutive nights in
laboratory. Data from
second night
ECG sampled at 500 Hz
1min, 2.5 min, 2.5 min time periods
Incorrect interbeat interval
detection adjusted manually
Peter et al., 2011
[35]
3M, 18F
48.2 y ± 10.4, 18
e75
DSM IV and PSQI >5 PSQI median 13 3M, 18F
48.5 y ± 11.1, 18
e75
Sex and age Interdisciplinary sleep
medicine centre
-outpatient department
Daytime measurement, 45
seated posture, 5e7 min
test
ECG sampled at 200 Hz
5e7 min time periods
Artifacts were removed
NS if any visual inspection
performed
Spiegelhalder
et al., 2011
[21]
36M, 22F
39.5 y ± 11.8
DSM IV. For further analysis
e SE >85% ¼ ‘without short
sleep’ vs SE <85% ¼ ‘short
sleep duration’
PSQI 11.2 ± 2.8, further
sleep characteristics
available for review
19M, 27F
37.3 y ± 11.4
No signiﬁcant
difference for sex, age,
BMI, BP or smoking
status
Sleep laboratory two
consecutive nights. Data
from second night
ECG sampled at 400 Hz
5 min time periods
Visually inspected for artifact or
inaccurate R wave detections and
corrected with manual editing
Ectopics corrected with
interpolation
Artifact >10 s duration discarded
(continued on next page)
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Table 2 (continued )
Author/s, date,
reference number
Patient number,
sex, age (mean, SD,
range)
Diagnostic criteria Insomnia severity Comparators
number, sex, age
(mean, SD, range)
Case-match
methodology
Setting HRV data capture and analysis
Yang et al., 2011
[38]
16M, 31F
43.9 y ± 10.4, 23
e63
DSM IV PSQI 10.7 ± 3.9 33M, 55F
41.6 y ± 11.7, 22
e64
No signiﬁcant
difference for sex ratio,
age, BMI
Participants' homes and
psychiatric wards 24 h
ambulatory ECG
ECG signals were automatically
processed and analysed by open
source HRV algorithms
2 min time periods
Data divided into wake and bed
time
Israel et al., 2012
[30]
24M, 30F
34.6 y ± 9.7
DSM IV Sleep characteristics
available for review
3M, 19F
26.5 y ± 7.3
No speciﬁc case-
matching methodology
reported
Sleep laboratory three
consecutive nights
ECG sampled at 1024 Hz
2 min time periods
Artifacts and ectopics edited
manually by interpolating
preceding successive beats
de Zambotti et al.,
2013 [26]
4M, 5F
23 y ± 2.4, 20e26
DSM IV and insomnia
history for 1 y
PSQI 9.67 ± 1.22, AIS
10.00 ± 3.16, HS
44.56 ± 4.03, further
sleep characteristics
available for review
4M, 5F
23.56 y ± 3.17, 19
e28
No signiﬁcant
difference for sex, age,
BMI
Sleep laboratory two
consecutive nights in
laboratory. Data from
second night
ECG sampled at 500 Hz
2 min time periods
R wave detection visually examined
Incorrectly detected R-peaks were
manually edited
Cellini et al., 2014
[24]
5M, 8F
23.31 y ± 2.50, 20
e28
Research diagnostic criteria
for primary insomnia, PSQI
5 and ISI 11
PSQI 10.0 ± 2.0, ISI
15.77 ± 3.27, further
sleep characteristics
available for review
7M, 6F
24.31 y ± 1.60, 20
e28
Controls were included
when they met
research diagnostic
criteria for normal
sleepers and PSQI <5
and ISI <11 No
signiﬁcant difference
for age, BMI, MEQ
Sleep laboratory two
consecutive nights in
laboratory. Data from
second night HRV recording
during evening cognitive
testing
ECG sampled at 512 Hz
3 min time periods
R wave detection visually examined
Incorrectly detected R-peaks were
manually edited
Missing and ectopic beats were
corrected by interpolation
de Zambotti et al.,
2014 [25]
5M, 8F
24.4 y ± 1.6, 20e28
Research diagnostic criteria
for primary insomnia, PSQI
5 and ISI 11
PSQI 10.0 ± 2.0, ISI
15.8 ± 3.3, further sleep
characteristics available
for review
7M, 7F
23.3 y ± 2.5, 23e28
Controls were included
when they met
research diagnostic
criteria for normal
sleepers and PSQI <5
and ISI <11
Sleep laboratory two
consecutive nights in
laboratory, Data from
second night
ECG sampled at 512 Hz
2 min periods - frequency domain
5 min periods - time domain
Visually inspected to ensure each
epoch is of stable sleep state, free of
arousal and artifact
Farina et al., 2014
[29]
38M, 47F
53.2 y ± 13.6, 27
e81
ICSD 2 NS, sleep characteristics
available for review
23M, 32F
54.2 y ± 13.9, 27
e76
Sex and age Participants' homes 24 h
home ambulatory PSG
ECG sampled at 256 Hz
5 min time periods, ﬁrst 5 min of
each sleep stage
Digital artifact recognition and
exclusion
Maes et al., 2014
[33]
17F
36.2 y ± 9.6, 19e53
DSM IV and SOL > 30 min,
at least ﬁve nights/week
NS, sleep characteristics
available for review
11F
37.6 y ± 12.6, 21
e59
No signiﬁcant
difference for age, BMI,
ESS, caffeine, alcohol or
smoking status
Sleep laboratory. Overnight
PSG
ECG sampled at 1000 Hz
5  5 min time periods
Artifacts of the RRI were adjusted
manually
Jiang et al., 2015
[31]
M25, F30
30.4 y ± 8.4, 22e38
DSM IV PSQI 8.6 ± 2.3 M29, F34
31.3 y ± 7.7, 23e39
No signiﬁcant
difference for sex ratio,
age, BMI, BP and HR
University laboratory
Tested differences in HRV
with posture, heart monitor
belt
ECG sampled at 1000 Hz
30 s time periods
30 min time periods every 3 h
Outlier RRI values removed
(<350 or >1500 ms)
Rothenberger
et al., 2015
[36]
19F
52.1 y ± 2.1
Insomnia symptom
questionnaire (incorporates
DSM IV)
NS 146F
52.1 y ± 2.1 (nested
case control study
within cohort)
Nested case-control
study (with no control
matching)
Participants' homes
Ambulatory EEG - three
nights. Data from second or
third night
ECG sampled at 1024 Hz
2 min epoch of NREM sleep
Automated detection with visual
inspection to identify and remove
artifact
Note: When case-match methodology was not reported, we have noted demographic results which highlight group characteristics. Abbreviations: AIS: Athens insomnia scale; BMI: body mass index; BP: blood pressure, DSM IV:
diagnostic and statistical manual of mental disorders, fourth edition; ECG: electrocardiogram; EEG: electroencephalogram; F: female; FFT: fast Fourier transformation; HR: heart rate; HRV: heart rate variability; Hz: hertz; IBI:
interbeat interval; ICSD: international classiﬁcation of sleep disorders; ICSD 2: international classiﬁcation of sleep disorders, second edition; ISI: insomnia severity index; ISQ: insomnia symptom questionnaire; M: male; MEQ:
morningness-eveningness questionnaire; NREM: non rapid eye movement sleep stage; NS: not speciﬁed; PSA: power spectral analysis; PSG: polysomnography; PSQI: Pittsburgh sleep quality index; PVC: premature ventricular
contraction; RRI: RR interval; SD: standard deviation; SE: sleep efﬁciency (%); SOL: sleep onset latency; TIB: time in bed; TST: total sleep time; WASO: wake time after sleep onset.
K
.L.D
odds
et
al./
Sleep
M
edicine
Review
s
xxx
(2016)
1
e
13
6Please
cite
this
article
in
press
as:D
odds
K
L,etal.,H
eartrate
variability
in
insom
nia
patients:A
criticalreview
ofthe
literature,Sleep
M
edicine
Review
s
(2016),http://dx.doi.org/10.1016/j.sm
rv.2016.06.004
Heart Rate Variability in Insomnia Patient Subtypes 15
Table 3
Differences in heart rate variability measures in insomnia patients compared to controls from the observational studies.
Author/s, date, reference number Time-domain measures Frequency-domain measures
Mean HR RRI SDNN SDANN RMSSD pNN50 Total power VLF LF LFnorm HF HFnorm LF/HF
Bonnet & Arand 1998 [20]C [ Y Y Y [
McMillan 2001 [34]C ns [ [ [ [ ns ns ns ns ns ns
Varkevisser et al., 2005 [37] B ns ns
Fang et al., 2008 [28] B ns ns ns ns
Jurysta et al., 2009 [32]C ns ns ns ns ns ns ns
de Zambotti et al., 2011 [27]C [ ns
Peter et al., 2011 [35] B ns ns ns ns ns ns ns
Spiegelhalder et al., 2011 [21]C ns Y ns ns ns ns
Short sleepers# ns Y Y Y Y ns
Yang et al., 2011 [38], ns w [s Y w
ns s
Y w
ns s
Y w
ns s
Y w
ns s
Y w, s Y w
ns s
ns w, s
Israel et al., 2012 [30]C ns ns
de Zambotti et al., 2013 [26]C ns ns ns ns ns ns
Cellini et al., 2014 [24] B ns Y
de Zambotti et al., 2014 [25]C ns ns ns ns
Farina et al., 2014 [29], [w,s [s [s ns ns [w ns ns [s
Maes et al., 2014 [33]C ns ns ns ns
Jiang et al., 2015 [31] B ns Y Y ns ns Y Y ns
Postural changey ns ns ns ns ns Y [ ns
Rothenberger et al., 2015 [36]C ns
Key: downwards arrow represent a statistically signiﬁcant decrease in heart rate variability measure in insomnia patients compared to controls; ns: no signiﬁcant difference
between insomnia patients and controls; s ¼ signiﬁcant only during sleep; t ¼ signiﬁcant only during transition from wake to sleep; upwards arrow represent a statistically
signiﬁcant increase in heart rate variability measure in insomnia patients compared to controls; w ¼ signiﬁcant only during wake; # short sleepers deﬁned according to sleep
efﬁciency; ypostural change from sitting to (prolonged) standing;C predominantly sleep HRV recording;B wake HRV recording;, 24-hour HRV recording.
Abbreviations: HF: high frequency (ms2); HR: heart rate; norm: power in normalised units; LF: low frequency (ms2); LF/HF: low frequency (ms2)/high frequency (ms2) ratio;
pNN50: percent of NN intervals >50 milliseconds different from previous (%); RMSSD: square root of the mean of the sum of the squares of differences between adjacent NN
intervals (ms); RRI: RR interval (ms); SDANN: standard deviation of the averages of NN intervals (ms); SDNN: standard deviation of all NN intervals (ms); VLF: very low
frequency (ms2).
K.L. Dodds et al. / Sleep Medicine Reviews xxx (2016) 1e13 7this time [46]. We identiﬁed several studies that measured HRV
during the sleep onset period with differing results. De Zambotti
et al. [27] found greater wake to sleep increases in HFnorm
(matched by a greater wake to sleep HR reduction) in insomnia
patients compared to controls, suggesting a greater increase in
vagal control during the sleep onset. Although not technically
related to the sleep onset process, Spiegelhalder et al. [21] found a
group by stage interaction indicating a dampened HR reduction
fromwake to (N2) sleep. Maes et al. [33], however, did not ﬁnd any
signiﬁcant differences between insomnia patients and controls
preceding sleep onset in either HR or HRV parameters.Daytime only
Daytime HRV testing of insomnia patients was undertaken in
four studies with contradictory results. Fang et al. [28] reported no
signiﬁcant differences in four frequency-domain HRVmeasures (TP,
LF, HF, LF/HF), whereas Cellini et al. [24] reported an increase in
sympathetic activity (based upon impedance cardiography)
together with decreased HF, correlating with parasympathetic ac-
tivity in insomnia patients. Two of the daytime HRV studies
involved a physiological challenge e baroreﬂex sensitivity and
postural change. Despite differences in the physiological pertur-
bation, one study did not ﬁnd any group differences [35], whilst the
other reported insomnia patients to have attenuated or absent HRV
responses to postural change [31].Extended recordings
We could only identify three studies with extended HRV re-
cordings. In a constant routine protocol whereby participants
remained awake in a semi recumbent position across 24 h, Varke-
visser et al. [37] did not ﬁnd any between-group differences in HR
or RMSSD. Both Yang et al. [38] and Farina et al. [29] utilised 24-
hour recordings but did not report 24-hour HRV outcomes.Please cite this article in press as: Dodds KL, et al., Heart rate variability in
Reviews (2016), http://dx.doi.org/10.1016/j.smrv.2016.06.004
Heart Rate Variability in Insomnia Patient SubtypesRisk of bias
Risk of bias of the observational studies is presented in Table 4.
There was considerable bias in many studies, with six studies not
taking cases from the same population as controls
[21,29,33e35,37]. This was evident in the absence of a consistent
methodology to match cases to controls in Table 2. The selection of
controls was problematic with most not abiding to the suggested
research diagnostic criteria for selection of insomnia controls [47].
Potential confounders such as age, sex and comorbidities were not
considered in HRV analyses. There was a wide age range between,
and within studies (Table 2). Spiegelhalder et al. [21] adjusted for
covariates and found age to signiﬁcantly impact on both time and
frequency-domain HRV measures (SDNN, RMSSD, pNN50, HF and
LF/HF), whilst sex affected time-domain measures (SDNN, RMSSD,
pNN50). No studies analysed sex by group interactions or accoun-
ted for women's reproductive stage or menstrual cycle phase [48].
Interventional studies
Demographics and data inclusion
All intervention studies were open label, single-arm clinical
trials. Participant numbers were mostly small with the largest
sample size of 31 patients [42]. The diverse age range is evident in
Table 5. Between the ﬁve studies, four different diagnostic methods
were used for classiﬁcation of insomnia. Insomnia severity of pa-
tients across studies was not able to be compared as one study
provided scores for the insomnia severity index [39], two for the
Athens insomnia scale [41,42] and two for the Pittsburgh sleep
quality index (known to measure sleep quality, not insomnia
symptoms) [40,43]. The longest follow-up time post intervention
cessation was eight weeks post-therapy [39]. As with the obser-
vational studies, there was no uniformity in data capture and
analysis methods, with the exception of the acupuncture and
acupressure intervention studies as these were performed by the
same research group [41,42].insomnia patients: A critical review of the literature, Sleep Medicine
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Table 4
Risk of bias assessment of observational studies.
Author/s, date,  
reference number 
Cases and controls 
are from 
comparable 
populaƟons 
The same 
exclusion criteria 
are used for cases 
and controls 
ParƟcipaƟon rate 
for cases and 
controls is 
comparable 
Comparison of 
parƟcipants and 
non-parƟcipants 
Cases are clearly 
defined and 
diﬀerenƟated 
from controls 
Controls are not 
cases 
Measures taken to 
prevent 
knowledge of 
primary exposure 
from influencing 
case 
ascertainment 
Exposure status 
measured in a 
standard, valid 
and reliable way 
PotenƟal 
confounders 
idenƟfied and 
accounted for in 
design and 
analysis 
Bonnet & Arand 1998 [20] ? 3 ? X 3 3 ? ? X 
McMillan et al. 2001 [34] X 3 ? ? X X ? X ? 
Varkevisser et al. 2005 [37] X 3 ? ? 3 X ? 3 3
Fang et al. 2008 [28] 3 3 3 ? 3 3 ? 3 ? 
Jurysta et al. 2009 [32] ? 3 ? ? 3 ? ? 3 ? 
de Zamboƫ et al. 2011 [27] 3 3 ?  X 3 3 ? 3 ? 
Peter et al. 2011 [35] X 3 ?  ? 3 3 ? 3 ? 
Spiegelhalder et al. 2011 [21] X 3 ?  X 3 X ? 3 3
Yang et al. 2011 [38] ? 3 ?  ? 3 ? ? 3 ? 
Israel et al. 2012 [30] ? 3 ?  ? 3 3 ? 3 X 
de Zamboƫ et al. 2013 [26] 3 3 ?  X 3 3 ? 3 ? 
Cellini et al. 2014 [24] 3 3 ?  ? 3 3 ? 3 ? 
de Zamboƫ et al. 2014 [25] 3 3 ? ? 3 3 ? 3 ? 
Farina et al. 2014 [29] X 3 ? ? 3 3 ? 3 ? 
Maes et al. 2014 [33] X 3 ?  ? 3 ? ? 3 ? 
Jiang et al. 2015 [31] ? 3 ? ? 3 ? ? 3 ? 
Rothenberger et al. 2015 [36] ? 3 3 ? 3 3 ? 3 ? 
Note: Case-control studies idenƟfied by the first author and year of publicaƟon. Studies were assessed for risk of bias using a modified version of the naƟonal insƟtute for health and care 
excellence (NICE) methodology checklist for case-control studies. Legend: green square with a Ɵck: well covered or adequately addressed; orange square with a quesƟon mark: not 
addressed, not reported or not applicable; red square with a cross: poorly addressed.
K.L. Dodds et al. / Sleep Medicine Reviews xxx (2016) 1e138HRV measures
All interventions evoked some change in at least one HRV
measure in insomnia patients (Table 6). Both acupuncture and
acupressure caused stimulation-dependent changes in HRV.
Cognitive behavioural therapy (CBT), gabapentin and acupuncture
interventions were associated with an increase in parasympathetic
activity (pNN50 and HF respectively). Heart rate variability mea-
sures that may represent sympathetic activity were reduced after
gabapentin (decreased LF, LFnorm and LF/HF ratio) and CBT re-
sponders (decreased LF). Interestingly, three (of the ﬁve) in-
terventions resulted in TP augmentation which contrasted with
ﬁndings from the observational studies which found this HRV
measure to be equivalent in insomnia patients and controls.Risk of bias
No randomised control trials of the HRV of insomnia patients
were identiﬁed. Therefore, no interventional studies achieved
random sequence generation, or undertook blinding of participants
or study personnel. The possibility of selective reporting was pre-
sent in all types of studies. Due to the absence of prospective
clinical trial registration we could not ascertain whether any
outcome switching has occurred except inside the research groups
that have maintained their HRV variable list. It was not clear why
only some HRV measures were used and if all HRV ﬁndings were
reported. Statistical under-powering of small studies must also bePlease cite this article in press as: Dodds KL, et al., Heart rate variability in
Reviews (2016), http://dx.doi.org/10.1016/j.smrv.2016.06.004
Heart Rate Variability in Insomnia Patient Subtypesaccounted for when considering the results. Risk of bias assessment
for interventional studies is presented in Table 7.
All studies
Technical considerations
Across all studies there was a wide range of data cleaning and
processing methods. Some authors used fully automated programs
whilst others performed visual inspection of the R wave detection
and manual editing for correction when required. There was
discrepancy in the handling of HRV time periods that included
artifact, sleep-related arousals and/or multiple sleep stages. Not
surprisingly, a range of statistical methods were applied, with some
but not all studies choosing to normalise the HRV measures.
Time of HRV recording
HRV outcomes reported in Tables 3 and 6 demonstrate a variety
of different collection periods. Heart rate variability measurements
were taken from participants in wake and/or sleep. Furthermore,
sleep-related HRV measures were from various sleep stages, ag-
gregates of sleep stages (e.g., NREM sleep combined), sleep cycles
(e.g., early NREM vs late NREM) or time periods (e.g., sleep onset).
For example, whilst both Bonnet and Arand [20] and Farina et al.
[29] reported an increase in the LF/HF ratio in insomnia patients
compared to controls, Bonnet and Arand [20] reported thismeasure
to be increased during stage one, two and REMwhereas Farina et al.insomnia patients: A critical review of the literature, Sleep Medicine
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Table 5
Study characteristics of ﬁve open-label single-arm intervention studies measuring heart rate variability in insomnia patients.
Author/s, date,
reference
number
Patient number,
sex, age (mean,
SD, range)
Diagnostic criteria Insomnia severity
(pre-treatment)
Intervention Follow-up time Setting HRV data capture and
analysis
Lo et al., 2010
[40]
7M, 11F
43.2 y ± 15.4
Subjective report of
difﬁculty initiating
sleep and/or
maintaining sleep
>3 mo
PSQI 13.54 Gabapentin
Mean dose 540 mg
Range 200e900 mg
Four weeks after
completion of dose
titration
Sleep
laboratory
ECG sampled at 400 Hz
10 min time periods
WASO and movement
periods were excluded
Chung et al.,
2011 [39]
Responders
6M, 10F
57.9 y ± 10.9
Non responders
4M, 6F
59.4 y ± 7.4
ICSD 2 Responders
ISI 19.5 ± 4.0, PSQI -
13.0 ± 4.0
Non responders
ISI 18.1 ± 4.9, PSQI -
14.9 ± 4.6
Cognitive
behavioural
therapy
four sessions over
eight weeks
Eight weeks after
commencement of
cognitive
behavioural
therapy
Not
speciﬁed
5 min time period
‘HRV measurements
followed standards of
the Task Force’
Litscher et al.,
2012 [41]
5M, 23F
41.9 y ± 14.6, 22
e82
Self-presentation to
hospital due to
insomnia and AIS
(value for inclusion
not speciﬁed)
AIS 12.4 ± 3.6 Acupuncture
Shenmen
acupuncture point
of wrist
10 min before,
20 min during and
10 min after
stimulation
Medical
university
ECG sampled at
4096 Hz
8  5 min time periods
Wang et al.,
2013 [42]
6M, 25F
54.3 y ± 10.6, 29
e82
Self-presentation to
hospital due to
insomnia and AIS
7
AIS 14.7 ± 4.4 Acupressure
Shenmen
accupressure point
of ear
10 min before,
20 min during and
10 min after
stimulation
Medical
university
As above
Tsai et al., 2015
[43]
Patients
14, sex not
speciﬁed
22.50 y ± 1.22, 20
e25
Controls
14, sex not
speciﬁed
23.07 y ± 1.64, 20
e25
Patients
DSM IV and PSQI >6
Controls
Satisﬁed with sleep
quality
<one week of sleep
disturbance
PSQI <5
Patients
PSQI 11.21 ± 1.97
Controls
Not applicable
Controlled
respiration at a
slow frequency rate
of 0.1 Hz and a
forced rate of 0.2 Hz
during daytime rest
Two days after each
intervention (one
week apart from
each other)
Home ECG sampled at 500 Hz
64s time periods
Automatic
PVC/noise rejection
RR intervals were
resampled and linearly
interpolated
Abbreviations: AIS: Athens insomnia scale; DSM IV: diagnostic and statistical manual of mental disorders, fourth edition; ECG: electrocardiogram; F: female; Hz: hertz; ICSD 2:
international classiﬁcation of sleep disorders, second edition; ISI: insomnia severity index; ISQ: insomnia symptom questionnaire; M: male; mg: milligrams; min: minute;
PSA: power spectral analysis; PSG: polysomnography; PSQI: Pittsburgh sleep quality index; PVC: premature ventricular contraction; RRI: RR interval; SE: sleep efﬁciency; SOL:
sleep onset latency; TST: total sleep time; WASO: wake time after sleep onset.
K.L. Dodds et al. / Sleep Medicine Reviews xxx (2016) 1e13 9[29] found this only in early N2. This made direct comparison be-
tween studies difﬁcult.Discussion
There are numerous reports in the literature that HRV is
impaired in insomnia patients. These typically draw heavily on the
ﬁndings of a small number of observational HRV research studiesTable 6
Heart rate variability measures in insomnia patients with an intervention.
Author/s, date, reference
number & intervention
Time-domain measures
Mean HR RRI SDNN SDANN RMSSD
Lo et al., 2010 [40]C
Gabapentin
Chung et al., 2011 [39] B
CBT responders
ns ns [ ns
CBT non-responders ns ns ns ns
Litscher et al., 2012 [41] B
Acupuncture
Y
Wang et al., 2013 [42] B
Acupressure
Y
Tsai et al., 2015 [43] B
At rest
ns
During paced breathing Y
Key: z signiﬁcant only when breathing at a rate of 0.2 Hz;C predominantly sleep HRV
Abbreviations: CBT: cognitive behavioural therapy; HF: high frequency (ms2); HR: heart ra
(ms2)/high frequency (ms2) ratio; ns: no signiﬁcant difference; pNN50: percent of NN inte
of the sum of the squares of differences between adjacent NN intervals (ms); RRI: RR int
standard deviation of all NN intervals (ms); VLF: very low frequency (ms2). Legend: down
ns: no signiﬁcant difference in HRV measures among insomnia patients after interve
intervention.
Please cite this article in press as: Dodds KL, et al., Heart rate variability in
Reviews (2016), http://dx.doi.org/10.1016/j.smrv.2016.06.004
Heart Rate Variability in Insomnia Patient Subtypes[20,21]. These case-control studies have reported a decrease HRV-
related parasympathetic activity in insomnia patients during
sleep and these HRV impairments have been used to support a
putative causal pathway for physiological hyperarousal in insomnia
[49]. This would be a logical inference; however, it is challenging to
draw ﬁrm conclusions from the studies in our review, with nearly
half of the observational studies reporting no signiﬁcant HRV dif-
ference between insomnia patients and controls. In addition, HRVFrequency-domain measures
pNN50 Total power VLF LF LFnorm HF HFnorm LF/HF
[ [ Y Y [ [ Y
[ [ [ Y ns ns
ns ns ns ns ns ns
ns [ [ ns
ns ns
ns ns Y
[z
recording; B wake HRV recording.
te; norm: power in normalised units; LF: low frequency (ms2); LF/HF: low frequency
rvals > 50 milliseconds different from previous (%); RMSSD: square root of the mean
erval (ms); SDANN: standard deviation of the averages of NN intervals (ms); SDNN:
wards arrow: decrease in HRVmeasure among insomnia patients after intervention;
ntion; upwards arrow: increase in HRV measure among insomnia patients with
insomnia patients: A critical review of the literature, Sleep Medicine
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Table 7
Risk of bias assessment of intervention studies.
Note: Studies that included an intervenƟon are listed and idenƟfied by the first author and year of publicaƟon. The cohcrane collaboraƟon’s tool for assessing risk of bias was used as a 
tool to help idenƟfy potenƟal areas of bias for each study. Legend: green square with a Ɵck: low risk of bias; orange square with a quesƟon mark: unclear risk of bias; red square with a 
cross: high risk of bias.
Author/s, date,  
reference number
Sequence 
generaƟon 
AllocaƟon 
concealment 
Blinding of 
parƟcipants 
Blinding of 
personnel 
Blinding of outcome 
assessors 
Incomplete outcome 
data (aƩriƟon and 
exclusions from 
analyses) 
SelecƟve reporƟng Other sources of bias 
Lo et al. 2010 [40] X X X X X ? ? X 
Chung et al. 2011 [39] X X X X X X ? X 
Litscher et al. 2012 [41] X X X X X 3 ? X 
Wang et al. 2013 [42] X X X X X 3 ? X 
Tsai et al. 2015 [43] X X X X X ? ? X 
K.L. Dodds et al. / Sleep Medicine Reviews xxx (2016) 1e1310was measured during a multitude of different states (wake, sleep
onset, various sleep stages, post-sleep wake), with a lack of
consistent ﬁndings across studies. When between-group differ-
ences were evident, they were often in dissimilar time and
frequency-domain HRVmeasures and not replicated consistently in
other studies. Furthermore, there appears to be insufﬁcient evi-
dence to determine if HRV in insomnia patients is impaired during
the day or how it may vary across the 24-hour cycle. We therefore
suggest that the evidence for HRV impairment in insomnia is
imperfect and that further studies are required.
Only one study examined HRV before and after cognitive
behavioural therapy [39], the gold-standard treatment for insomnia
patients [50e54]. Interestingly, despite a uniform increase in HR in
insomnia patients inmost case-control studies (refer toTable 3), HR
was only lowered during acupressure and acupuncture. Conversely,
whilst there was no difference in TP in case control studies, it
increased in three (of ﬁve) interventions. HRV changes were not
consistent in insomnia patients across interventions studies. This
may be related to the intervention modality, for instance, ear
accupressure was unlikely to affect insomnia severity [42]. There-
fore, the impact of interventions on HRV autonomic characteristics
in insomnia patients needs further investigation using well-
designed randomised controlled trials to mitigate bias and
enhance the clinical application of the ﬁndings.
Highly disparate populations were investigated across the
studies in our review. In many studies cases and controls were
retrospectively selected and despite providing statistical compari-
son between the groups, there was a lack of case-match method-
ology reporting. Sample sizes were generally small which limited
the generalisability of the ﬁndings. The largest of the studies
reviewed had 85 cases and 55 controls, derived from non-
comparable populations [29]. It is likely that many studies were
underpowered and this may have impacted on the ﬁndings.
Several diagnostic methods and insomnia severity scales were
used, making it difﬁcult to compare populations between studies.
An example of this is the use of sleep efﬁciency for insomnia patient
eligibility. Whilst two studies only included insomnia patients
when PSG sleep efﬁciency was 85% or less [20,34], others included
insomnia patients with high sleep efﬁciencies of greater than 90%
[26,27]. Only one study classiﬁed the severe insomnia phenotype of
total sleep time less than 6 h [21,44]. This study quantiﬁed short-
sleep duration insomnia using PSG-derived sleep efﬁciency,
whereby those with a sleep efﬁciency of less than 85% werePlease cite this article in press as: Dodds KL, et al., Heart rate variability in
Reviews (2016), http://dx.doi.org/10.1016/j.smrv.2016.06.004
Heart Rate Variability in Insomnia Patient Subtypesconsidered to be short-sleepers. This subgroup analysis revealed
differences between short-sleeping insomniacs and controls (refer
to Table 3); however, no within-group comparisons were made
between these insomnia patients i.e., short sleep duration insomnia
patients and thosewith a longer sleep time. Although it was not the
focus of our review, we are not aware of any other published
research that has used HRV to phenotype insomnia patients.
Sex, sex-ratio and age of participants and controls were diverse.
This is of particular concern given the known inﬂuence imparted on
HRV by sex and age [55,56]. Evidence from a recent meta-analysis
found females to have both higher mean HR and greater vagal ac-
tivity evident in a number of HRV measures [56]. Researchers
should be mindful of possible HRV implications from co-morbid
sleep disorders (particularly sleep obstructive sleep apnoea) when
designing studies particularly given the impact of confounders on
HRV [5,57]. Stimulants, medications and medical comorbidities
were often unreported and may have inﬂuenced HRV ﬁndings.
Considering the tremendous amount of inter-individual vari-
ability already present in HRV measures, methodological consid-
erations for HRV analysis are of utmost importance [58]. Standards
for the measurement and physiological interpretation were
developed in 1996 by the task force of the European society of
cardiology and the North American society of pacing and electro-
physiology, with updated recommendations on the use of novel
HRV techniques in the 2015 position statement [1,14]. Despite
stating that ‘…the complete signal should be carefully edited using
visual checks andmanual corrections of individual RR intervals and
QRS complex classiﬁcations’, many insomnia-HRV studies have not
used these standards [1]. Notably, only four case-control studies
[21,28,29,32] and three interventional studies [39,40,43] refer-
enced the task force guidelines when describing methodology.
Erroneous HRV results may have arisen from physiological artifact
(such as ectopic heart beats), technical methods or the algorithms
used for R wave detection and editing. Signal length and disconti-
nuity can also easily affect power spectral analysis, obscuring HRV
ﬁndings [59]. Quintana et al. [60] have recently published guide-
lines for reporting HRV in psychiatry, speciﬁcally outlining the
different aspects required when reporting HR collection, RR inter-
val analysis, cleaning methods and HRV calculation techniques. For
researchers examining HRV during sleep, a number of additional
difﬁculties must be considered, including the inherent autonomic
changes evident in different sleep stages, circadian effect, the in-
ﬂuence of comorbid sleep disorders, variable recording lengths andinsomnia patients: A critical review of the literature, Sleep Medicine
19
Research agenda
1) Develop recommendations for the measurement, anal-
ysis and reporting of HRV in sleep and circadian research
to aid the interpretation, reproducibility and cross-
comparison of results.
2) Perform large longitudinal studies of insomnia patients
and controls that incorporate 24-hour recordings to
determine the heart rate variability of insomnia patients
across the sleepewake cycle.
3) Consider the retrospective and prospective validation of
the cardiovascular disease predictive power of heart rate
variability measures in insomnia patients and appropri-
ately matched controls (possibly via a nested case-
control study within a cardiovascular disease cohort
study).
4) Explore whether heart rate variability can be used to
phenotype the heterogeneous insomnia population.
K.L. Dodds et al. / Sleep Medicine Reviews xxx (2016) 1e13 11the inability to control respiratory rate. Until further clariﬁcation is
provided about how to handle these factors, researchers should
report all aspects of their study protocol, participant demographics,
analysis techniques and HRV ﬁndings.
The bidirectional relationship between electroencephalogram
(EEG) and HRV in insomnia has also been examined to gain a better
understanding of insomnia pathophysiology. Jurysta and colleagues
[32] found decreased linear coupling between HF HRV power and
delta EEG power in insomnia compared to controls. Maes et al. [33]
examined the sleep onset period and ﬁrst NREM sleep cycle and
revealed signiﬁcant associations between EEG microstructure (K-
complexes within one second followed by 8e12 Hz EEG activity)
and a lowered HF in SWS. Whilst HRV may be similar between
insomnia and controls, the relationship between HRV and EEG
appears altered and different from controls. Further research is
required to elucidate coherence between HRV and EEG frequency
domains.
Limitations of our review include the use of different risk of bias
assessment tools, determined by only one author. No attempts
were made to contact study authors when the method of HRV
analysis was unclear. We were unable to perform a meta-analysis
due to lack of comparable HRV measures, different study designs,
populations, measurement techniques and analyses.
A number of studies in this review have drawn conclusions
about the associations between physiological hyperarousal, HRV
and cardiovascular disease. It is tempting to deduce that an increase
in sympathetic-related HRV measures will be mirrored by a
decrease in parasympathetic-related HRV measures and that this
explains autonomic dysfunction. However, the traditional notion of
an antagonistic autonomic nervous system is now questioned [61].
Bonnet and Arand [20] described an increase in sympathetic and
decrease in parasympathetic activity across all reported sleep
stages but these ﬁndings have not been replicated in the past 18
years. The additional questioning of the correlation between LF and
LF/HF with sympathetic activity makes it unlikely that HRV alone
can assist in determining causal pathways between autonomic
dysfunction and cardiovascular morbidity in the insomnia popu-
lation. Certainly the ﬁndings from this review cannot support this
link.
Future research should employ 24-hour HRV recordings. Previ-
ous cardiovascular studies have shown associations with impaired
HRV in 24-hour and mortality and morbidity and whilst this does
not demonstrate causality, it would provide evidence of a link be-
tween physiological hyperarousal in insomnia and cardiovascular
risk. Moreover, the inﬂuence of known confounders, such as age
and sex, must be considered in prospective analyses.
In conclusion, our critical review of the insomnia-HRV research
studies revealed varied results and a lack of consistent HRV ﬁndings
in insomnia patients. We suggest that longitudinal studies (of large
sample sizes using repeat measures) are required to determine the
relationship, if present, between HRV and insomnia.Practice points
1) There is inconsistent evidence to suggest that heart rate
variability is impaired in insomnia.
2) We cannot deduce if or how insomnia interventions alter
heart rate variability and autonomic dysfunction.
3) Measurements from short-term heart rate recordings
cannot be compared to 24 hour recordings, thus
the use of heart rate variability as a prognostic tool for
cardiovascular disease in insomnia patients is not yet
possible.
Please cite this article in press as: Dodds KL, et al., Heart rate variability in
Reviews (2016), http://dx.doi.org/10.1016/j.smrv.2016.06.004
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Boolean search strategy for each database.
Search performed on 25th January 2016
No limitations on publication date, type or language
CINAHL e 9 results
(MH “Heart Rate Variability” OR “heart rate variability” or HRV)
AND (MH “Insomnia” OR insomnia*)
Embase e 182 results
(hrv OR 'heart rate variability'/exp OR 'heart rate variability')
AND insomni*
Google Scholar e 21 results
Did not search for patents or citations.
(intitle: “heart rate variability” OR intitle:HRV) AND (inti-
tle:insomnia OR intitle:insomniac OR intitle:insomniacs)
PubMed e 60 results
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Chapter 3: HRV at Sleep Onset 
 
Preamble 
Sleep is a dynamic state, consisting of sleep stages and cycles with differing 
physiology and function. In general, vagal-dominance is expected in healthy sleepers (de 
Zambotti, Covassin, Tona, Sarlo, & Stegagno, 2011). As many insomnia patients are 
symptomatic prior to sleep onset, it has been proposed that this is when autonomic 
dysregulation may be present at this time (de Zambotti et al., 2011). 
Although physiological activity during the transition from wake to sleep have long 
been subject to investigation (Freedman & Sattler, 1982; Lamarche & Ogilvie, 1997; Merica 
& Gaillard, 1992; Trinder, 2012; Trinder et al., 2001), there are only three studies that have  
investigated the HRV of insomnia patients around or before/after sleep onset (de Zambotti 
et al., 2011; Maes et al., 2014; Spiegelhalder et al., 2011).  
de Zambotti and colleagues undertook a comprehensive assessment of 
cardiovascular activity present in a small number of insomnia patients (n = 8) compared to 
good sleeping controls (n = 8) (2011). Outcomes included HRV and those from impedance 
cardiography; cardiac output, stroke volume and pre-ejection period. Using their findings 
from both measures, it was concluded that insomnia patients had continuously high 
sympathetic activity across the sleep onset period accompanied by gradually increasing 
parasympathetic activity, compared to good sleeping controls. 
In a larger study of 58 insomnia patients and 46 healthy controls, Spiegelhalder et al. 
(2011) investigated HRV during wake, NREM and REM sleep. Although the sleep onset 
period was not directly investigated, pre-post comparisons between wake and sleep (REM 
and NREM) were undertaken. Resultantly, a lower wake-to-sleep (NREM) HR reduction was 
found amongst insomnia patients when compared to controls.  
More recently, Maes et al. (2014) looked at electroencephalography (EEG) and ECG 
at the sleep onset period exploring whether a correlation between the two domains based 
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on the presence of systemic hyperarousal. Higher HR and increased beta-EEG power in sleep 
onset period was found in patients with insomnia (n = 17) but not in the controls (n = 11). 
This was present despite no statistical significant between-group differences in HRV 
measures. 
The following article comprised the first direct comparison of HRV across the sleep 
onset period (10 minutes prior and 10 minutes after sleep onset: American Academy of 
Sleep Medicine-defined) of insomnia patient subtypes, determined from objectively derived 
sleep-parameters. Although methodology is adequately described in the publication, further 
details are provided below to describe explicitly the step-by-step process used for HRV 
analysis.  
Sleep onset time was manually extracted from the sleep staging file and imported 
into Excel. A worksheet was created to determine the sleep onset period in 2 minute 
windows, from 10 minutes before, to 10 minutes after sleep onset. Individual European 
Data Files (EDF) containing the nocturnal ECG were exported from the PSG recording 
program (RemLogic) to Kubios. Using the Excel worksheet to define the sleep onset period, 
20 minutes of the recording was segmented into two-minute time samples (10 time samples 
in total).  
Automated QRS detection was visually checked over the entire sample. Any 
erroneously marked R waves were removed. Any ectopics (atrial or ventricular) were 
marked as artifact, as was any signal noise that prevented viewing a discernible R wave. Any 
undetected R waves were checked. Once the 20 minute sleep onset period ECG had been 
inspected and edited (as required), ‘very low’ artifact correction was applied. No detrending 
method was applied. 
Frequency bands of 0.04 to 0.15 Hz for low frequency (LF) and 0.15-0.4 Hz for high 
frequency (HF) were utilised. The interpolation rate was set at 4 Hz with a Fast Fourier 
Transformation window width of 256 seconds (50% overlap). Values were checked for 
biological possibility against standards paper and previous research on insomnia patients 
(Nunan, Sandercock, & Brodie, 2010; Spiegelhalder et al., 2011). Data were then exported 
from Kubios for statistical analysis. 
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Limitations not otherwise mentioned within the manuscript (but pertaining 
specifically to HRV) include not controlling for diet (i.e. stimulants in food and/or drink), 
circadian periodicity, menstrual cycle, and menopause. Finally, one limitation of HRV 
analysis over the sleep onset period is that it may not possess stationarity, important for the 
accurate analysis of the recording. Nonetheless, this was not such a concern in the present 
study given the observational nature of our study (using subtypes from the same sample).  
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Clusters of Insomnia Disorder: An Exploratory Cluster Analysis of Objective 
Sleep Parameters Reveals Differences in Neurocognitive Functioning, 
Quantitative EEG, and Heart Rate Variability
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Study Objectives: To empirically derive and evaluate potential clusters of Insomnia Disorder through cluster analysis from polysomnography (PSG). We 
hypothesized that clusters would differ on neurocognitive performance, sleep-onset measures of quantitative (q )-EEG and heart rate variability (HRV).
Methods: Research volunteers with Insomnia Disorder (DSM-5) completed a neurocognitive assessment and overnight PSG measures of total sleep time 
(TST), wake time after sleep onset (WASO), and sleep onset latency (SOL) were used to determine clusters.
Results: From 96 volunteers with Insomnia Disorder, cluster analysis derived at least two clusters from objective sleep parameters: Insomnia with normal 
objective sleep duration (I-NSD: n = 53) and Insomnia with short sleep duration (I-SSD: n = 43). At sleep onset, differences in HRV between I-NSD and 
I-SSD clusters suggest attenuated parasympathetic activity in I-SSD (P < 0.05). Preliminary work suggested three clusters by retaining the I-NSD and 
splitting the I-SSD cluster into two: I-SSD A (n = 29): defined by high WASO and I-SSD B (n = 14): a second I-SSD cluster with high SOL and medium WASO. 
The I-SSD B cluster performed worse than I-SSD A and I-NSD for sustained attention (P ≤ 0.05). In an exploratory analysis, q-EEG revealed reduced 
spectral power also in I-SSD B before (Delta, Alpha, Beta-1) and after sleep-onset (Beta-2) compared to I-SSD A and I-NSD (P ≤ 0.05).
Conclusions: Two insomnia clusters derived from cluster analysis differ in sleep onset HRV. Preliminary data suggest evidence for three clusters in insomnia 
with differences for sustained attention and sleep-onset q-EEG.
Clinical Trial Registration: Insomnia 100 sleep study: Australia New Zealand Clinical Trials Registry (ANZCTR) identification number 12612000049875. 
URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=347742.
Keywords: sleep, Insomnia Disorder, polysomnography, cluster analysis, and phenotyping
Citation: Miller CB, Bartlett DJ, Mullins AE, Dodds KL, Gordon CJ, Kyle SD, Kim JW, D’Rozario AL, Lee RS, Comas M, Marshall NS, Yee BJ, Espie CA, 
Grunstein RR. Clusters of Insomnia Disorder: an exploratory cluster analysis of objective sleep parameters reveals differences in neurocognitive functioning, 
quantitative EEG, and heart rate variability. SLEEP 2016;39(11):1993–2004.
INTRODUCTION
Insomnia is a prevalent and heterogeneous disorder that has 
been linked to impaired cardiovascular and neurobiological 
functioning.1–6 A number of classical clinical insomnia sub-
types have been identified from self-reports of patients and 
include difficulty with initiating sleep, maintaining sleep, 
early-morning awakening with an inability to return to 
sleep, nonrestorative sleep, and paradoxical insomnia among 
others.7–12 Two objective subtypes of insomnia have been pro-
posed by dichotomizing total sleep time (TST) derived from 
first-night polysomnography (PSG), and these groups differ 
on meaningful clinical outcomes.5 It remains unclear whether 
more than two subtypes of insomnia exist, especially under 
Diagnostic and Statistical Manual of Mental Disorders, Fifth 
Edition (DSM-5).7 Uncertainty however in the number of in-
somnia subtypes may be addressed through an empirical 
method by cluster analysis. Cluster analysis might be a way 
pii: sp-00060-16 http://dx.doi.org/10.5665/sleep.6230
Significance
Using cluster analysis, we derived at least two clusters of Insomnia Disorder, replicating previous findings of long and short objective sleep duration 
insomnia. Research volunteers with Insomnia Disorder and short objective sleep duration (I-SSD) displayed attenuated sleep-onset heart rate variability 
relative to those with insomnia and normal sleep duration (I-NSD) and may be at risk of future cardiometabolic ill health. An exploratory 3-cluster 
solution was uncovered by splitting the short sleep cluster into two: I-SSD A (sleep maintenance difficulties) and I-SSD B (sleep-onset and maintenance 
difficulties). The 3-cluster solution identified reduced sleep-onset quantitative-EEG power in I-SSD B relative to both I-NSD and I-SSD A. I-SSD B 
performed worse than I-SSD A and I-NSD for sustained attention.
to describe meaningful subtypes. No previous cluster analysis 
in DSM-5 Insomnia Disorder patients used a limited number 
variables from PSG.13–16
Cluster analysis is a data-driven method of generating 
candidates for meaningful phenotypes.17,18 A key advantage 
of this technique is the nonsubjective demarcation of cluster 
boundaries, which may provide clinicians with data-driven 
cut-points between phenotypes.19 Resulting clusters need to be 
tested for meaningful clinical differences between patients for 
outcomes that are not used to build the clusters.20 To do this 
we identified a number of insomnia based “biomarkers” from 
previous literature that may be more impaired in one cluster 
compared to another.3–6,21 Insomnia Disorder is fundamentally 
difficulty regulating sleep-wake transitions, and we should test 
these clusters for both markers of the hypothesized cardiovas-
cular and neurobiological sequelae, and where possible during 
the process of sleep-wake transition.3,4
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The aim of this study was to empirically derive clusters built 
from first-night PSG-derived sleep parameters (TST, sleep 
onset latency: SOL, and wake time after sleep onset: WASO) 
and to test for cluster differences in candidate biomarkers in 
volunteers with DSM-5 Insomnia Disorder.7 If meaningful 
clusters exist they may differ on neurocognitive performance, 
sleep-onset measures of quantitative (q)-EEG and heart rate 
variability (HRV).
METHODS
Research Volunteers
Research volunteers with Insomnia Disorder were recruited 
through responses to a database, clinic advertisements, on-
line, and in the local community and were initially screened 
over the telephone using a standardized assessment tool (based 
on Morin and Espie).22 Eligible volunteers (recruited between 
February 2012 until August 2014) attended the sleep clinic and 
underwent a comprehensive sleep interview and medical ex-
amination by a Sleep Physician or Sleep Psychologist to deter-
mine the presence of Insomnia Disorder through the following 
inclusion criteria: Insomnia Disorder as diagnosed by the 
DSM-5,7 specifically: difficulty initiating or maintaining sleep 
or waking up too early at least 3 nights per week, for at least 
3 months, with adequate opportunity and circumstances for 
sleep and a stable sleep/wake schedule, and a complaint of day-
time impairment (e.g., occupational, social, academic settings). 
In line with research diagnostic criteria for 
insomnia,8 exclusion criteria included: illicit 
substance dependence or alcohol/caffeine, 
severe or unstable psychiatric disorders, a 
known sleep disorder other than insomnia, 
cognitive impairment, and pregnancy or lac-
tation. Volunteers also recorded daily sleep 
diaries after screening and prior to the labo-
ratory assessment (similar to Morin22). All 
data were collected at the Woolcock Institute 
of Medical Research, University of Sydney, 
Australia (see Figure 1 for an overview). This 
study was reviewed and approved by the 
Royal Prince Alfred Hospital Ethics Review 
Committee, Sydney, Australia (Protocol No 
X11-0392 & HREC/11/RPAH/620); Clinical 
Trial Registration number: 12612000049875 
(ANZCTR). All volunteers gave written in-
formed consent.
Clinical and Demographic Outcomes
Demographic variables included: age, sex, 
body mass index (BMI kg/m2), education 
(highest attained), employment status, eth-
nicity, medication, alcohol consumption 
and smoking status and medical comor-
bidities including: heart disease, cancer, 
etc.,23 assessed by a self-report electronic 
questionnaire prior to the overnight sleep 
study. Clinical insomnia-related outcomes 
included: insomnia duration, insomnia as 
a child, family history of insomnia, Insomnia Severity Index 
(ISI: Morin),24 the 21-item version of the Depression Anxiety 
and Stress Scale (DASS),25 Epworth Sleepiness Scale (ESS),26 
Flinders Fatigue Scale (FFS),27 16-item version of the Dysfunc-
tional Beliefs and Attitudes About Sleep scale (DBAS),28 and 
the Ford Insomnia Response to Stress Test (FIRST).29 Volun-
teer reported questionnaires were also captured prior to sleep 
during the in-lab visit by electronic questionnaires. A paper 
based point in time assessment of the Daytime Insomnia 
Symptom Scale (DISS) was used prior to lights out to quan-
tify subjective reports of pre- and post-sleep alertness, mood 
(negative and positive) and sleepiness/fatigue.30,31
Sleep
One night of PSG was used to define objective sleep architec-
ture and continuity variables. A specific research montage was 
applied [EEG: F3, Fz, F4, C3, Cz, C4, Pz, O1, Oz, O2, all signals 
used ground at FPz and common reference at CPz], electroocu-
lographic (EOG: horizontal and vertical), electrocardiographic 
(ECG) and electromyographic (EMG: submental) recordings. 
Data were recorded on the Embla (n = 92: Mortara, Broomfield, 
CO) and Alice (n = 4: Respironics, Pittsburgh, PA) systems 
(512 Hz) and scored visually by one experienced sleep scorer, 
and each study was then independently checked for quality as-
surance by another independent scorer according to American 
Academy of Sleep Medicine (AASM) criteria.32 Each volunteer 
was set-up between 20:00–21:00 and could select a lights out 
Figure 1—Study CONSORT flow diagram.
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time with lights on at 06:00. Blood pressure was captured prior 
to sleep and on awakening the next morning. To determine 
sufficient sleep opportunity for all patients, video recording 
around the time for lights out and lights on was used to verify 
time in bed prior to initiating sleep (lights out) and leaving the 
bed the next morning (lights on).
Cluster Formation through Cluster Analysis
A hierarchical cluster analysis (Ward method using the squared 
Euclidean distance) was used to identify potential insomnia 
clusters. This technique allows for the formation of subgroups 
within complex data.19,33,34 It is recommended for smaller data 
sets (100 patients) where groupings are examined in succes-
sive steps until a number of relatively homogenous subgroups 
become statistically and clinically meaningful. Here, distinct 
clustering variables (at least 2), were chosen on theoretical 
grounds and previous research findings.5,35 Standardized (con-
verted to z-scores: see Milligan36) objective sleep parameters, 
including TST, SOL, and WASO were used.35 In order to derive 
the number of clusters, a dendrogram (hierarchical tree dia-
gram used to represent the distance between cases of cluster 
groupings) was used in combination with agglomeration find-
ings of the coefficients (see Table S1 in the supplemental mate-
rial). In the case that a single cluster solution is not entirely clear, 
all possible cluster solutions were examined against external 
variables associated with insomnia for validity including: neu-
rocognitive performance,37 and sleep-onset measures of quan-
titative EEG (q-EEG) and heart rate variability (HRV). The 
sleep-onset period was selected because of difficulty regulating 
sleep-wake transitions in insomnia. Entry into sleep may hold 
unique insights into physiological differences, reflecting cor-
tical and physiological hyperarousal,3,4,21,38–40 and the perception 
of sleep during this process41–43 between insomnia clusters.
Neurocognitive Outcomes
Neurocognitive performance was measured at approximately 
18:00 on the night of the sleep study prior to PSG overnight 
assessment. The tasks lasted approximately 40 min using a 
web-based platform, and were delivered on a laptop computer 
with a 17-inch color display, keyboard, and mouse. Volunteers 
practiced with the researcher until confident with the tasks. 
Three cognitive tasks of executive functioning previously used 
in insomnia studies were employed and included: working 
memory (N-back 2); percentage of total accuracy, total number 
of incorrect and missed responses,6 sustained attention (Letter 
Cancellation Test: LCT); mean correctly marked targets and 
the trial duration of the second sustained attention and pro-
cessing speed task,44 and planning and problem solving (Tower 
of London: ToL); percentage of errors and mean response la-
tency.45 Patients did not receive any task-related feedback about 
their performance.
Quantitative EEG at Sleep Onset
EEG artifact-free epochs, from C3 and C4 (referenced to the 
right mastoid), were analyzed for power spectra using a previ-
ously validated standard fast Fourier transform with a rectan-
gular weighted window for each non-overlapping 5-s epoch.46 
Primarily, C3 was chosen as it is traditionally recommended 
for use in scoring sleep47 and has been used previously for 
spectral analysis in insomnia research.48,49 A sleep-onset pe-
riod of 10 min either side of AASM-defined sleep-onset was 
divided into 1-min intervals for absolute (natural logarithm 
transformation) spectral bands: delta (0.5–4.5 Hz), theta (4.5–8 
Hz), alpha (8–12 Hz), sigma (12–15 Hz), beta-1 (16–24 Hz) and 
beta-2 (24–32 Hz) frequencies. The 20-min sleep-onset period 
was selected as it may best reflect difficulty with the wake-to-
sleep transition in insomnia. Absolute power was selected as a 
first principle analysis for two reasons: (1) In absolute power, 
all frequency bands are independent from one another and this 
is more advantageous for interpretation as opposed to relative 
power which is based on a ratio. (2) Individual patient variation 
may be reduced by using relative as opposed to absolute power, 
which may result in a source of bias.42
HRV at Sleep Onset
A similar approach was employed for HRV obtained from a 
2-lead ECG (512 Hz) during PSG assessment for 10 min either 
side of sleep onset (divided into 2-min intervals). Kubios HRV 
Version 2.1 was used for HRV analysis.50 Manual artifact iden-
tification and RR data editing was performed prior to analysis. 
Two-minute intervals that did not contain ≥ 80% normal R-R 
intervals were rejected and data with numerical values > 4 SD 
above the mean of the whole sample were excluded as deemed 
biological implausible.51 Time-domain measures: heart rate 
(HR: bpm), standard deviation of all N-N intervals (SDNN: 
ms), root mean square of successive R-R intervals (rMSSD: 
ms), percentage (%) of successive R-R intervals that differ 
by > 50 ms (pNN50); and frequency-domain measures: high 
frequency (HF: ms2) and a low frequency (LF)/HF ratio were 
employed.52–54
Statistical Analysis
Differences between clusters in demographic, clinical, sleep 
and neurocognitive outcome variables were assessed through 
univariate one-way analysis of variance (ANOVA), Kruskal-
Wallis tests or χ2 tests among the cluster groups. In relation 
to neurocognitive variables, known confounders (age, gender, 
and education) were always inserted as covariates (see Table 1 
and Table S2 in the supplemental material). For both q-EEG 
and HRV analyzes, linear mixed model analysis, with fixed 
effects for time (wake-to-sleep) and cluster group, and random 
intercepts effects for between-subject variation, were imple-
mented for each outcome variable with age and gender as co-
variates. Least significant differences were employed for post 
hoc comparisons between cluster groups. Effect size scores 
were calculated for significant pair-wise group comparisons 
where appropriate. P was set at < 0.05 for all analyzes. All data 
were analyzed (by CBM) using SPSS software (IBM v 22.0.0; 
IBM Corp, Armonk, NY, USA).
RESULTS
Volunteer Characteristics
One hundred volunteers with insomnia consented for this 
phenotyping experiment and 96 (61 females) were included in 
the analysis (see Figure 1) with a mean (SD) age of 41.4 years 
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Table 1—Demographic, sleep parameters (used to cluster individuals), and clinical information between insomnia subgroups in the 2-cluster solution.
Mean (± SD)
Overall
(n = 96)
I-NSD Cluster
(n = 53)
I-SSD Cluster
(n = 43) ANOVA F (P)
Effect Size (d, r )
I-NSD vs. I-SSD
Age (y), mean (SD), range 41.4 (11.8), 23–75 38.6 (11.6), 23–66 44.8 (11.2), 23–75 6.97 (0.010)* 0.54
BMI (kg/m2) 25.0 (4.3) 24.7 (4.2) 25.4 (4.4) 0.63 (0.429) 0.16
Total sleep time (min) 346.1 (67.8) 392.3 (35.4) 289.2 (53.4) 117.97a (< 0.001)** 2.27
Sleep onset latency (min) 25.3 (23.9) 18.0 (11.7) 34.32 (31.2) 10.57a (< 0.01)* 0.69
Wake time after sleep onset (min) 72.5 (58.6) 39.9 (22.6) 112.6 (64.4) 49.84a (< 0.001)** 1.51
Insomnia Severity Index 17.3 (4.8) 18.0 (4.0) 16.5 (5.5) 2.07a (0.154) 0.31
Insomnia duration (y) 10 (11) 10 (10) 10 (14) 0.03b (0.855) 0.02
DASS - Depression 6 (12) 6 (12) 4 (9) 0.42b (0.518) 0.07
DASS - Anxiety 4 (6) 4 (7) 4 (7) 0.18b (0.669) 0.11
DASS - Stress 15.3 (9.0) 15.8 (8.3) 14.7 (10.0) 0.34 (0.560) 0.12
Epworth Sleepiness Scale 6.4 (4.5) 6.2 (4.5) 6.7 (4.5) 0.38 (0.541) 0.11
Flinders Fatigue Scale 18.0 (6.4) 18.4 (6.2) 17.5 (6.7) 0.43 (0.513) 0.14
Ford Insomnia Response to Stress Test 24.0 (6.1) 24.3 (5.9) 23.7 (6.4) 0.27 (0.608) 0.10
Dysfunctional Beliefs and Attitudes about Sleep scale 6.1 (1.7) 6.2 (1.4) 5.9 (2.0) 0.85 (0.359) 0.17
Pre-sleep DISS - Alert cognition 52.2 (16.0) 52.0 (16.7) 52.4 (15.2) 0.01 (0.917) 0.03
Pre-sleep DISS - Negative mood 27.9 (17.0) 27.7 (16.4) 28.2 (18.8) 0.02 (0.889) 0.03
Pre-sleep DISS - Positive mood 46.0 (12.8) 47.2 (13.4) 44.4 (11.9) 1.08 (0.302) 0.22
Pre-sleep DISS - Sleepiness / fatigue 54.7 (17.7) 55.6 (17.8) 53.6 (17.7) 0.32 (0.576) 0.11
Apnea-hypopnea index 3.1 (5.7) 2.8 (5.1) 3.5 (8.2) 1.91b (0.167) 0.14
Evening systolic blood pressure (mm Hg) 115.3 (14.3) 115.4 (15.9) 115.3 (12.3) 0.00 (0.974) 0.00
Evening diastolic blood pressure (mm Hg) 74.5 (9.4) 74.6 (9.5) 74.3 (9.5) 0.04 (0.850) 0.00
Morning systolic blood pressure (mm Hg) 107.0 (13.5) 106.0 (14.8) 108.2 (11.9) 0.61 (0.439) 0.02
Morning diastolic blood pressure (mm Hg) 71.0 (9.1) 69.8 (8.9) 72.5 (9.1) 1.95 (0.166) 0.30
Number of alcoholic drinks per week (standard units) 4.0 (6) 4.0 (5) 3.3 (6) 0.55b (0.459) 0.08
Binary Variables n (%) n (%) n (%) χ2 (P) Effect Size (V )
Sex (f) 61 (63.5%) 36 (67.9%) 25 (58.1%) 0.98 (0.322) 0.10
Insomnia as a child 16 (16.7%) 10 (18.9%) 6 (14.0%) 0.45 (0.503) 0.07
Family history 28 (29.2%) 17 (32.1%) 11 (25.6%) 0.02 (0.880) 0.02
Education, highest attained
High school 12 (12.5%) 8 (15.1%) 4 (9.3%) 0.58 (0.447) 0.08
College graduate 47 (49.0%) 22 (41.5%) 25 (58.1%) 3.05 (0.081) 0.18
Post graduate 32 (33.3%) 21 (39.6%) 11 (25.6%) 1.84 (0.175) 0.14
Ethnicity 
Central South Asian 4 (4.2%) 3 (5.7%) 1 (2.3%) 0.70c (0.624) 0.85
East Asian 1 (1.0%) 1 (1.9%) 0 (0%) 0.84c (1.00) 0.09
South East Asian 2 (2.1%) 1 (1.9%) 1 (2.3%) 0.02c (1.00) 0.01
White Caucasian 88 (91.7%) 47 (88.7%) 41 (95.4%) 0.85c (0.457) 0.10
Employment 
Full-time 65 (67.7%) 40 (75.5%) 25 (58.1%) 2.27 (0.132) 0.16
Part-time 16 (16.7%) 8 (15.1%) 8 (18.6%) 0.34 (0.590) 0.06
Unemployed 11 (11.5%) 4 (7.5%) 7 (16.3%) 2.07c (0.151) 0.15
Medical comorbidities 35 (36.5%) 15 (28.3%) 20 (46.5%) 2.76 (0.096) 0.17
Mild-to-moderate depression/anxiety 11 (11.5%) 5 (9.4%) 6 (14.0%) 0.12 (0.914) 0.02
Heart disease 0 (0%) 0 (0%) 0 (0%) 0 (0.0) –
Cancer 0 (0%) 0 (0%) 0 (0%) 0 (0.0) –
High blood pressure 1 (1.0%) 1 (1.9%) 0 (0%) 1.31c (0.441) 0.20
Neurologic 0 (0%) 0 (0%) 0 (0%) 0 (0.0) –
Breathing 8 (8.3%) 5 (9.4%) 3 (7.0%) 1.43c (0.417) 0.21
Urinary 1 (1.0%) 1 (1.9%) 0 (0%) 1.31c (0.441) 0.20
Diabetes 1 (1.0%) 0 (0%) 1 (2.3%) 0.81c (1.00) 0.16
Chronic pain 8 (8.3%) 3 (5.7%) 5 (11.6%) 0.19c (0.709) 0.07
Gastrointestinal 6 (6.3%) 1 (1.9%) 5 (11.6%) 0.03c (1.00) 0.03
Thyroid 3 (3.1%) 1 (1.9%) 2 (4.7%) 0.16c (1.00) 0.07
Other 11 (11.5%) 5 (9.4%) 6 (14.0%) 0.12 (0.914) 0.02
Current smoker 8 (8.3%) 4 (7.5%) 4 (9.3%) 0.08c (0.780) 0.03
Past smoker 29 (30.2%) 11 (20.8%) 18 (41.9%) 4.76 (0.029)* 0.22
Never smoked 58 (60.4%) 37 (69.8%) 21 (48.8%) 4.93 (0.026)* 0.23
Medication 49 (51.0%) 23 (43.4%) 26 (60.5%) 2.32 (0.127) 0.16
Prescription sleep aid 9 (9.4%) 6 (11.3%) 3 (7.0%) 1.56c (0.279) 0.18
Over the counter sleep aid 2 (2.1%) 0 (0%) 2 (4.7%) 1.92c (0.490) 0.20
Prescription psychiatric medication 5 (5.2%) 3 (5.7%) 2 (4.7%) 0.33c (0.660) 0.08
Other medication 31 (32.3%) 13 (24.5%) 18 (41.9%) 1.26 (0.263) 0.16
Means, standard deviations (SD) and effect size (Cohen’s d, r  for variables not normally distributed or Cramér V for binary variables) for each cluster comparison are provided. a Welch statistic correction 
for violation of homoscedasticity. b Kruskal-Wallis test with median (inter-quartile range) for variables not normally distributed. c Fisher exact test correction for cells with n < 5. Significant main effects are 
in bold. *P < 0.05. **P < 0.001. Medical comorbidities: Neurologic (seizures, Parkinson disease), Breathing (asthma, emphysema), Urinary (kidney disease, prostate problems), Chronic pain (arthritis, back 
pain, gout, migraines) and Gastrointestinal (stomach, irritable bowel syndrome, ulcers). ANOVA, analysis of variance; DASS, Depression, Anxiety, and Stress scales; DISS, Daytime Insomnia Symptom 
Scale; I-NSD, Insomnia with Normal Sleep Duration; I-SSD, Insomnia with Short Sleep Duration. 
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(11.8). Mean (SD) insomnia severity (ISI) was 17.3 (range: 
1–28; SD = 4.8): 21 (22%) volunteers experienced insomnia 
symptoms for the last 5 years, 17 (18%) had symptoms for 
5–10 years; 31 (32%) for 10–20 years; 21 (22%) reported symp-
toms longer than 20 years, with 16 (17%) volunteers reporting 
symptoms as a child. Using PSG-derived sleep, the average 
(SD) TST = 346.1 (67.8) mins, SOL = 25.3 (23.9) mins and 
WASO = 72.5 (58.6) mins (see Table 1).
Cluster Characteristics
Cluster analysis revealed two possible solutions (see Table S1 
in the supplemental material). The outcomes for both the 
2- and 3-cluster solutions were compared and contrasted in 
an attempt to solve ambiguity. Solution 1 identified an In-
somnia with normal sleep duration (I-NSD) cluster (n = 53) 
and an Insomnia with short sleep duration (I-SSD) cluster 
(n = 43). Solution 2 preserves the I-NSD cluster (n = 53) 
and splits the I-SSD cluster into two further clusters to 
make three: Insomnia with short sleep duration type-A (I-
SSD A: defined by high WASO) (n = 29) and Insomnia with 
short sleep duration type-B (I-SSD B: defined by high SOL 
and medium WASO) (n = 14). Table 1 displays the cluster 
group mean (SD) scores for each of the three sleep vari-
ables defining cluster solutions 1 and 2. Between-group 
differences with estimations of effect size calculations 
are also listed. Figure 2 displays all volunteers in cluster 
groups for both possible solutions across the 3-dimensions 
for PSG-derived TST, SOL, and WASO (see Video 1 and 
the description of Video 1 in the supplemental material). 
In the 2-cluster solution, we found I-NSD had significantly 
higher TST and reduced WASO and SOL compared to the 
I-SSD cluster. In support of the 3-cluster solution, I-SSD A 
were significantly higher for WASO than I-NSD and I-SSD 
B, whereas I-SSD B is significantly higher for SOL than 
I-SSD A and I-NSD (see Table 1 and Figure 2). There were 
no differences between clusters for PSG-sleep study re-
cording time (difference between lights-off until lights-on) 
across solution 1: I-NSD (mean = 450.9; SD = 36.9 mins); 
I-SSD (mean = 438.4; SD = 40.0 mins) (P > 0.10) or solu-
tion 2: I-SSD A (mean = 436.1; SD = 44.6 mins); I-SSD B 
(mean = 443.1; SD = 29.30 mins) (P > 0.20).
Neurocognitive Outcomes
For neurocognitive outcome parameters: in solution 1 
(2-cluster), the I-NSD and I-SSD clusters did not differ in neu-
rocognitive measures (see Table 2). In solution 2 (3-cluster), 
LCT sustained attention task scores were better in I-SSD A 
compared to I-SSD B (P < 0.05, d = 0.93) and in I-NSD (better) 
compared to I-SSD B (P = 0.05, d = 0.63: see Table 3).
Quantitative EEG at Sleep Onset
Of the 96 patients, 94 were included for analysis (1 could not be 
analyzed due to a different sampling rate between C3 and C4 
and another had a corrupt data file). For q-EEG spectral bands, 
there were no overall between cluster differences in either cluster 
solution 1 or 2. At C3, mixed model analysis revealed signifi-
cant cluster × time (wake-to-sleep) interactions for mean absolute 
Delta power in both solutions 1 and 2 (P < 0.05). Before sleep-
onset, comparisons revealed a significant reduction in solution 
2 Delta power in I-SSD B vs. I-SSD A and I-SSD B vs. I-NSD 
(P < 0.05). The alpha power interaction was significant in both 
solutions 1 and 2 (P ≤ 0.0001). Before sleep onset, comparisons 
Figure 2—Clusters of all 96 volunteers with insomnia displayed in 
3-dimensions according to PSG-defined total sleep time (TST), sleep 
onset latency (SOL), and wake time after sleep onset (WASO). Cluster 
solution 1: Insomnia with Normal Sleep Duration (I-NSD: Diamonds; 
n = 53) vs. Insomnia with Short Sleep Duration (I-SSD: Both circles; 
n = 43). Cluster solution 2: Insomnia with Normal Sleep Duration (I-NSD: 
Diamonds; n = 53) vs. Insomnia with Short Sleep Duration type-A 
(I-SSD A: Gray circles; n = 29) vs. Insomnia with Short Sleep Duration 
type-B (I-SSD B: Black circles; n = 14).
Table 2—A 2-cluster solution defined by polysomnography is not associated with any neurocognitive performance measurements.
Mean (± SE)
Neurocognitive Outcomes Effect Size (d )
Overall I-NSD Cluster I-SSD Cluster ANCOVA F (P) I-NSD vs. I-SSD
N-Back 2: Percentage of total accuracy 85.9 (1.3)% 86.6 (1.8)% 85.2 (2.0)% 0.25 (0.622) 0.11
N-Back 2: Total number incorrect 5.3 (0.5) 5.1 (0.8) 5.4 (0.8) 0.05 (0.826) 0.06
N-Back 2: Total number missed 11.2 (1.5) 10.6 (2.1) 11.9 (2.3) 0.17 (0.680) 0.09
LCT: Mean of correctly marked targets 50.7 (1.7) 52.5 (2.1) 51.2 (2.4) 0.14 (0.706) 0.07
LCT: Final trial duration (sec) 321.4 (66.0) 327.3 (90.4)  315.4 (102.9) 0.70 (0.405) 0.21
ToL: Percentage of errors 32.3 (1.9)% 34.1 (2.6)% 30.5 (2.9)% 0.82 (0.369) 0.21
ToL: Mean response latency (sec) 11.4 (65.2) 10.6 (86.7) 12.2 (97.9) 1.42 (0.237) 0.03
Means and standard errors (adjusted for age, gender, and education) and effect size (Cohen’s d) are provided for each cluster comparison. ANCOVA, 
analysis of covariance; LCT, Letter Cancellation Test; ToL, Tower of London; I-NSD, Insomnia with Normal Sleep Duration; I-SSD, Insomnia with Short 
Sleep Duration.
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revealed I-SSD B to have a lower alpha power compared to I-SSD 
A (P < 0.05) and I-NSD (P = 0.07). Interactions were also signifi-
cant for beta-1 and sigma power in solution 2 only (P < 0.0001) 
with reductions in beta-1 only in I-SSD B vs. I-SSD A (P < 0.05) 
before sleep. A nonsignificant reduction was found for sigma 
power between I-SSD B vs. I-SSD A before sleep (P = 0.07). 
The beta-2 power interaction was significant in both solutions 
(P ≤ 0.01). Before sleep onset, a reduction in beta-2 power was 
found in I-SSD B vs. I-SSD A (P = 0.05). After sleep-onset, 
I-SSD B showed significantly reduced beta-2 power vs. I-SSD 
A (P < 0.05) and I-NSD (P = 0.05). Theta power displayed an in-
teraction for both solutions (P ≤ 0.05) but no significant compari-
sons. In solution 1, there were no significant between cluster × 
time differences for I-NSD vs. I-SSD. Similar results were found 
at C4 (see Figure 3 and Figure S1 in the supplemental material).
HRV at Sleep Onset
For HRV analysis, out of the 96 volunteers, 1 was left out of the 
analysis due to a corrupt data file and 9 patients were removed 
from the analysis for the following reasons: irregular rhythm 
throughout the recording (n = 3), excessive artifact (n = 3) and 
unable to visualise the ECG from recording (n = 3). From the 
86 volunteers, 93 (10.8%) Two-minute segments were missing 
or removed due to artifact and 4 were removed due to extreme 
outliers > 4 SD (0.5%). Mixed model analysis revealed mean 
cluster differences in solution 1 for both rMSSD and pNN50 
(P < 0.05) with lower values (attenuated) for the I-SSD cluster 
(rMSSD (ms): M (SE) = 44.3 (3.1) vs. 34.4 (3.5); pNN50 (ms): 
M (SE) = 22.4 (2.5) vs. 13.4 (2.7): see Figure 4. HF and the 
LF/HF ratio approached significance (P < 0.10). In solution 2, 
pNN50 displayed a nonsignificant mean reduction (lower) in 
I-SSD A vs. I-NSD (P = 0.07). There were no significant cluster 
differences for HR, SDNN, or HF across either solutions 1 or 
2. In solution 2 only, the cluster × time (wake-to-sleep) in-
teraction approached for the LF/HF ratio (P < 0.07), reduced 
(P < 0.05) in I-NSD (M (SE) = 1.9 (0.3) compared to I-SSD A 
(M (SE) = 2.8 (0.4) before sleep-onset (see Figure 4).
DISCUSSION
Exploratory cluster analysis of 96 volunteers with Insomnia 
Disorder derived at least two clusters from objective sleep 
parameters TST, SOL, and WASO: Insomnia with Normal Sleep 
Duration (I-NSD: n = 53) and Insomnia with Short Sleep Dura-
tion (I-SSD: n = 43). We were unable to rule out a 3-cluster solu-
tion that retained the I-NSD cluster and split the I-SSD into two: 
I-SSD A (n = 29) defined by high WASO; and I-SSD B (n = 14) 
a second I-SSD cluster with high SOL and medium WASO. It 
was not possible to evaluate a 4-cluster solution due to a lack 
of statistical power. More than one cluster solution appears to 
exist in volunteers who have Insomnia Disorder. We now have 
a testable model of two cluster solutions to use in analysis of 
data from existing and future insomnia cohorts. Indeed, we are 
currently evaluating insomnia cluster response to cognitive be-
havioural therapy in a new separate sample of patients grouped 
according to empirical solutions derived here (ANZCTR Clin-
ical Trial Registration Number: 12615000751572).
Three steps are required to evaluate the usefulness of groups 
derived from cluster analysis. First, both the 2-cluster (I-NSD 
and I-SSD) and the 3-cluster solutions (I-NSD, I-SSD A and 
I-SSD B) resulted in groups that were significantly distin-
guished by the cluster input parameters: TST, SOL, and WASO 
(see Table 1). Second, when characterizing clusters in terms of 
clinical and demographic outcomes, there were no differences 
in traditional self-reported measures of insomnia between 
clusters for any solution in this select volunteer sample (see 
Table 1 and Table S2 in the supplemental material). Clusters 
do not appear to be identifiable from classic measures of in-
somnia and may offer novel information. This is in line with 
recent literature where subjective sleep measures are unable 
to detect insomnia-related morbidity outcomes between I-SSD 
and I-NSD.55 The 2-cluster (I-SSD and I-NSD) solution may 
represent previous findings of long and short objective sleep 
duration insomnia and the distribution of volunteers across 
this solution is similar (I-NSD = 53 vs. I-SSD = 43).5 Third and 
most importantly, to test the external validity of the clusters 
we evaluated for between cluster differences in four outcomes 
that were not used to build the clusters including neurocogni-
tive performance and sleep-onset measures of HRV and qEEG.
Sleep Onset Heart Rate Variability
In the 2-cluster (I-SSD and I-NSD) solution only, differences 
were found for sleep-onset measures of HRV. I-SSD displayed 
Table 3—A 3-cluster solution defined by polysomnography is associated with neurocognitive performance measurements of sustained attention.
Mean (± SE)
Neurocognitive Outcomes Effect Size (d )
Overall
I-NSD
Cluster
I-SSD A
Cluster 
I-SSD B 
Cluster ANCOVA F (P)
I-NSD vs. 
I-SSD A
I-NSD vs. 
I-SSD B
I-SSD A vs. 
I-SSD B
N-Back 2: Percentage of total accuracy 85.3 (1.5)% 86.5 (1.8)% 87.1 (2.6)% 82.3 (3.3)% 0.73 (0.485) 0.07 0.35 0.41
N-Back 2: Total number incorrect 5.5 (0.6) 5.2 (0.7) 4.4 (1.1) 6.9 (1.3) 1.10 (0.337) 0.13 0.36 0.49
N-Back 2: Total number missed 11.0 (1.7) 10.5 (2.1) 14.3 (2.9) 8.1 (3.7) 0.93 (0.398) 0.26 0.18 0.44
LCT: Mean of correctly marked targets 50.7 (1.7) 52.1 (2.1) 56.3 (3.1) 43.6 (3.8) 3.24 (0.045)* 0.30 0.63 ¥ 0.93*
LCT: Final trial duration (sec) 320.9 (75.0) 327.9 (90.8) 307.8 (135.9) 326.9 (167.9) 0.73 (0.488) 0.33 0.02 0.32
ToL: Percentage of errors 31.2 (2.1)% 33.9 (2.6)% 33.3 (3.8)% 26.4 (4.7)% 1.02 (0.367) 0.05 0.45 0.40
ToL: Mean response latency (sec) 11.4 (71.6) 10.5 (0.9) 13.2 (1.3)  10.6 (1.6) 1.52 (0.225) 0.04 0.00 0.04
Means and standard errors (adjusted for age, gender, and education) and effect size scores (Cohen’s d) are provided for each cluster comparison. Significant effects 
are in bold. *P < 0.05. ¥ P = 0.05. ANCOVA, analysis of covariance; LCT, Letter Cancellation Test; ToL, Tower of London. I-NSD, Insomnia with Normal Sleep Duration; 
I-SSD A, Insomnia with Short Sleep Duration type-A; I-SSD B, Insomnia with Short Sleep Duration type-B. 
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Figure 3—Quantitative analysis of sleep-EEG spectra during sleep-onset at C3 shows reduced Absolute Power (Ln) in the 3-cluster solution only. 
Quantitative EEG analysis of mean (SE) delta (0.5–4.5 Hz), theta (4.5–8 Hz), alpha (8–12 Hz), sigma (12–15 Hz), beta-1 (16–24 Hz), and beta-2 (16–32 Hz) 
frequency bands (Ln Absolute Power adjusted for age and gender) for 10 min before-to-after American Academy of Sleep Medicine (AASM) defined sleep 
onset. I-NSD, Insomnia with Normal Sleep Duration; I-SSD, Insomnia with Short Sleep Duration; I-SSD A, Insomnia with Short Sleep Duration type-A; 
I-SSD B, Insomnia with Short Sleep Duration type-B. *P < 0.05.
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Figure 4—Analysis of heart rate variability during sleep-onset shows impaired variability in the 2-cluster solution only. Mean (SE) Heart rate (HR: bpm), 
standard deviation of all N-N intervals (SDNN: ms), root mean square of successive R-R Interval differences (rMSSD: ms), percentage (%) of successive 
R-R Intervals that differ by more than 50 ms (pNN50); high frequency (HF: ms2) and a low frequency (LF)/HF ratio (adjusted for age and gender) for 10 min 
before-to-after American Academy of Sleep Medicine (AASM) defined sleep onset for both the 2 and 3-cluster solutions (adjusted for age and gender). 
I-NSD, Insomnia with Normal Sleep Duration; I-SSD A, Insomnia with Short Sleep Duration type-A; I-SSD B, Insomnia with Short Sleep Duration type-B. 
*P < 0.05.
Heart Rate Variability in Insomnia Patient Subtypes 34
SLEEP, Vol. 39, No. 11, 2016 2001 Clusters of Insomnia Disorder—Miller et al.
attenuated parasympathetic activity (pNN50 and rMSSD) 
compared to I-NSD. This finding is consistent with previous re-
search where HRV measures were indicative of reduced para-
sympathetic activity in patients with insomnia.53 In a clearly 
defined I-SSD phenotype, reduced parasympathetic activity 
may contribute to adverse cardiometabolic health outcomes 
found in I-SSD.5 Measures of sympathovagal balance between 
the clusters were not attributed to increased sympathetic ac-
tivity in the I-SSD group found previously in insomnia com-
pared to controls.56 Longitudinal follow-up data over several 
years with large numbers of patients are more appropriate to 
evaluate risk of cardiometabolic ill-health in I-SSD57 compared 
to associations from cross-sectional samples of patients.58 The 
3-cluster solution did not reveal significant differences perhaps 
due to a lack of statistical power.
Sleep Onset Quantitative EEG
Using q-EEG, there were no significant between-cluster differ-
ences for solution 1 (I-NSD vs. I-SSD). In the 3-cluster solution 
only, consistent reductions were found for the I-SSD B (high 
SOL) cluster in Delta, Alpha and Beta-1 activity before sleep 
initiation and Beta-2 activity after sleep compared to both 
I-SSD A and I-NSD clusters. Reduced activation however is 
not in line with the hyperarousal hypothesis where increased 
high-frequency beta and gamma activation has been found at 
sleep-onset and across the night compared to controls.4,39,42,48 
Reduced activation may reflect a previous finding where lower 
Beta-2 (18−29.75 Hz) power was observed in sleep-onset in-
somnia compared to sleep maintenance insomnia subtypes 
during sleep initiation59 Krystal et al. also showed reduced 
Beta (16.5–30.0 Hz) power in patients with objective I-SSD 
compared to I-NSD.60 Heightened cortical arousal may be 
higher in those with I-NSD, contribute to subjective insomnia 
and is linked to nonrestorative sleep.5,60,61 Here, results sug-
gest a specific impaired short sleep insomnia cluster (I-SSD 
B), which displayed reduced power in the Beta-1 (16–24 Hz) 
and Beta-2 (24–32 Hz) frequency range. Figure 3 and Figure S1 
in the supplemental material may suggest a 2-cluster solution, 
not a 3-cluster solution and classification error of volunteers 
by cluster analysis may have caused this. A control group may 
have revealed cortical hyperarousal to be present in both the 
I-NSD and I-SSD groups, in line with the hyperarousal hy-
pothesis and recent findings of adolescent insomnia subtypes.62 
Further investigation of the sleep-onset process between clus-
ters of insomnia is warranted.
Neurocognitive Performance
No differences were found in cognitive performance between 
I-SSD and I-NSD. This is in contrast to previous findings where 
I-SSD patients were found to be impaired.37,63 Lack of differ-
ences may be due to the sample of volunteers recruited here 
who were otherwise healthy apart from Insomnia Disorder and 
performed well across the range of cognitive domains. In solu-
tion 2, the I-SSD B cluster performed worse than both I-SSD A 
and I-NSD for sustained attention (P ≤ 0.05). This is very pre-
liminary evidence of neurocognitive impairment within a spe-
cific objective PSG-derived cluster of Insomnia Disorder and 
again may reflect an overall I-SSD group finding because of 
cluster classification error. Phenotyping studies have found im-
pairments in task processing speed, set-switching attention and 
visual memory in those with I-SSD.37,63 Daytime impairments 
have been found to be of small-to-moderate magnitude in 
studies of individuals with insomnia compared to controls.6,64 
Variability found in case-control studies may be attributed to 
certain insomnia clusters performing better than others (i.e., 
I-NSD / I-SSD A vs. I-SSD B: see Table 3). Combined with 
reduced q-EEG activation at sleep-onset the I-SSD B cluster 
appears most impaired relative to both I-SSD A and I-NSD.
Limitations
Only three input parameters were used for cluster analysis 
as these were limited by the sample size of 96 volunteers.65,66 
More clusters may exist with larger samples of volunteers. A 
lack of variability may have caused a type II statistical error 
as the sample recruited was somewhat homogeneous (gen-
erally healthy, educated, and white) reflecting the local de-
mographics of the one recruitment site at Sydney, Australia. 
Further testing in more diverse patient groups may establish 
the external validity of these clusters. Apart from Insomnia 
Disorder, the sample appeared somewhat healthy and this may 
have been due to data capture, as our questions on comorbidity 
were open-ended (i.e., asking the patient to enter the presence 
of other disease rather than selecting from a list). This may 
have resulted in underestimation of comorbidity, but the error 
is unlikely to be large as most of our patients were recruited 
from our insomnia clinic by referral or by advertisements 
in clinic. A type I statistical error may have occurred due to 
the many outcomes that were tested between clusters. Error 
in cluster classification may have caused a 3-cluster solution 
when results here may better reflect a 2-cluster (I-NSD and 
I-SSD) solution with I-SSD B being the most impaired. The 
lowest score on the ISI in this sample was 1 followed by 7 in 
the next lowest volunteer with a mean = 17.3 (range: 1–28; 
SD = 4.8). The collection of the ISI occurred two weeks after 
consent and may have reflected spontaneous remission. Sen-
sitivity analysis suggested that this did not affect cluster clas-
sification or our overall conclusions. As only one night of PSG 
recorded sleep was measured, it could be argued that night-
to-night variability may limit cluster classification. The sleep 
parameters (TST, SOL, and WASO) have been found to be reli-
able over several years and I-SSD and I-NSD phenotypes were 
persistent over three sleep periods, suggesting a single PSG 
night may be a reliable classification.35 Poor neurocognitive 
performance may have affected subsequent PSG sleep in the 
I-SSD B cluster. However, alert cognition prior to sleep initia-
tion was not different between clusters suggesting against this 
notion. A protocol limitation is related to time in bed which 
was compromised, as lights on was at 06:00 for all clinical and 
research volunteers in our laboratory. Forced awakening may 
have taken place in some volunteers. There were no signifi-
cant between cluster differences for total PSG-sleep study re-
cording time (lights-off until lights-on).
CONCLUSIONS
In summary, exploratory cluster analysis of objective sleep 
parameters (TST, SOL, and WASO) derived at least two 
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distinct clusters of Insomnia Disorder: Insomnia with Normal 
Sleep Duration (I-NSD) and Insomnia with Short Sleep Dura-
tion (I-SSD) from a volunteer sample. At sleep-onset, I-SSD 
displayed attenuated parasympathetic activity compared to 
I-NSD. A second solution suggested preliminary evidence for 
three clusters including; I-NSD and two groups of I-SSD (I-
SSD A and I-SSD B). The I-SSD B cluster appeared impaired 
on neurocognitive sustained attention (lower compared to both 
I-NSD and I-SSD A) and q-EEG with lower power compared 
to I-NSD and I-SSD A before and after sleep-onset. Clusters 
should now be evaluated in further samples of patients for 
prognosis and treatment response.
ABBREVIATIONS
AASM, American Academy of Sleep Medicine
AHI, apnea-hypopnea index
ANOVA, analysis of variance
ANCOVA, analysis of covariance
BMI, body mass index
bpm, beats per minute
CI, confidence interval
d, Cohen’s d
DASS, depression anxiety and stress scale
DBAS, dysfunctional beliefs and attitudes about sleep scale
DISS, daytime insomnia symptom scale
DSM, Diagnostic and Statistical Manual of Mental Disorders
ECG, electrocardiography
EEG, electroencephalography
EMG, electromyographic
EOG, electrooculography
ESS, Epworth Sleepiness Scale
FIRST, Ford insomnia response to stress test
FFS, Flinders Fatigue Scale
HF, high frequency
HR, heart rate
HRV, heart rate variability
I-NSD, insomnia with normal sleep duration
ISI, insomnia severity index
I-SSD, insomnia with short sleep duration
I-SSD A, insomnia with short sleep duration type-A
I-SSD B, insomnia with short sleep duration type-B
LCT, letter cancellation test
LF, low frequency
Ln, natural logarithm
M, mean
n, number
pNN50, percentage (%) of successive R-R intervals that differ 
by more than 50 ms
PSG, polysomnography
q-EEG, quantitative electroencephalography
rMSSD, root mean square of successive R-R intervals
SD, standard deviation
SE, standard error
SDNN, standard deviation of all N-N intervals
SOL, sleep onset latency
ToL, Tower of London
TST, total sleep time
WASO, wake time after sleep onset
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Chapter 4: HRV Across the Night  
 
Preamble 
As explained in the Introduction (Chapter 1), it has been posited that physiological 
hyperarousal may be present particularly amongst short-sleep duration insomnia patients 
across 24-hours. The literature review (Chapter 2) highlighted that HRV findings from case-
control and intervention studies of insomnia patients are inconsistent. Chapter 3 presented 
the findings from HRV analysis of insomnia subtypes across the sleep onset period, which 
found evidence of impaired parasympathetic activity marked by a reduction in select HRV 
measures (PNN50, RMSSD) in the short-sleeping phenotype.  
A limited number of studies have used 24-hour recordings to investigate HRV in 
insomnia patients (compared to controls) despite the advantages of enabling standardised 
recording length and cross-comparison with large studies from the cardiology domain that 
have successfully used HRV as a tool for risk stratification (Farina et al., 2014; Kleiger et al., 
2005; Yang et al., 2011). Moreover, no research has been performed with the a priori aim of 
investigating the cardiovascular activity of insomnia patient subtypes across the entire night 
to assess the present of persistent cardiovascular autonomic changes. 
 This chapter contains a manuscript that extends the work of Chapter 3, with the 
primary aim of investigating HRV over the entire nocturnal period. As hyperarousal is 
thought to be a constant phenomenon (Bonnet & Arand, 1997; Bonnet & Arand, 2010a; 
Riemann, 2010; Riemann et al., 2010), it was hypothesized that HRV changes would extend 
beyond the sleep onset period. 
It is important to note that data are from the same Insomnia 100 patient group as 
Chapter 2. Furthermore, patient subtypes and nomenclature are consistent; I-SSD (insomnia 
with short-sleep duration), and I-NSD (insomnia with normal [objective] sleep duration). 
One final point of clarification; it can be noted that PRANA software program was used for 
the following manuscript whereas Kubios was employed for the previous sleep onset 
analysis. A number of software programs are available for HRV analysis; Kubios is freely 
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available and can be downloaded from the internet. Other sleep researchers have used this 
program, it is widely accepted within the literature, and has been formally validated 
(Tarvainen, Niskanen, Lipponen, Ranta-Aho, & Karjalainen, 2014). Kubios is well-suited for 
short recordings but edits cannot be saved after the outputs have been created. A further 
challenge with Kubios is that it does not have capability to incorporate the sleep staging file 
and therefore analysis of HRV according to sleep stage is not automated. PRANA is a more 
complex program and enables the incorporation of a sleep staging file. Edits can be saved 
(and returned to at a later time, if required) which is beneficial when checking numerous, 
extended recordings. Further procedural details on HRV analysis using PRANA are presented 
in Appendix B.  
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Abstract (250/250) 
Study Objectives 
Insomnia patients of the Insomnia 100 phenotyping study have previously been placed into one of 
two subtypes, insomnia with short-sleep duration (I-SSD) or insomnia with normal-sleep duration (I-
NSD). This was based on cluster analysis using polysomnography (PSG)-derived sleep metrics: total 
sleep time, sleep onset time, and wake after sleep onset time. In this case-control study we 
examined whether nocturnal heart rate variability (HRV) differs between these subtypes. It was 
hypothesized that I-SSD patients would have impaired HRV compared to I-NSD patients. 
Methods 
Insomnia Disorder patients (DSM-V) completed overnight PSG, which provided sleep metrics for 
cluster analysis and electrocardiography (ECG) for HRV analysis. In accordance with gold-standard 
HRV methodology, each ECG was visually checked for accurate R-wave detection, and manually 
corrected as required. HRV analysis was performed from lights-off to lights-on (and separately by 
sleep/wake stage) using time and frequency-domain measures. We tested for differences in HRV 
measures between the subtypes using General Linear Models where we controlled for age as a core 
confounder. 
Results 
34 I-SSD patients (18F, 45.5 ± 10.5 years) and 41 I-NSD patients (21F, 37.6 ± 10.9 years) had ECG 
suitable for HRV analysis. There were no significant nocturnal HRV differences between subtypes 
after controlling for age.  
Conclusion 
I-SSD patients did not have significant (relative) reductions in HRV measures representative of 
parasympathetic activity. We were therefore unable to demonstrate HRV impairment in this 
subtype. Larger sample sizes are required to definitively determine a small to medium effect size 
difference in HRV between insomnia patient subtypes. 
Keywords 
Cluster Analysis, Electrocardiography, Polysomnography, Sleep, Sleep Initiation and Maintenance 
Disorders 
Details of Clinical Trial 
“Insomnia 100 sleep study” 
URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=347742 
Registration: Australia New Zealand Clinical Trials Registry (ANZCTR)  
Registration number: ACTRN12612000049875 
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Statement of Significance (107/120) 
- This is the first study to compare the nocturnal heart rate variability of insomnia patient 
subtypes that have been empirically-derived using objective sleep parameters.  
- We did not find any significant differences in nocturnal heart rate variability (from lights-off 
to lights-on) between short-sleep duration insomnia patients and normal-sleep duration 
insomnia patients when controlling for age. 
- Heart rate variability measured during nocturnal polysomnography cannot presently be used 
as evidence of 24-hour cardiovascular autonomic dysregulation in short-sleep duration 
insomnia patients. 
- Future research should aim to use adequately powered sample sizes that can reliably detect 
small effect sizes and incorporate long-term electrocardiography to investigate around-the-
clock cardiovascular activity. 
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Introduction 
Heart rate variability (HRV) provides insight into cardiovascular autonomic activity through the 
analysis of the beat-to-beat interval.1 HRV has evolved to become a ubiquitous tool with many 
applications; 1) for researching autonomic nervous system activity, response to pharmacotherapy, 
and disease mechanisms 2) for clinical diagnostic purposes, whereby decreased HRV is often 
indicative of a disease state, particularly those associated with autonomic dysregulation and 3) for 
risk stratification and prognosis of disease and mortality.2-4 
Epidemiological studies support an association between insomnia and cardiometabolic disease.5,6 
Although there is heterogeneity in the insomnia population,7,8 some studies have reported a short-
sleeping phenotype, thought to be driven by systemic, 24-hour hyperarousal.9-12 Investigators of the 
Penn State Cohort have shown short-sleep (less than six hours) insomnia patients have severe 
cardiometabolic sequelae, with increased mortality and incident hypertension compared with 
longer-sleeping insomnia patients.13-16 As such, it has been hypothesized that cardiovascular 
autonomic dysfunction is present in short sleep insomnia and reflected in HRV changes in measures 
representative of reduced parasympathetic activity during sleep .16  
We previously identified HRV differences in insomnia patient subtypes during sleep onset.17 Our 
subtypes were derived through cluster analysis using PSG measures of total sleep time, sleep onset 
time, and wake after sleep onset instead of a dichotomous cut-point of sleep duration to determine 
groupings (for example, greater or less than six hours of total sleep time). Given that hyperarousal in 
insomnia patients is posited to be present throughout the 24-hour sleep-wake cycle,11 we were 
interested in extending our initial analysis to investigate the full night.  
Previous work has examined HRV of insomnia patients with short-sleep duration (defined as those 
with a PSG sleep efficiency of less than 85%) finding significant reductions in three HRV measures  
(HR, PNN50, RMSSD) representative of parasympathetic activity.18 However, HRV comparisons were 
made to healthy controls, not insomnia patient subtypes.18 It is therefore not known whether HRV 
differences exist according to insomnia subtype as this has not been previously investigated.19  
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In this study, we aim to comprehensively assess nocturnal HRV between our previously determined 
insomnia patient subtypes. We hypothesize that insomnia patients with short-sleep duration will 
exhibit impaired HRV with reduced parasympathetic activity across the night when compared to 
normal sleep-duration insomnia patients. 
Methods 
This case-control study was a sub-analysis of our previously described exploratory observational 
study. This was a study of 100 patients, which was a pre-selected sample size (with no formal 
quantitative power calculation) thought to be of sufficient size to detect clinically meaningful patient 
subtypes.17 The current analyses are covered under the original ethical approval of the Royal Prince 
Alfred Hospital (Protocol Number X11-0392, HREC/11/RPAH/620) and the written informed consent 
given by patients. This study was prospectively registered with the Australia New Zealand Clinical 
Trials Registry (ACTRN12612000049875). 
Patients 
Volunteers responded to advertisements in the community and clinic and were subsequently 
telephone screened and clinically reviewed by either a sleep physician or sleep psychologist at a 
screening appointment at the Woolcock Institute of Medical Research Clinic. All included patients 
met criteria for Insomnia Disorder based on the fifth edition of the Diagnostic and Statistical Manual 
of Mental Disorders, reporting difficulties with at least one core symptom of sleep initiation, sleep 
maintenance or early morning awakening for at least three nights per week for at least three months 
causing significant negative impact upon daytime functioning.20 Patients were 18+ years of age, and 
free from illicit substance use, alcohol and caffeine dependence, severe psychiatric disorders, 
cognitive impairment, and pregnancy or lactation. They were not shift workers nor aware of the 
presence of a co-morbid sleep disorder. Recruitment occurred between February 2012 and August 
2014.17  
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Insomnia subtypes were determined using Ward’s hierarchical cluster analysis. This empirically-
based approach detected subtypes based on a priori selected variables. We chose three sleep 
parameters derived from polysomnography (PSG); total sleep time (TST), sleep onset latency (SOL), 
and wake after sleep onset (WASO). As we previously reported, three subtypes may exist, however, 
only the two subtype solution revealed significant differences in HRV at sleep onset.17 This solution 
was also used for the present analysis.  
Study protocol 
Patients performed a pre-laboratory assessment consisting of a two week sleep diary, concurrent 
actigraphy, and questionnaires. The laboratory assessment comprised an overnight sleep study at 
the Woolcock Institute of Medical Research Clinical Sleep Laboratory (New South Wales, Australia) 
between March 2012 and August 2014. Patients were setup for their study from 20:00. Full PSG was 
performed and scored according to American Academy of Sleep Medicine criteria guidelines and 
recommendations.21 Lights-off time was at the discretion of the patient. Lights-on time was 
standardized at 06:00. Only the studies recorded with RemLogic software v. 3.2 (Mortara, 
Milwaukee, USA) were included in the present study. 
Electrocardiographic recording and heart rate variability analysis 
In order to assess our primary aim of evaluating nocturnal HRV measures of insomnia patient 
subtypes we included all ECG data from lights-off to lights-on (commonly referred to as ‘time in 
bed’). A modified Lead II Einthoven ECG configuration (torso electrode placement) was used. Studies 
required continuous sampling at 512Hz to ensure no variations when determining the fiducial point 
of the QRS complex, the series of deflections of the ECG trace that represent ventricular 
depolarisation. An ECG filter was applied; low frequency= 0.3Hz, high frequency= 70Hz. 
PSG studies were imported into PRANA software v. 12.06.20 (PhiTools, Strasbourg, France) for HRV 
analysis and R-waves were automatically detected. The ECG signal from the entire overnight 
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recording was then visually examined by KLD and artifact identification and manual RR interval (the 
interval between two R waves of neighbouring QRS complexes) correction was performed. Artifact 
was deemed as any signal noise that prevented viewing a discernible R wave and/or any beat not 
been preceded by a p wave (deeming it to be of sinus origin). Studies that contained ≥ 20% artifact 
or cardiac dysrhythmias were excluded (Figure 1).22 Inter-beat interval analysis of the edited signal 
(termed the NN interval, where N denotes a normal beat) was performed. For frequency-domain 
analysis, further resampling of the NN interval occurred using Fast Fourier transform routine 
(sampling rate= 10Hz), which corresponded to 30-second sleep staging epochs. This enabled 
estimation of low frequency (LF= 0.04 – 0.15 Hz) and high frequency (HF= 0.14 – 0.40 Hz) power 
spectra.  
Time-domain measures selected for analysis were 1) heart rate (HR), 2) standard deviation of the NN 
interval (SDNN), and 3) the square root of the mean squared differences of successive NN intervals 
(RMSSD). RMSSD was selected in preference to NN50 and PNN50 (as per the HRV Standards).2 
Frequency-domain measures included 1) low frequency (LF), 2) high frequency (HF), and 3) the LF to 
HF ratio (LF/HF). Very low frequency power was not analysed given the need for 24-hour 
recordings.2 As recordings were of different durations, frequency-domain measures were reported 
in normalized units (nu; %). 
Data analysis 
All statistical analyses were performed using Statistical Analysis System software v. 9.4 (North 
Carolina, USA) by NSM and KLD. Univariate differences between subtypes were tested using 
independent samples t-tests, Wilcoxon, or chi-square tests, as appropriate. We visually inspected 
histograms of continuous data and then scatterplots of HRV measures against age to assess 
normality and identify outliers that may affect statistical test assumptions. Effect size differences 
between normally distributed outcomes variables are quantified using Cohen’s d. We tested 
whether HRV variables were different between the subtypes using General Linear Models (GLM) 
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where we controlled for age as a core confounder.23,24 There were no interactions between age and 
subtype when statistically tested inside the initial GLMs or on visual inspection of scatterplots with 
regression lines for age for each of the two subtypes in any of the six HRV measures investigated. As 
such we have reported only the estimates from models without interaction terms. To test 
differences in whole night measures we set alpha at 0.05 and used 95% confidence limits. Individual 
sleep stages (wake [W], non-rapid eye movement-stage N1 [N1], non-rapid eye movement-stage N2 
[N2], non-rapid eye movement-stage N3 [N3], rapid eye movement sleep [REM]) had a corrected 
alpha value of 0.01 and confidence limits of 99% for each stage in order to conserve an overall 5% 
false positive rate within each HRV measure. Post hoc power calculations were undertaken using 
G*Power v. 3.1 (Dusseldorf, Germany).25 
Results 
Patient progress through the study is outlined in Figure 1. Demographic details of the I-SSD and I-
NSD patient subtypes (Table 1). By design, the patient subtypes differed on sleep indices (TST, SOL 
and WASO) because these were used to define the subtypes.17 The I-SSD subtype reported greater 
number of medical comorbidities. The primary publication provides a more comprehensive overview 
of the patients enrolled.17  
Insert Table 1 about Figure 1 about here 
There were no significant differences in nocturnal HR (from lights-off to lights-on) between insomnia 
subtypes before and after adjustment for age (Figure 2 & Table 2). After adjusting for age there were 
no differences between the subtypes in any of the six all-night HRV measures (Table 2). All 
unadjusted analyses comparing insomnia subtypes for each HRV variable and sleep stages are in 
supplementary tables (Tables S1-S7). 
Insert Table 2 and Figure 2 about here 
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Discussion  
We compared nocturnal HRV (from lights-off to lights-on) between I-SSD and I-NSD patient 
subtypes. Previous research has shown that HRV is altered in insomnia patients compared to good-
sleeping controls, although the evidence is inconsistent.19 After adjusting for between-group 
differences in age, we did not find any significant differences in nocturnal HRV across the six 
measures we calculated. Thus, we did not find support for our hypothesis; I-SSD patients did not 
have impaired HRV (less parasympathetic activity) compared to the I-NSD subtype. 
Most previous studies have compared insomnia patients to good-sleeping controls without 
examining short-sleepers.18,26-29 In the only report comparing the HRV of short-sleepers to controls, 
evidence of decreased parasympathetic-related HRV measures (SDNN, RMSSD, PNN50, and HF) were 
found in short sleepers (PSG sleep efficiency <85%).18 We have previously shown lower values for 
two parasympathetic-related HRV measures (RMSSD and PNN50) during the sleep-onset period in I-
SSD patients.17 Using the entire ECG from the same dataset in this study, I-SSD patients had 
numerically lower values for three HRV measures of parasympathetic activity (SDNN, RMSSD and 
HF), although they failed to reach statistical significance. Adjusted analyses using age as a 
confounder were responsible for this non-significant finding. This is in contrast to Speigelhalder et al. 
however they did not report any HRV measures of the entire recording period of the sleep study.18  
It was evident from Table S4 that RMMSD (an indicator of parasympathetic activity) was significantly 
lower during N3 amongst I-SSD patients compared to their longer sleeping counterparts. This was in 
contrast to the findings in Table S5, where there were no between-group differences in HF nu (also 
an indicator of parasympathetic activity). Furthermore, whilst RMSSD was lower in N3 compared to 
Wake and N1 (in both I-SSD and I-NSD), HF nu values for N3 were higher. Several factors may have 
contributed to these incongruent results. 
The time spent in Wake and REM varied according to insomnia patient subtype. As demonstrated in 
Table 1, significantly different amounts of time were spent in Wake and in REM which may have 
Heart Rate Variability in Insomnia Patient Subtypes 51
Heart rate variability and insomnia 
 
11 
 
influenced the statistical time-domain HRV measures. Accordingly, SDNN also had lower values for 
N3 than Wake and N1 in both I-SSD and I-NSD patients (refer to Table S3).  
RMSSD had very high standard deviations amongst both patient subtypes for Wake, N1 and N3. 
Similarly elevated standard deviations were evident in Table S3 for SDNN. These deviations were 
particularly prominent in the I-NSD group.  Large inter-individual differences are to be expected 
within the heterogeneous insomnia population given that homogenous ‘healthy’ populations can 
have individual variations of HRV values in excess of 250,000%.26 Measures of RMSSD are also highly 
variable under conditions of enhanced vagal outflow due to the rapid speed of parasympathetic 
nerve activity.26 Healthier individuals (such as those in the I-NSD group) may therefore have higher 
vagal activity and increased standard deviations for time-domain measures reflective of 
parasympathetic activity.26  
We found no difference in mean HR between I-SSD and I-NSD subtypes. Previous research has 
shown differences between HR in insomnia and good-sleeping controls,26,29,30 but others have found 
no HR differences between these groups.18,31,32 HR reduction during NREM, which is a consistent 
finding, and the change in HR between NREM and REM sleep stages in the present study were of 
similar magnitude to previous research.18 Our findings do not extend to nocturnal sympathetic 
activation during wake and sleep and this needs to be explored further in these insomnia subtypes. 
An unforeseen consequence was the number of patients excluded from the I-SSD subtype due to 
dysrhythmia (see Figure 1). The majority of previous HRV-related studies of insomnia patients have 
not reported whether patients exhibited dysrhythmias during the ECG recording. As HRV is reliant on 
the calculation of the time interval between R-waves from consecutive QRS complexes, it is 
imperative that consecutive beats are of sinus origin.33 We visually inspected the complete ECG 
recording of every patient and excluded all patients with dysrhythmia. This is both a strength and 
limitation; although we were confident in the accuracy of our findings, previous studies that have 
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not followed this stringent process may have included insomnia patients with poorer cardiovascular 
health resulting in HRV differences between insomnia patients and controls. 
As our primary study was intended to be representative of a clinical sample of insomnia patients, it 
neither excluded those with medical comorbidities or on medication. After reviewing self-reported 
prescribed medications, we found one I-SSD patient had consumed a class-II antiarrhythmic 
(atenolol), and one I-NSD patient had consumed a class-IV antiarrhythmic (verapamil) and also 
digoxin. Both were in sinus rhythm on the night of their sleep study and had HRs within normal 
ranges for both sleep and wake. These patient’s data were included. Confounders for HRV may 
include caffeine,34 alcohol,35,36 and nicotine 37,38 which were not restricted on the day of testing. In 
addition, our insomnia clinical sample were younger than insomnia subtypes of previous studies 
(Vgontzas et al.15 reported their short-sleep group [less than six hours total sleep time] had a median 
age ~ 54 years). Longitudinal studies of our I-SSD subtype might reveal HRV differences when they 
are of a similar age to comparative samples. The possibility also remains that both patient subtypes 
may have impaired HRV relative to controls.  
We used time-domain HRV measures (HR, SDNN, RMSSD) despite recordings of non-standardized 
duration. Historically, 24-hour HRV recordings are used to determine cardiovascular risk.39,40 Our 
patient’s recordings ranged between 345 to 514.5 minutes, although there were no significant 
between-group differences in duration (from lights-off to lights-on), suggesting that HRV recording 
length did not influence the results.  
We deliberately did not control for sleep-wake differences between the groups. There were several 
reasons for this; 1) the short-sleeping phenotype is thought to be driven by persistent 
hyperarousal,9-11 2) in our recent systematic review we were unable to conduct a meta-analysis of 
previous insomnia-HRV studies due to the heterogeneous reporting of HRV analyses at different 
times of the night 3) seminal HRV research from the cardiology field linking HRV to incident 
cardiovascular disease have used long-term recordings.39,40 Similarly, we chose to present both LF 
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(nu) and HF (nu) despite their mathematical equivalence in order to facilitate cross-comparison with 
other studies.41  
The lack of statistical difference after adjusting for age may have been related to sample size, as we 
calculated our study to be 80% powered to determine effect sizes over 0.66. The largest effect size 
we observed was 0.27 for which we were only 21% powered to detect. Case-control studies that are 
smaller than ours that report statistically significant but small effects, may be reporting false positive 
findings because they were unable to detect reliably what are probably subtle effects, if they exist at 
all.19,42 Future researchers may consider that the 95% confidence limits we report in Table 2 are wide 
enough that we cannot rule out the possibility that if real effects exist they may be anywhere in the 
small effect size range (i.e. anywhere up to Cohen's d= 0.50 standard deviations but probably not 
larger). As such, we have calculated sample sizes for effect sizes d= 0.50, 0.35, and 0.20 as these 
represent the largest, middle of the range, and smallest of what are considered 'small' effects. With 
equal numbers of cases and controls to achieve 80% power, future studies will need 128, 260 or 788 
participants to detect effect sizes of 0.5, 0.35, and 0.2 respectively.  
In summary, we did not find significant evidence of impaired HRV amongst insomnia patients with 
short-sleep duration compared to the longer-sleeping subtype across the entire nocturnal sleep 
period (beyond sleep onset). Whilst there were univariate differences in nocturnal parasympathetic 
activity in the I-SSD subtype these differences were attenuated significantly and became non-
significant when adjusted for age differences. Therefore, we were unable to support the notion that 
overnight HRV alterations are present in short-sleep insomnia patients compared to the longer-
sleeping subtype. 
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Figure titles and captions 
Figure 1: CONSORT flow diagram 
Note: ECG= electrocardiogram, HRV= heart rate variability. Square boxes depict parent study. 
Round-edge boxes depict present study. 
Figure 2: Nocturnal mean heart rate of insomnia patient subtypes from lights-off to lights-on a) 
unadjusted and b) adjusted for age 
Note: Table displays Means and 95% Confidence Intervals. Unadjusted heart rate data are also 
presented for all patients in both groups highlighted in red circles and black squares. Abbreviations: 
I-SSD= insomnia with short sleep duration, I-NSD= insomnia with normal sleep duration. 
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Tables 
Table 1. Participant demographics 
Characteristics 
I-SSD n= 34 
  Mean (SD) 
I-NSD n= 41 
Mean (SD) 
p 
Age, range 45.5 (10.5), 26-75 37.6  (10.9), 23-65 0.002 
Female 18 (53%) 28 (68%) 0.17 
Insomnia Severity Index 16.0 (5.5) 18.0 (4.3) 0.07 
Total sleep time (min) 293.3 (54.9) 393.0 (37.2) - 
Sleep onset latency (min) 34.5 (32.3) 18.6 (12.0) - 
Wake-time after sleep onset (min) 105.5 (59.6) 38.3 (23.2) - 
Duration: lights-off to lights-on (min) 436.9 (41.8) 451.3 (38.3) 0.13 
Duration: Wake (mins) 136.6 (55.6) 56.7 (28.3) <0.001 
Duration: N1 (min) 12.6 (7.6) 10.7 (7.7) 0.29 
Duration: N2 (min) 162.8 (45.8) 223.6 (38.9) <0.001 
Duration: N3 (min) 69.0 (28.3) 79.4 (27.1) 0.11 
Duration: REM (min) 48.9 (19.9) 79.5 (23.8) <0.001 
BMI (kg/m2)  25.8 (4.7) 24.4 (4.0) 0.16 
Self-reported medical comorbidities (n=70)  18 (55%) 10 (27%) 0.02 
Self-reported  heart disease  0 (0%) 0 (0%) - 
On average, more than 2 caffeinated 
beverages per day  
8 (24%) 8 (21%) 0.76 
Caffeine on day of study  25 (74%) 30 (79%) 0.59 
High risk alcohol consumption  1 (3%) 0 (0%) 0.27 
Alcoholic beverages on day of study  4 (12%) 4 (10%) 0.81 
Past smoker  16 (47%) 8 (20%) 0.01 
Current smoker  3 (9%) 4 (10%) 0.68 
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Note: Caffeinated beverages were scored using an average caffeine level of 88mg per drink (for 
coffee) and rounded to 100mg. High risk alcohol consumption was considered ≥36 standard drinks 
per week, as per the 2001 National Health and Medical Research Council Australian Alcohol 
Guidelines: Health Risks and Benefits which stipulates different consumption levels according to 
sex.43 p values <0.05 are bolded. Abbreviations: BMI= Body mass index, I-NSD= insomnia with 
normal sleep duration, I-SSD= insomnia with short sleep duration, kg= kilogram, m= metre, min= 
minute, n= number, SD= standard deviation. 
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Table 2. Nocturnal HRV measures (from lights-off to lights-on) of insomnia patient subtypes adjusted 
for age 
HRV 
measure 
I-SSD n= 34 
Mean age= 45.5 
LSM (SE) 
I-NSD n= 41 
Mean age= 37.6 
LSM (SE) 
Mean 
difference 
[95% CI] 
P 
Effect size  
[95% CI] 
HR (bpm) 62.8 (1.4) 62.9 (1.2) 
0.18 
[ -3.6, 4.0] 
0.93 
0.02 
[-0.47, 0.51] 
SDNN (ms) 68.7 (5.2) 71.2 (4.7) 
2.44 
[-11.9, 16.7] 
0.73 
0.08 
[-0.38, 0.54] 
RMSSD (ms) 56.2 (6.8) 64.8 (6.1) 
8.67 
[-10.1, 27.4] 
0.36 
0.22 
[-0.25, 0.68] 
HF (nu) 36.0 (1.8) 39.0 (1.7) 
3.01 
[-2.1, 8.1] 
0.24 
0.27 
[-0.19, 0.73] 
LF (nu) 64.0 (1.8) 61.0 (1.7) 
-3.01 
[- 8.1, 2.1] 
0.24 
-0.27 
[0.19, -0.73] 
LF/HF 16.8 (3.4) 12.6 (3.1) NC 0.37 NC 
Note: Numerical values in this table are derived from generalised linear models. Cohen’s d effect size 
with 95% Confidence Intervals. Adjusted mean with unadjusted pooled standard deviation to 
calculate effect size. Abbreviations: bpm= beats per minute, CI= confidence intervals, HF (nu)= high 
frequency power (normalized units), HR= heart rate, I-NSD= insomnia with normal sleep duration, I-
SSD= insomnia with short sleep duration, LF/HF= low frequency power (normalized units) to high 
frequency power (normalized units) ratio, LF (nu)= low frequency power (normalized units), LSM= 
least squares mean, ms= millisecond, NC= not calculated, RMSSD= square root of the mean squared 
differences of successive NN intervals, SDNN= standard deviation of the NN interval. 
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Supplemental material 
Table S1. Nocturnal HRV measures (from lights-off to lights-on) of insomnia patient subtypes 
(unadjusted) 
HRV 
measure 
I-SSD 
n= 34 
Mean (SD) 
I-NSD 
n= 41 
Mean (SD) 
Mean difference 
[95% CI] 
p 
 
Effect size  
[95% CI] 
HR (bpm) 63.1 (7.1) 62.7 (8.1) -0.4  [-3.9, 3.2] 0.83 0.05 [-0.51, 0.42] 
SDNN 
(ms) 
64.0 (26.3) 75.1 (34.7) 11.2 [-3.2, 25.6] 0.13 0.36 [-0.10, 0.82] 
RMSSD 
(ms) 
50.8 (31.8) 69.3 (45.8) 18.5 [0.6, 36.5] 0.04 0.46 [0.01, 0.91] 
HF (nu) 34.3 (9.5) 40.5 (12.3) 6.2 [1.0, 11.3] 0.02 0.56  [0.09, 1.02] 
LF (nu) 65.7 (9.5) 59.5 (12.3) 6.2 [1.0, 11.3] 0.02 0.56  [0.09, 1.02] 
LF/HF 8.4 (5.3, 23.8) 4.8 (3.0, 16.8) NC 0.04 NC 
Note: The LF/HF ratio required nonparametric testing and is therefore reported with Means and 
Inter Quartile Ranges. Abbreviations: bpm= beats per minute, CI= confidence intervals, HF (nu)= 
high frequency power (normalized units), HR= heart rate, I-NSD= insomnia with normal sleep 
duration, I-SSD= insomnia with short sleep duration, LF/HF= low frequency power (normalized units) 
to high frequency power (normalized units) ratio, LF (nu)= low frequency power (normalized units), 
ms= millisecond, NC= not calculated, RMSSD= square root of the mean squared differences of 
successive NN intervals, SDNN= standard deviation of the NN interval. 
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Table S2. Heart Rate (HR) of insomnia patient subtypes according to wake or sleep stage 
(unadjusted) 
 
Stage 
I-SSD 
n= 34 
Mean (SD) 
I-NSD 
n= 41 
Mean (SD) 
Mean 
difference 
[99% CI] 
p 
Effect size  
[99% CI] 
W 66.5 (7.3) 66.5 (7.6) 0.0 
[-4.5, 4.6] 
0.98 0.0 
[-0.61, 0.62] 
N1 63.1 (7.2) 63.9 (7.7) 0.9 
[-3.7, 5.4] 
0.62 0.12 
[-0.49, 0.72] 
N2 60.6 (7.2) 61.2 (8.1) 0.6 
[-4.1, 5.4] 
0.73 0.08 
[-0.53, 0.70] 
N3 62.2 (7.1) 62.5 (9.1) 0.3 
[-4.7, 5.4] 
0.87 0.04 
[-0.57, 0.65] 
REM 63.7 (6.9) 64.2 (8.1) 0.5 
[-4.2, 5.2] 
0.78 0.07 
[-0.55, 0.68] 
Abbreviations: CI= confidence intervals, I-NSD= insomnia with normal sleep duration, I-SSD= 
insomnia with short sleep duration, N1= non-rapid eye movement-stage N1, N2= non-rapid eye 
movement-stage N2, N3= non-rapid eye movement-stage N3, REM= rapid eye movement, W= wake. 
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Table S3. SDNN of insomnia patient subtypes according to wake or sleep stage (unadjusted) 
 
Stage 
I-SSD 
n= 34 
Mean (SD) 
I-NSD 
n= 41 
Mean (SD) 
Mean 
difference 
[99% CI] 
p 
Effect size  
[99% CI] 
W 81.7 (38.5) 135.2 (153.0) 53.5 
[-13.1, 120.1] 
0.006# 
 
0.46 
[-0.11, 1.03] 
N1 75.8 (34.8) 121.1 (134.4) 45.3 
[-13.3, 103.9] 
0.023# 1.00 
[-0.29, 2.29] 
N2 62.7 (30.9) 71.5 (30.5) 8.8 
[-10.0, 27.6] 
0.22 0.29 
[-0.33, 0.90] 
N3 40.7 (17.6) 63.5 (69.5) 22.8 
[-7.5, 53.0] 
0.020# 0.43 
[-0.14, 1.00] 
REM 62.2 (28.2) 68.8 (28.5) 6.6 
[-10.8, 24.0] 
0.32 0.23 
[-0.38, 0.85] 
Note: #Wilcoxon Test for nonparametric data used to calculate p value. Abbreviations: CI= 
confidence intervals, I-NSD= insomnia with normal sleep duration, I-SSD= insomnia with short sleep 
duration, N1= non-rapid eye movement-stage N1, N2= non-rapid eye movement-stage N2, N3= non-
rapid eye movement-stage N3, REM= rapid eye movement, W= wake. 
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Table S4. RMSSD of insomnia patient subtypes according to wake or sleep stage (unadjusted) 
 
Stage 
I-SSD 
n= 34 
Mean (SD) 
I-NSD 
n= 41 
Mean (SD) 
Mean 
difference 
[99% CI] 
p 
 
Effect size  
[99% CI] 
W 63.6 (46.8) 130.2 (225.4) 66.7 
[-30.5, 163.9] 
0.03# 0.39 
[-0.18, 0.97] 
N1 49.5 (31.1) 115.3 (191.6) 65.8 
[-16.1, 147.8] 
0.007# 0.46 
[-0.11, 1.03] 
N2 52.0 (41.7) 66.3 (37.2) 14.3 
[-9.9, 38.4] 
0.12 0.36 
[-0.25, 0.98] 
N3 37.5 (19.2) 68.5 (95.5) 31.0 
[-10.1, 72.1] 
0.009# 0.43 
[-0.14, 1.00] 
REM 41.4 (32.8) 55.2 (34.1) 13.8 
[-6.8, 34.3] 
0.08 0.41 
[-0.20, 1.02] 
Note: #Wilcoxon Test for nonparametric data used to calculate p value. Abbreviations: CI= 
confidence intervals, I-NSD= insomnia with normal sleep duration, I-SSD= insomnia with short sleep 
duration, N1= non-rapid eye movement-stage N1, N2= non-rapid eye movement-stage N2, N3= non-
rapid eye movement-stage N3, REM= rapid eye movement, w= wake. 
 
 
 
 
 
 
 
 
  
Heart Rate Variability in Insomnia Patient Subtypes 62
Heart rate variability and insomnia 
 
22 
 
Table S5. High Frequency normalized units (HF nu) of insomnia patient subtypes according to wake 
or sleep stage (unadjusted) 
 
Stage 
I-SSD 
n= 34 
Mean (SD) 
I-NSD 
n= 41 
Mean (SD) 
Mean 
difference 
[99% CI] 
p 
 
Effect size  
[99% CI] 
W 29.9 (9.3) 31.9 (10.7) 2.0 
[-4.2, 8.2] 
0.40 0.20 
[-0.42, 0.81] 
N1 32.9 (12.9) 37.8 (12.8) 4.9 
[-2.9, 12.8] 
0.10 0.38 
[-0.23, 1.00] 
N2 34.9 (10.8) 41.2 (13.7) 6.3 
[-1.4, 13.9] 
0.03 0.50 
[-0.11, 1.11] 
N3 46.2 (13.3) 49.7 (14.8) 3.5 
[-5.2, 12.2] 
0.29 0.25 
[-0.37, 0.86] 
REM 25.8 (9.3) 33.1 (13.1) 7.3 
[0.5, 14.2] 
0.006 0.63 
[0.04, 1.23] 
Abbreviations: CI= confidence intervals, I-NSD= insomnia with normal sleep duration, I-SSD= 
insomnia with short sleep duration, N1= non-rapid eye movement-stage N1, N2= non-rapid eye 
movement-stage N2, N3= non-rapid eye movement-stage N3, REM= rapid eye movement, w= wake. 
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Table S6. Low Frequency normalized units (LF nu) of insomnia patient subtypes according to wake or 
sleep stage (unadjusted) 
 
Stage 
I-SSD 
n= 34 
Mean (SD) 
I-NSD 
n= 41 
Mean (SD) 
Mean 
difference 
[99% CI] 
p 
 
Effect size  
[99% CI] 
W 70.1 (9.3) 68.1 (10.7) -2.0 
[-8.2, 4.2] 
0.40 -0.20 
[-0.81, 0.42] 
N1 67.1 (12.9) 62.2 (12.8) -4.9 
[-12.8, 2.9] 
0.10 -0.38 
[-1.00, 0.23] 
N2 65.1 (10.8) 58.8 (13.7) -6.3 
[-13.9, 1.4] 
0.03 -0.50 
[-1.11, 0.11] 
N3 53.8 (13.3) 50.3 (14.8) -3.5 
[-12.2, 5.2] 
0.29 -0.25 
[-0.86, 0.37] 
REM 74.2 (9.3) 66.9 (13.1) -7.3 
[-14.2, -0.5] 
0.006 -0.63 
[-1.23, -0.04] 
Abbreviations: CI= confidence intervals, I-NSD= insomnia with normal sleep duration, I-SSD= 
insomnia with short sleep duration, N1= non-rapid eye movement-stage N1, N2= non-rapid eye 
movement-stage N2, N3= non-rapid eye movement-stage N3, REM= rapid eye movement, w= wake. 
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Table S7. Low Frequency to High Frequency ratio (LF/HF) of insomnia patient subtypes during 
overnight polysomnography (unadjusted) 
Stage 
I-SSD 
n= 34 
Median (IQR) 
I-NSD 
n= 41 
Median (IQR) 
Mean 
difference 
[99% CI] 
p 
Effect size 
[99% CI] 
W 15.8 
(9.1, 61.5) 
18.1 
(5.7, 61.4) 
N/A 0.72 N/A 
N1 3.7 
(2.3, 8.6) 
3.3 
(1.9, 5.5) 
N/A 0.30 N/A 
N2 3.9 
(2.5, 6.5) 
3.6 
(1.9, 5.5) 
N/A 0.57 N/A 
N3 2.0 
(1.3, 3.1) 
1.8 
(1.0, 3.0) 
N/A 0.57 N/A 
REM 5.5 
(3.5, 10.9) 
3.8 
(2.4, 6.2) 
N/A 0.05 N/A 
Abbreviations: CI= confidence intervals, I-NSD= insomnia with normal sleep duration, I-SSD= 
insomnia with short sleep duration, N1= non-rapid eye movement-stage N1, N2= non-rapid eye 
movement-stage N2, N3= non-rapid eye movement-stage N3, REM= rapid eye movement, W= wake. 
Note: Because the majority of the ratios in this table required nonparametric testing we decided to 
test all variables with the Wilcoxon test and report them as Medians and Inter Quartile Ranges (IQR).  
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Table S8. Primary complaint of insomnia patient subtypes 
Characteristic I-SSD 
n= 34 
I-NSD 
n= 41 
Mixed pattern insomnia 16 18 
Sleep-onset problems 3 8 
Sleep-maintenance problems 8 10 
Early morning awakening problems 7 5 
Abbreviations: I-NSD= insomnia with normal sleep duration, I-SSD= insomnia with short sleep 
duration. 
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Abbreviations 
BMI, Body Mass Index  
bpm, beats per minute 
CI, Confidence Intervals 
CONSORT, Consolidated Standards Of Reporting Trials 
ECG, Electrocardiographic/electrocardiogram 
GLM, General Linear Model 
HF, High Frequency 
HR, Heart Rate 
HRV, Heart Rate Variability 
I-NSD, Insomnia with Normal Sleep duration 
IQR, Inter Quartile Range 
I-SSD, Insomnia with Short Sleep Duration 
LF, Low Frequency 
LSM, Least Squares Mean 
ms, millisecond 
M, Mean 
Min, minute 
N, n, number 
NNI, NN interval, where N denotes a normal beat of sinus origin 
N1, Non-Rapid Eye Movement Sleep, stage N1 
N2, Non-Rapid Eye Movement Sleep, stage N2 
N3, Non-Rapid Eye Movement Sleep, stage N3 
nu, normalized units 
PNN50, percentage (%) of successive NN intervals that differ by more than 50 milliseconds 
PSG, Polysomnography 
REM, Rapid Eye Movement sleep 
RMSSD, Root Mean Square of Successive R-R intervals 
RRI, RR interval, where R denotes the R wave of a QRS complex 
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SD, Standard Deviation 
SDNN, Standard Deviation of all N-N intervals 
SE, Standard Error 
SOL, Sleep Onset Latency 
TST, Total Sleep Time  
W, Wake 
WASO, Wake-time After Sleep Onset 
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Enrolled insomnia patients (n= 100) 
One night polysomnography (n= 97) 
Assessed for eligibility (n=  150) 
Excluded (n= 50) 
 Not meeting inclusion criteria (n= 28) 
 Declined to participate (n= 16) 
 Other reasons (n=  6) 
Initial email / telephone contact  (n=  444) 
Excluded (n= 2) 
 Dysrhythmia (n= 2)  
Nocturnal ECG for HRV analysis (n= 84) 
Excluded (n= 12) 
 ncorrect ECG sampling rate (n= 6) 
 ncompatible recording software (n= 4) 
 Insufficient R-wave  detection (n=2) 
Insomnia with normal sleep duration;  
I-NSD (n=41) 
Insomnia with short sleep duration;  
I-SSD  (n=34) 
Excluded (n= 3) 
 Patient left study without providing reason (n=  2) 
 Sleep diary too onerous (n= 1)  
Excluded (n= 7) 
 Dysrhythmia (n= 4)  
 >20% artifact (n=  3) 
Insomnia with short-sleep duration (n= 41) Insomnia with normal sleep duration (n= 43) 
Cluster analysis, N=96 
HRV analysis, N=75 
PSG failure (n= 1) 
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Chapter 5: Conclusion  
 
SUMMARY AND SIGNIFICANCE OF FINDINGS 
The aim of my research was to determine whether differences in HRV exist in 
objective insomnia patient subtypes. The literature review of Chapter 2 uncovered the 
discrepancies present in the previous insomnia-HRV literature, underlining the incumbent 
need to perform research of insomnia patient subtypes, and to do so with stringent 
methodology.  
As the first study to compare the HRV of short and normal sleep-duration insomnia 
subtypes, the case-control study presented in Chapter 3 found short sleep-duration 
insomnia patients have significant reductions HRV measures (RMSSD and PNN50) that 
correlated with parasympathetic activity during the sleep onset period. In one of the largest 
insomnia-HRV studies to date, this provided evidence that parasympathetic activity was 
attenuated in insomnia patients with short sleep-duration, compared to the normal sleep-
duration subtype, prior to, and following sleep onset. This was consistent with the study 
hypothesis that the short sleep-duration insomnia subtype would have impaired HRV. 
The extent to which HRV was impaired in short-sleep duration insomnia during sleep 
was explored in Chapter 4, via examination of HRV analysis across the entire nocturnal sleep 
recording. Preliminary analysis showed that age was a significant confounder between the 
insomnia subtypes. After controlling for age, there were no statistically significant between-
group HRV differences. Therefore, whilst the first study supported the overall hypothesis (of 
impaired HRV amongst I-SSD patients when compared to I-NSD patients) it was challenged 
by the findings of the second study.  
DISCUSSION 
Differences between insomnia patients and controls at selective time points were 
previously reported by Farina (2014) with reductions to HRV in early wake/sleep stages 
(wake before sleep and N2), but not during deep SWS (N3), REM sleep, or post-sleep wake. 
In line with the Psychobiological Model (Espie, 2002; Espie et al., 2006), the failure to inhibit 
wakefulness (impairing the automaticity of sleep) may conceivable have the greatest 
ramifications on HRV at sleep onset. Alternatively, it may be that the timing of insomnia 
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patient symptoms (constituting the clinical subtypes of insomnia, i.e. sleep onset vs sleep 
maintenance vs early awakening vs mixed-pattern) has more of an influence on 
psychobiology than acknowledged within this empirically-derived cluster approach. Others 
have corroborated the results of Chapter 4, showing no HRV differences in insomnia 
patients (albeit compared to controls) in nocturnal HRV. De Zambotti (2014) failed to find 
differences in vagal activity between insomnia patients and controls using whole-night 
recordings when performing an hour-by-hour analysis of HRV commencing from lights-off 
time.  
The presence of constant HRV impairment in insomnia patients is, however, a 
reasonable deduction. It has previously been established that somatic symptoms, 
psychiatric illnesses, females, and older individuals have reduced parasympathetic activity 
evidenced through HRV; each of which is also associated with insomnia (Kemp & Quintana, 
2013; Koenig & Thayer, 2016; Nunan et al., 2010; O'Brien, O'Hare, & Corrall, 1986; Thayer, 
Sollers, Friedman, & Koenig, 2015; Voss, Heitmann, Schroeder, Peters, & Perz, 2012). 
Similarly, the Neurocognitive Model of insomnia posits a pluralistic perspective of 
hyperarousal (linking cognitive, cortical, and somatic arousal) (Perlis et al., 2009; Perlis et al., 
1997).  Whilst HRV is traditionally considered a physiological determinant of autonomic 
hyperarousal in insomnia, the mind-body (heart) interconnection must not be minimized; 
HRV may have concurrently been influenced by interplay from cognitive and cortical 
hyperarousal (Bonnet & Arand, 1997; Bonnet & Arand, 2010a; Riemann, 2010; Riemann et 
al., 2010).  
It is therefore warranted to question whether HRV was indeed reduced across both 
the sleep onset period and across the whole night even though results of the present study 
did not show this. Careful review of Table 2 (Chapter 4) suggests a signal may be present 
with (non-significant) numerical reductions in the parasympathetic related measures 
analyzed – SDNN, RMSSD and HF. The direction of change in these HRV measures was 
similar to previous studies comparing short-sleepers to controls [significantly reduced HR, 
PNN50, RMSSD during wake and sleep] (Spiegelhalder et al., 2011) and the first comparison 
of subtypes presented in Chapter 3 [significantly reduced RMSSD and PNN50 in I-SSD 
patients during the sleep onset period]. Additional research into the temporal patterning of 
HRV across the night is warranted and may offer important insights into the complexity of 
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cardiac autonomic activity of insomnia patient subtypes. Pertinent questions include 
whether HRV impairments are restored across the night, and if so, if there is a difference in 
rate of recovery between insomnia patient subtypes. The addition of Pre-Ejection Period 
measurements (to complement HRV findings) would allow more precise characterisation of 
such sympathovagal activity across sleep cycles. 
 There are a number of factors that need to be considered in relation to these 
findings - 
Sample size 
As detailed in the discussion section of Chapter 4, it is quite possible that, despite 
having one of the largest insomnia patient groups studied to date, it was underpowered. 
Post hoc analysis revealed that for insomnia patient case-control studies to achieve 80% 
power, they would need to have greater than 128 patients to detect modest effect sizes.  
Patient demographics 
The clinical sample used for both case-control studies was relatively young (median 
age = 41.5 years). Even though the I-SSD group was significantly older than the longer-
sleeping patients, they were younger than the short-sleep duration group of the USA Penn 
State cohort (Vgontzas et al., 2010). As the insomnia patients in the current study age, there 
may be an increase cardiovascular risk, beyond that associated with normal ageing. A 
repeated-measure study of the Insomnia 100 patients in the future (~ 10 years’ time) would 
be required to test this assumption.  
Sleep/wake influences 
Sleep generally, is a time of parasympathetic-dominance compared to wake. To test 
for the possibility of constant physiological hyperarousal, continuous measures are required. 
The daytime cardiac autonomic activity, which contains greater amounts of sympathetic 
activity, may have been different between the short-sleep, and normal-sleep duration 
insomnia subtypes. We did not have the ability to undertake daytime testing in this 
population. 24-hour HRV during sleep and wake has previously been measured in insomnia 
patients (and controls), however the 24-hour HRV outcomes were not reported (Farina et 
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al., 2014; Yang et al., 2011).  Furthermore, neither of the empirical studies presented within 
this thesis accounted for the possibility of circadian influences.  
Environmental issues 
Given that the studies were performed in a sleep laboratory, a reverse first-night 
effect phenomenon may have been present. This might result in less psychological distress 
and greater sleep consolidation. Whether this influences HRV findings is yet to be tested 
(Hauri & Olmstead, 1989; Riedel, Winfield, & Lichstein, 2001). 
It is imperative that the theoretical limitations of HRV are also considered in 
relationship to the hyperarousal hypothesis. There are no time-domain measures that 
specifically represent sympathetic activity (Trinder, Waloszek, Woods, & Jordan, 2012). 
Additionally, there remains uncertainty surrounding the physiological interpretation of both 
LF (nu) and LF/HF (Billman, 2013), as physiological correlates of sympathetic activity. The 
only frequency-domain measure that can be confidently associated with autonomic activity 
is HF, which has been shown to be representative of parasympathetic activity (Malik, 1998; 
Malik et al., 1996). 
Thus, if the hyperarousal model is based upon the classical notion of an increase in 
sympathetic and concomitant decrease in parasympathetic activity, HRV alone cannot be 
used to support or refute this concept. This rather simplistic approach does not belie the 
complex interplay of parasympathetic and sympathetic activity that governs cardiac 
autonomic control. The possibility of synergistic, rather than antagonistic, activity between 
the parasympathetic and sympathetic branches of the autonomic nervous system has been 
largely ignored in the hyperarousal hypothesis of insomnia despite being previously 
suggested by Bernston (1993) that these divisions can act reciprocally, independently or 
coactively. Possibly, the use of more invasive autonomic surrogates, such as 
microneurography, or HRV in combination with other measures (impedance cardiography) 
would provide greater understanding of parasympathetic/sympathetic balance (Malik, 1998; 
Zygmunt & Stanczyk, 2010).  
Considering HRV within Spielman’s Three P model, it is unclear when exactly 
hyperarousal (with subsequent HRV alterations) develops. This poses the following 
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questions: Is hyperarousal present in patients who develop insomnia when in a pre-morbid 
(i.e. pre-insomnia) state? If that is the case, could higher baseline levels of hyperarousal act 
as a predisposing factor for insomnia? Supporting the notion of pre-morbid vulnerability, a 
recent meta-analysis of eight studies (n = 21, 988 participants) reported reduced SDNN in 
healthy people (without known cardiovascular disease) to be predictive of increased risk of 
a cardiovascular event (Hillebrand et al., 2013). On the contrary, is it only after development 
of chronic insomnia (with conditioned arousal) that second-order changes arise, marked by 
objective measures, such as HRV? It may be that HRV impairment is a correlate of the 
pathophysiological changes that develop due to chronic insomnia. An additional speculation 
is that the relationship between insomnia and impaired HRV has a bi-directional 
relationship.  
FUTURE RESEARCH 
HRV measurement is inexpensive, non-invasive, and easily attainable via routine 
PSG. However, a major caveat of easy data acquisition is the potential for research without 
clear intention and the subsequent data mining of the many HRV outputs (Ernst, 2014). In 
order to disentangle the associations between HRV and insomnia aetiology, hyperarousal, 
and cardiovascular disease, well-designed studies will be required. For this reason, 
recommendations for further insomnia-HRV research are provided below.   
Purposefully-selected participants  
Participant samples that are representative of clinical insomnia patients (such as was 
used in the current studies) are best suited to provide outcomes with immediate clinical 
relevance. However, studies including patients of narrow age ranges or single sex (see for 
example de Zambotti et al., 2014; de Zambotti et al., 2013; de Zambotti, Sugarbaker, 
Trinder, Colrain, & Baker, 2015; de Zambotti, Trinder, Colrain, & Baker, 2017) are better 
placed to understand underlying physiological mechanisms. All future insomnia-HRV 
research should endeavour to maximise patient sample size and include comparison 
between insomnia patient subtypes and also, to well-matched, good sleeping controls.  
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24-hour recordings 
The duration of HRV recordings in the field of sleep research is generally dictated by 
PSG length. This creates a predicament as a six to eight hour recording cannot be classified 
as short-term or long-term for HRV purposes, despite the fact that specific HRV measures 
are best suited to certain recording durations (e.g. time domain measures are best suited 
for use with 24-hour recordings) (Malik, 1998; Malik et al., 1996). Long-term ECG recordings 
are necessary for insomnia-HRV research and would improve the accuracy and external 
validity of future studies. Ideally, 24-hour HRV recordings would be sampled chronologically 
from insomnia patients to determine if cardiac autonomic activity changes with insomnia 
duration. This would address allostatic load which may present in insomnia patients and 
explain the development of co-morbid chronic disease (Chen, Redline, Shields, Williams, & 
Williams, 2014). HRV recordings from ambulatory monitoring would have the additional 
advantage of circumventing any confounding effect of the sleep laboratory.  
The possibility also remains that there may be differences in insomnia patient 
subtypes during specific sleep stages and/or cycles. As this has been the first comparison of 
insomnia subtypes, studies powered to detect differences during sleep stages, would 
provide evidence of the effect of sleep state on HRV.  
Collaboration with neuroscience  
Further exploration of the interaction and relationship between physiological and 
cortical activity has begun (Cervena et al., 2014; Jurysta et al., 2009; Maes et al., 2014; Wei 
et al., 2016) and is likely to be the direction of future studies. For example, emerging 
research has investigated the HRV and quantitative EEG coherence in insomnia patients at 
different times of the night (Jurysta et al., 2009) whilst others have investigated cerebral 
cortical response to changes to heart beat in insomnia patients, probing for the presence of 
increased ‘interoceptive sensitivity’ (Wei et al., 2016). Such research may provide a deeper 
understanding of the pathophysiology of Insomnia Disorder and differences in patient 
subtypes (if present).  
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HRV guidelines for sleep research  
Guidelines for HRV use within the field of sleep research are required, and should 
follow the lead of Quintana, Alvares, and Heathers (2016) who recently published HRV 
recommendations for use in psychiatry. Consensus on how to handle technical artifact (from 
the PSG), arousals from sleep, the analysis of HRV during differing sleep stages and cycles, 
varied recording lengths, and comorbid sleep conditions (such as insomnia and obstructive 
sleep apnoea) would undoubtedly be of use for all sleep researchers when designing, 
analyzing, and reporting future studies.  
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Appendix A: Supplemental Material for Chapter 3 
 
Table S1—Re-formed agglomeration table of cluster coefficients used to demark the optimal number of clusters 
through the change in coefficients as clustering increases.  
No. clusters Agglomeration last step Coefficients this step Change 
2 285.000 182.599 102.401 
3 182.599 125.046 57.553 
4 125.046 87.826 37.220 
5 87.826 74.546 13.280 
6 74.546 61.930 12.616 
7 61.930 53.753 8.177 
After 3 clusters, successive clustering adds little to distinguishing between cases. The dotted line denotes the 
demarcation point (at a 3-cluster solution). 
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Table S2—Demographic, sleep parameters (used to cluster individuals) and clinical information between insomnia subgroups in the exploratory 3-cluster 
solution. 
  Effect size (d, r) 
Mean 
(+/- SD) 
Overall  
(N=96) 
I-NSD Cluster 
(N=53) 
I-SSD A Cluster  
(N=29) 
I-SSD B Cluster 
(N=14) ANOVA F (p) 
I-NSD vs.  
I-SSD A 
I-NSD vs.  
I-SSD B 
I-SSD A vs. 
I-SSD B 
Age (y), mean (SD), range 41.4 (11.8), 
23-75 
38.6 (11.6), 
23-66 
46.0 (10.8),  
23-75 
42.3 (12.3),  
26-60 
3.99 (.022)* 0.66 0.31 0.33 
BMI (kg/m2) 25.0 (4.3) 24.7 (4.2) 25.0 (3.5) 26.4 (6.0) 0.87 (.449) 0.08 0.33 0.29 
Total Sleep Time (mins) 346.1 (67.8) 392.3 (35.4) 286.1 (59.2) 295.6 (57.8) 63.86 (<.001)** 2.18 2.02 0.16 
Sleep Onset Latency (mins) 25.3 (23.9) 18.0 (11.7) 16.4 (11.1) 71.5 (26.0) 28.86a (<.001)** 0.14 2.65 2.76 
Wake-time After Sleep Onset (mins) 72.5 (58.6) 39.9 (22.6) 129.3 (67.5) 78.0 (40.7) 27.53a (<.001)** 1.78 1.16 0.92 
ISI  17.3 (4.8) 18.0 (4.0) 16.1 (5.8) 17.5 (5.0) 1.54 (.220) 0.38 0.11 0.26 
Insomnia duration (y) 10 (11) 10 (10) 10 (13) 8 (15) 0.04b (.980) 0.01 0.03 0.03 
DASS - Depression 6 (12) 6 (12) 4 (10) 5 (10) 0.72b (.697) 0.09 0.00 0.00 
DASS - Anxiety 4 (6) 4 (7) 4 (6) 6 (7) 0.75b (.689) 0.16 0.01 0.01 
DASS - Stress 15.3 (9.0) 15.8 (8.3) 13.6 (9.3) 16.7 (11.2) 0.71 (.496) 0.25 0.09 0.30 
ESS 6.4 (4.5) 6.2 (4.5) 7.2 (4.5) 5.8 (4.4) 0.64 (.530) 0.22 0.09 0.31 
FFS 18.0 (6.4) 18.4 (6.2) 17.3 (6.9) 17.9 (6.4) 0.26 (.774) 0.17 0.08 0.09 
FIRST 24.0 (6.1) 24.3 (5.9) 23.3 (6.3) 24.4 (6.9) 0.28 (.750) 0.16 0.02 0.17 
DBAS 6.1 (1.7) 6.2 (1.4) 5.8 (1.9) 6.1 (2.2) 0.55 (.580) 0.24 0.05 0.15 
Pre-sleep DISS - Alert cognition 52.2 (16.0) 52.0 (16.7) 53.3 (15.7) 50.5 (14.6) 0.15 (.865) 0.08 0.10 0.18 
Pre-sleep DISS - Negative mood 27.9 (17.0) 27.7 (16.4) 26.1 (16.8) 32.4 (19.7) 0.65 (.525) 0.10 0.26 0.34 
Pre-sleep DISS - Positive mood 46.0 (12.8) 47.2 (13.4) 44.8 (13.0) 43.8 (9.7) 0.56 (.574) 0.18 0.29 0.09 
Pre-sleep DISS - Sleepiness / fatigue 54.7 (17.7) 55.6 (17.8) 53.5 (19.0) 53.7 (15.3) 0.16 (.855) 0.11 0.11 0.01 
AHI 3.1 (5.7) 2.8 (5.1) 3.7 (8.5) 3.3 (6.2) 2.45b (.293) 0.17 0.06 0.13 
Evening systolic blood pressure (mmHg) 115.3 (14.3) 115.4 (15.9) 115.9 (13.1) 114.0 (10.8) 0.08 (.920) 0.03 0.10 0.16 
Evening diastolic blood pressure (mmHg) 74.5 (9.4) 74.6 (9.5) 74.0 (8.8) 74.7 (11.0) 0.04 (.959) 0.07 0.01 0.07 
Morning systolic blood pressure (mmHg) 107.0 (13.5) 106.0 (14.8) 107.5 (11.2) 109.4 (13.5) 0.39 (.678) 0.11 0.24 0.15 
Morning diastolic blood pressure (mmHg) 71.0 (9.1) 69.8 (8.9) 72.0 (9.1) 73.4 (9.4) 1.09 (.341) 0.24 0.39 0.15 
Number of alcoholic drinks per week 
(standard units) 
4.0 (6) 4.0 (5) 4.0 (8) 2.0 (7) 1.94b (.380) 0.01 0.17 0.17 
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Binary Variables N (%) N (%) N (%) N (%) X2 (p) Effect size (V) 
Sex (f) 61 (63.5%) 36 (67.9%) 15 (51.7%) 10 (71.4%) 2.56 (.278) 0.16 0.03 0.19 
Insomnia as a child (y) 16 (16.7%) 10 (18.9%) 2 (6.9%) 4 (28.6%) 3.41c (.206) 0.17 0.09 0.28 
Family history  28 (29.2%) 17 (32.1%) 9 (31.0%) 2 (14.3%) 0.25c (.955) 0.03 0.02 0.05 
Education, highest attained          
High school 12 (12.5%) 8 (15.1%) 2 (6.9%) 2 (14.3%) 0.98c (.685) 0.11 0.02 0.11 
College graduate 47 (49.0%) 22 (41.5%) 14 (48.3%) 11 (78.6%) 5.59 (.061) 0.09 0.29 0.24 
Post graduate 32 (33.3%) 21 (39.6%) 10 (34.5%) 1 (7.1%) 6.12c (.048)* 0.03 0.30 0.34 
Ethnicity          
Central South Asian 4 (4.2%) 3 (5.7%) 1 (3.4%) 0 (0%) 0.97c (1.00) 0.05 0.11 0.11 
East Asian 1 (1.0%) 1 (1.9%) 0 (0%) 0 (0%) 0.84c (1.00) 0.08 0.06 . 
South East Asian 2 (2.1%) 1 (1.9%) 1 (3.4%) 0 (0%) 0.56c (1.00) 0.05 0.06 0.11 
White Caucasian 88 (91.7%) 47 (88.7%) 27 (93.1%) 14 (100%) 1.51c (.758) 0.05 0.15 0.15 
Employment          
Full-time 65 (67.7%) 40 (75.5%) 17 (58.6%) 8 (57.1%) 2.28 (.327) 0.15 0.14 0.01 
Part-time 16 (16.7%) 8 (15.1%) 5 (17.2%) 3 (21.4%) 0.46c (.799) 0.04 0.08 0.05 
Unemployed 11 (11.5%) 4 (7.5%) 5 (17.2%) 2 (14.3%) 2.44c (.320) 0.16 0.11 0.04 
Medical Comorbidities  35 (36.5%) 15 (28.3%) 15 (51.7%) 5 (35.7%) 4.02 (.134) 0.23 0.05 0.17 
Mild-to-moderate depression/anxiety 
 
11 (11.5%) 5 (9.4%) 3 (10.3%) 3 (21.4%) 4.00c (.141) 0.15 0.34 0.48 
Heart disease  0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (.) . . . 
Cancer  0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (.) . . . 
High blood pressure  1 (1.0%) 1 (1.9%) 0 (0%) 0 (0%) 1.78c (1.00) 0.19 0.12 . 
Neurologic  0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (.) . . . 
Breathing  8 (8.3%) 5 (9.4%) 2 (6.9%) 1 (7.1%) 1.81c (.473) 0.24 0.07 0.13 
Urinary  1 (1.0%) 1 (1.9%) 0 (0%) 0 (0%) 1.80c (1.00) 0.19 0.12 . 
Diabetes  1 (1.0%) 0 (0%) 0 (0%) 1 (7.1%) 4.41c (.118) . 0.46 0.46 
Chronic pain  8 (8.3%) 3 (5.7%) 5 (17.2%) 0 (0%) 1.65c (.624) 0.15 0.22 0.31 
Gastrointestinal  6 (6.3%) 1 (1.9%) 1 (3.4%) 0 (0%) 0.66c (1.00) 0.00 0.12 0.12 
Thyroid  3 (3.1%) 1 (1.9%) 2 (6.9%) 0 (0%) 0.76c (1.00) 0.11 0.12 0.18 
Other  11 (11.5%) 5 (9.4%) 5 (17.2%) 1 (7.1%) 0.23c (1.00) 0.00 0.07 0.07 
Current smoker  8 (8.3%) 4 (7.5%) 3 (10.3%) 1 (7.1%) 0.39c (.878) 0.05 0.08 0.05 
Past smoker  29 (30.2%) 11 (20.8%) 13 (44.8%) 5 (35.7%) 5.13 (.075) 0.25 0.14 0.09 
Never smoked  58 (60.4%) 37 (69.8%) 13 (44.8%) 8 (57.1%) 5.53 (.115) 0.26 0.12 0.12 
Medication  49 (51.0%) 23 (43.4%) 17 (58.6%) 9 (64.3%) 2.37 (.317) 0.14 0.15 0.04 
Prescription sleep aid  9 (9.4%) 6 (11.3%) 3 (10.3%) 0 (0%) 2.67c (.378) 0.10 0.29 0.25 
Over the counter sleep aid  2 (2.1%) 0 (0%) 2 (6.9%) 0 (0%) 2.82c (.266) 0.27 . 0.20 
Prescription psychiatric medication 5 (5.2%) 3 (5.7%) 1 (3.4%) 1 (7.1%) 0.81c (.839) 0.12 0.01 0.11 
Other medication  31 (32.3%) 13 (24.5%) 11 (37.9%) 7 (50%) 2.35c (.312) 0.08 0.28 0.24 
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Means, standard deviations and effect size (Cohen's d, r for variables not normally distributed or Cramér's V for binary variables) for each cluster comparison are 
provided. a Welch’s statistic correction for violation of homoscedasticity. b Kruskal-Wallis test with median (inter-quartile range) for variables not normally 
distributed. c Fisher’s exact test correction for cells with n<5. Significant effects are in bold. Neurologic disorders (seizures, Parkinson's disease), Breathing 
disorders (asthma, emphysema), Urinary disorders (kidney disease, prostate problems), Chronic pain (arthritis, back pain, gout, migraines) and Gastrointestinal 
complaints (stomach, irritable bowel syndrome, ulcers). AHI: Apnea Hypopnea Index; ANOVA: analysis of variance; DASS: Depression, Anxiety, and Stress scales; 
DBAS: Dysfunctional Beliefs and Attitudes about Sleep scale; DISS: Daytime Insomnia Symptom Scale; ESS: Epworth sleepiness scale; FFS: Flinders Fatigue Scale; 
FIRST: Ford Insomnia Response to Stress Test; I-NSD: Insomnia with Normal Sleep Duration; I-SSD A: Insomnia with Short Sleep Duration type-A; I-SSD B: 
Insomnia with Short Sleep Duration type-B. * = p <.05. ** = p<.001. 
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Figure S1—Quantitative analysis of sleep-EEG spectra during sleep onset at C4. 
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Quantitative EEG analysis of Mean (SE) Delta (0.5-4.5 Hz), Theta (4.5-8 Hz), Alpha (8-12 Hz), Sigma (12-15 Hz), Beta-1 (16-
24 Hz) and Beta-2 (16-32 Hz) frequency bands (Ln Absolute Power adjusted for age and gender) for 10 minutes before-
to-after American Academy of Sleep Medicine (AASM) defined sleep onset. I-NSD: Insomnia with Normal Sleep Duration; 
I-SSD: Insomnia with Short Sleep Duration; I-SSD A: Insomnia with Short Sleep Duration type-A; I-SSD B: Insomnia with 
Short Sleep Duration type-B. * = p <.05. 
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Appendix B: Heart Rate Variability (HRV) analysis using the PRANA® 
(Polygraphic Recording Analyser) software suite 
 
 
HRV analysis using PRANA, Standard Operating Procedure, Version 11, 4 November 2016, page 1 
 
 
STANDARD OPERATING PROCEDURE (SOP) 
Heart Rate Variability (HRV) analysis using the PRANA® (Polygraphic Recording Analyser) software suite 
 
Created by: Kirsty Dodds  
Date created: April 2016 
SOP Version:  11 
Last amended: November 2016 
Applicable to: Woolcock Institute of Medical Research 
 
EQUIPMENT 
Hardware  
 64 bit Computer 
 Wide monitor 
 Mouse 
 PRANA dongle [must be plugged into computer for HRV plug-in to work] 
 
Software  
 PRANA software, version 12.06.20 
 
 
Figure 1. Software licence 
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FOLDER AND FILE NOMENCLATURE (see page 21 of PRANA User Manual for further details) 
Use Setup tab in PRANA manager to arrange PRANA folders prior to your analysis.  
Folders must exist within the computer’s PRANA folder (or, if desired, on the network drive) before using setup tab in 
the PRANA manager to map file location. 
Once these folders have been created for your specific project, do not change any folder names as this can affect the 
software’s availability to locate the correct files at a later date. 
 
Record folder 
Contains EDFs and text files 
Report folder 
Contains analysis reports,  
e.g. event mark reports (evt.*.xls), analysis trend reports (pra.*.xls), and sleep score reports (hpn.*.xls) 
Result folder 
Contains all the analysis files created using the software plug-ins that can be read by the profiler program, 
e.g. PRANA Heart Rate Variables (channel.*.hrv files) and PRANA Spectral Power Array (channel.*.spc files) 
Session folder  
Session files (data that PRANA creates that creates information with full name of recording file, montage and 
settings associated with that session), 
e.g. continuous (.cnt) and sequential (.spi) files directly loaded by the software  
Can be used to open an already existing session 
Has same content as PRANA Manager 
Setting 
Used to store the plug-in settings, montage and calibration files. They may be edited, saved and loaded during 
reviewing and analysis sessions.  
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PROCEDURE 
Open file  
Ensure that the text file is present in the same folder and named the same as the sleep study as this will be required 
for sleep staging information and the generation of the hypnogram. 
Open EDF from personal/shared drive on computer 
Click Session  Save 
Click Ok, then Yes 
 
Configure montage  
HRV analysis in PRANA uses some contextual information derived from other channels, i.e. EMG and EEG for 
automated artefact detection. These channels and their position on screen can be edited as below. In order to allow 
batch processing, a common set of settings is required. 
Click Review  Montage  Settings 
To set up quantified montage, deselect Position checkbox (top left corner) to eliminate all channels and then select: 
1. C3 (change to position 2), click on trace, change amplitude to -100 to 100mV so that it doesn’t interfere with 
the ECG channel. Click on trend panel and check that the selected amplitude range is appropriate at other 
times throughout evening, adjust amplitude accordingly. 
Click Next >> 
Deselect Position checkbox (top left corner) to eliminate all channels and then select: 
2. ECG (change to position 1), click on trace, change amplitude to -1 to 1mV.  
3. EMG (change to position 3), click on trace, change amplitude to -100 to 100mV so that it doesn’t interfere 
with the ECG channel. 
If ECG trace is inverted, change amplitude to +1mv to -1mV. 
Continue to click Next >> and deselect Position checkbox (top left corner) to eliminate all remaining channels 
Click Ok  
Click Session  Save As 
Rename file with extension _HRV 
Click Ok, then Yes 
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Set-up HRV analysis parameters  
To enable clear visualisation of the ECG 
Ensure window is full-screen  
To change HRV settings 
Click Analysis  Heart-Rate Variability 
Check Heartbeat detection and Interbeat interval analysis settings 
Ensure Control checkboxes are unchecked 
Control is purely for graphical display (visualisation) of the heart rate detection (for each epoch) and for graphical 
display of the interbeat interval analysis (again, for each epoch). This doesn’t change the algorithm or analysis 
output. 
Ensure Supervise checkbox is checked 
This will instruct the plugin to automatically launch event supervision right before the execution of interbeat interval 
analysis. The usefulness of this is that the current supervision will process all of the event markers or artefacts that 
have been automatically detected or manually marked on the signal and apply a set of settings that you can visualise 
in the [Event  Setting] window for each type of event there is a set of supervision attributes which are applied when 
you check the supervise checkbox in the HRV analysis window before you perform the interbeat interval analysis e.g.  
the merging of two overlapping but separately marked artifacts. 
Click Close 
To change the length of epoch (not recommended as 30 second windows correlate with sleep staging epochs) 
Analysis  Heart-Rate Variability 
Change Window length (1200s = 5 minute windows when using a 75% overlap) 
 
Perform analysis 
Run analysis for artifact detection and heart-rate variability analysis. 
Plug-ins  Launcher  using the Ctrl key select Artifact Detection and Heart-Rate Variability Analysis from Selected 
Plug-ins window. See Fig. 1 below. 
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Figure 2. Use of the PRANA Plug-in Launcher 
Click Run 
 This will take approximately 20 minutes depending on the processing speed of the computer that is being used. 
Click Close 
Generate trend report (automatic analysis) and save. This will enable you to compare the results before and after 
editing of the ECG. 
Click Reports  Trend Report Generator 
Results (downwards arrow)  HRV-parameters 
Click Styles  State reports 
Click ok 
Copy data from text file 
Open Excel and paste data 
Save Excel spreadsheet 
Close WordPad and Excel 
To change what is on the trend reports, alter the setup of the Trend Report Generator in the Plug-in settings. 
 
Visually inspect ECG and HRV 
Use trend panel to show results of HRV analysis 
Right click trends panel  Arrays  HRV spectral array (.spc) 
Right click trends panel  Features  ECG  HR variability, see Fig. 2 below 
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Figure 3. Configuring the trends panel 
 
Visualise and edit heart-beat detection 
To change the label for markers (e.g. Ectopic Beats) 
This will make it more distinct from the R wave markers. The hot keys can also be changed under settings. Note that 
the hot keys are case sensitive. 
Click Event Settings Markers  Ectopic Beat  Choose Mark (square) and Colour (hot pink)  Ok 
 
To edit the RR interval 
Click Event  Start 
Look at epoch 
Insert a missing R-wave peak marker by maintaining the shift key pressed and mouse-clicking on the peak of a 
visually identified R-wave that has been missed by automated detection. 
Delete an erroneous R-wave peak by selecting the corresponding marker by mouse-click and then pressing the Del 
key. 
Highlight artifact. Click on highlighted segment, use keyboard to type “X” and then use the arrow keys to position. 
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Artifact is any signal noise that prevents viewing a discernible R wave OR a beat that has not been preceded by a p 
wave (deeming it to be of sinus origin). 
Press Enter after any edits to save changes 
Check the edits by clicking on first R wave peak marker present in the viewing pane and using the right sideways 
arrow in Event viewer to check each beat 
When satisfied with ECG, save the file 
Click Session  Save  OK 
Progress to next epoch and repeat until entire recording has been reviewed 
 
Re-run Interbeat interval analysis 
Click Analysis Heart-Rate Variability 
Deselect heartbeat detection  
Click OK  Run 
 
Save outputs 
For visualisation  
Tools  Profiler 
For time series results 
Session  Export  Results 
Select file Type – PRANA Heart-rate Features (file ending in .hrv) 
Double click on desired file 
Choose export location 
Click Ok 
Copy data from text file 
Open Excel and paste data 
Save spreadsheet 
Close WordPad and Excel 
The default setting will give output in 30 second epochs 
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For sleep stages or sleep cycle results 
Reports  Trend Report Generator 
Results (downwards arrow)  HRV-parameters 
Styles  State reports 
Click Ok 
Open Wordpad 
Copy data from text file 
Open Excel and paste data 
Save spreadsheet 
Close WordPad and Excel 
To change what is on the trend reports, alter the setup of the Trend Report Generator in the Plug-in settings. Note 
that all outputs will also be on PRANAs folder of C drive. 
 
Change outputs 
Open Profiler 
Click Settings  Configure 
Select desired HRV measure 
Click Add 
Use arrows to position HRV measure accordingly (this position will be reflected in the data output) 
 
Analysing outputs 
25 HRV measures are available.  
The following analysis times may be most beneficial: 
 Scoring: All. This is commonly referred to as Time In Bed (lights off to lights on time) 
 Scoring: Wake 
 Scoring: N1 
 Scoring: N2 
 Scoring: N3 
 Scoring: R 
 Scoring: N2-N3 is classic NREM (N2 is not typically reported) 
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Determine/gauge amount of artifact 
Method #1  
Analysis  Event series  ECG.des  Artifact rate  Generate report 
This calculates the Event Temporal Density – the number of events per minute of each event type – as a result file 
that can then be exported 
Method #2 
Tools  Profiler  ECG.des  Artifact occurrence or rate  Generate report 
 
Ensure manual edits incorporated 
Compare trend reports before and after manual ECG editing 
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PRANA HRV Training with EGI 
Written by Florian Chapiot, software developer 
Perform time-varying HRV analysis 
PRANA has a dedicated software plug-in featuring a state-of-the-art HRV analysis for long-term recordings including 
an ECG signal. In contrast with other analysis packages designed for the analysis of short ECG recording sections 
(such as the traditional 5-min effort/resting test), PRANA offers a streamlined HRV analysis of consecutive ECG 
segments from fullnight or 24-h PSG recordings and provide all the analysis results as time series. 
The algorithms used in this software plug-in are fully configurable through a graphical user interface and come with 
default settings selected for the analysis of standard human PSG recordings.  
The HRV analysis is performed in multiple steps. First, the R-wave peaks are automatically detected. As an option, 
the result of automated R-wave detection can be manually edited. Finally, the resulting R-R intervals are analyzed 
resulting in a set of time- and frequency-domain parameters. All the resulting time series from HRV analysis can then 
be used with the software Export tools, the Trend Report Generators and the Profiler Time Series tools for 
visualization and further processing. 
Automated heartbeat detection 
Erroneous R-wave detections may result from an ECG signal contaminated by various kind of artifacts (motion, 
myographic activity, sensor detachment, etc.). Several available options may improve the R-wave detection: 
 ECG signal filtering, 
 ECG signal resampling to improve time accuracy, 
 Different detection algorithms (R-wave peak default, QRS-complex centroid), 
 Selection of time window duration to speed up detection (30-sec default), 
 Adjustable heartbeat characteristics for support of multiple species (human default, rodents, etc.), 
 Automated detection of artifacts present in the recorded ECG signal (through the Artifact detection plug-in). 
Depending on the ECG signal quality and following the Cardiology Task Force  recommendations (Circulation 1996), a 
manual inspection/editing of automatically detected R-waves, may be necessary prior to the analysis of the interbeat 
intervals. 
Manual editing of the heartbeat detection results 
After an automated detection, the resulting heartbeat are displayed directly on the ECG signal in the Traces panel of 
the Reviewer. These markers can be edited by activating the Reviewer Marking mode (Start pushbutton in the Event 
panel of the Reviewer Toolbar). With the automatic event type marking option selected, the following marking 
actions are possible: 
 Inserting an additional R-wave peak marker by maintaing the shift key pressed and mouse-clicking on the 
peak of a visually identified R-wave that has been missed by automated detection, 
 Deleting an R-wave peak erroneously detected by selecting the corresponding marker by mouse-click and 
then pressing the Del key, 
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 Marking an ECG signal artifact by mouse-clicking, dragging and dropping over the corresponding signal 
segment. If the resulting event is not of the artifact type, select it using the mouse and press the Shift + x 
keys to change its type to an artifact. 
It is important not to re-run an automated heartbeat detection after manual editing as all manually edited R-wave 
peak markers would be deleted by doing so. 
After a manual editing of the markers and artifacts on the ECG signal, the interbeat interval analysis needs to be 
carried out so that the results of manual editing are taken into account.  
Interbeat interval analysis 
Optimized for the analysis of PSG recordings usually scored for sleep stages into 30-sec epochs, the interbeat interval 
analysis of the PRANA HRV analysis plug-in is by default carried out on the whole scoring time range using 
consecutive 2-min epochs with a 75% overlap, which results in a time resolution identical to that of sleep stage 
scoring. This facilitates further merging and stage-wise sorting of the HRV time- and frequency-domain parameters 
obtained from HRV analysis. 
Prior to the actual analysis of the interbeat intervals, the software plug-in scans the existing R-wave peak markers to 
identify events such as ectopic and missing beats, and sequences of tachycardia and bradycardia, according to 
certain user -selectable criteria. Prior to the interbeat interval analysis, ectopic beats identified from the existing R-
wave peak markers are discarded from the R-R interval series in order to deduce the corresponding N-N (normal-to-
normal) interval series, which is actually processed for time-and frequency-domain analysis.  
In a similar way, and if the corresponding option is selected, R-R intervals overlapping with contaminated segments 
of ECG signal marked as an artifact, either by automated detection or manual editing, are also discarded prior to the 
N-N interval analysis. 
Then, the actual N-N interval analysis is carried out on all consecutive time-epochs included in the recording under 
analysis.  
Time-domain parameters are extracted directly for each consecutive epoch of the clean N-N interval series.  
Except when the Lomb-Scargle method is selected (method designed for the analysis of irregularly-sampled series), 
frequency-domain analysis includes a further resampling (at 10 Hz by default) of the N-N interval series prior to the 
estimate of its frequency spectrum using various user-selectable methods (DFT default, Welch, etc.). 
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